="" Omics of Covid-19 disease – coViki

Omics of Covid-19 disease

(Unterschied zwischen Versionen)
Wechseln zu: Navigation, Suche
Zeile 798: Zeile 798:
 
{{tp|p=35284913|t=2022. Th1, Th2 and Th17 inflammatory pathways synergistically predict cardiometabolic protein expression in serum of COVID-19 patients.|pdf=|usr=}}
 
{{tp|p=35284913|t=2022. Th1, Th2 and Th17 inflammatory pathways synergistically predict cardiometabolic protein expression in serum of COVID-19 patients.|pdf=|usr=}}
 
{{tp|p=33683246|t=2021. A novel multi-omics-based highly accurate prediction of symptoms, comorbid conditions, and possible long-term complications of COVID-19.|pdf=|usr=}}
 
{{tp|p=33683246|t=2021. A novel multi-omics-based highly accurate prediction of symptoms, comorbid conditions, and possible long-term complications of COVID-19.|pdf=|usr=}}
 +
{{tp|p=32199615|t=2020. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses.|pdf=|usr=}}
 +
{{tp|p=35235083|t=2022. Identification of the Hub Genes and the Signaling Pathways in Human iPSC-Cardiomyocytes Infected by SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=34787756|t=2022. Identification of Key Pathways and Genes in SARS-CoV-2 Infecting Human Intestines by Bioinformatics Analysis.|pdf=|usr=}}
 +
{{tp|p=33367597|t=2021. Structure and regulation of coronavirus genomes: state-of-the-art and novel insights from SARS-CoV-2 studies.|pdf=|usr=}}
 +
{{tp|p=33040727|t=2020. Transcription Factor Nrf2 as a Potential Therapeutic Target for Prevention of Cytokine Storm in COVID-19 Patients.|pdf=|usr=}}
 +
{{tp|p=34920080|t=2022. The spike protein of SARS-CoV-2 induces heme oxygenase-1: Pathophysiologic implications.|pdf=|usr=}}
 +
{{tp|p=32544429|t=2020. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach.|pdf=|usr=}}
 +
{{tp|p=34237472|t=2021. In silico analysis of the aggregation propensity of the SARS-CoV-2 proteome: Insight into possible cellular pathologies.|pdf=|usr=}}
 +
{{tp|p=33478554|t=2021. Mechanistic modeling of the SARS-CoV-2 disease map.|pdf=|usr=}}
 +
{{tp|p=34220199|t=2021. Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins.|pdf=|usr=}}
 +
{{tp|p=34014278|t=2021. 3DBionotes COVID-19 Edition.|pdf=|usr=}}
 +
{{tp|p=33693506|t=2021. COVID-19: disease pathways and gene expression changes predict methylprednisolone can improve outcome in severe cases.|pdf=|usr=}}
 +
{{tp|p=33017003|t=2021. VIRTUS: a pipeline for comprehensive virus analysis from conventional RNA-seq data.|pdf=|usr=}}
 +
{{tp|p=34289024|t=2021. SPOT: a web-tool enabling swift profiling of transcriptomes.|pdf=|usr=}}
 +
{{tp|p=32805023|t=2021. Mechanistic insights into SARS-CoV-2 epidemic via revealing the features of SARS-CoV-2 coding proteins and host responses upon its infection.|pdf=|usr=}}
 +
{{tp|p=33244583|t=2021. Novel SARS-CoV-2 encoded small RNAs in the passage to humans.|pdf=|usr=}}
 +
{{tp|p=32374823|t=2020. COVID-2019-associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak.|pdf=|usr=}}
 +
{{tp|p=33618659|t=2021. Effects of Cell Proteostasis Network on the Survival of SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=32754004|t=2020. Expansion of Single Cell Transcriptomics Data of SARS-CoV Infection in Human Bronchial Epithelial Cells to COVID-19.|pdf=|usr=}}
 +
{{tp|p=35205046|t=2022. Viral and Host Genetic and Epigenetic Biomarkers Related to SARS-CoV-2 Cell Entry, Infection Rate, and Disease Severity.|pdf=|usr=}}
 +
{{tp|p=34801852|t=2022. Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets.|pdf=|usr=}}
 +
{{tp|p=33655247|t=2021. A single-cell and spatial atlas of autopsy tissues reveals pathology and cellular targets of SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=32587961|t=2021. Transcriptogram analysis reveals relationship between viral titer and gene sets responses during Corona-virus infection.|pdf=|usr=}}
 +
{{tp|p=33655243|t=2021. The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.|pdf=|usr=}}
 +
{{tp|p=33655248|t=2021. An Autoantigen Profile of Human A549 Lung Cells Reveals Viral and Host Etiologic Molecular Attributes of Autoimmunity in COVID-19.|pdf=|usr=}}
 +
{{tp|p=33619490|t=2021. Association of CXCR6 with COVID-19 severity: Delineating the host genetic factors in transcriptomic regulation.|pdf=|usr=}}
 +
{{tp|p=33619478|t=2021. The Host Interactome of Spike Expands the Tropism of SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=33594364|t=2021. Bifurcated monocyte states are predictive of mortality in severe COVID-19.|pdf=|usr=}}
 +
{{tp|p=33594362|t=2021. Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19.|pdf=|usr=}}
 +
{{tp|p=34845446|t=2021. Systematic temporal analysis of peripheral blood transcriptomes using TrendCatcher identifies early and persistent neutrophil activation as a hallmark of severe COVID-19.|pdf=|usr=}}
 +
{{tp|p=34845452|t=2021. Genome-wide characterization of SARS-CoV-2 cytopathogenic proteins in the search of antiviral targets.|pdf=|usr=}}
 +
{{tp|p=34931188|t=2021. SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-beta signaling.|pdf=|usr=}}
 +
{{tp|p=34075382|t=2021. CovidExpress: an interactive portal for intuitive investigation on SARS-CoV-2 related transcriptomes.|pdf=|usr=}}
 +
{{tp|p=34373855|t=2021. A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases.|pdf=|usr=}}
 +
{{tp|p=34462747|t=2021. Woodsmoke particulates alter expression of antiviral host response genes in human nasal epithelial cells infected with SARS-CoV-2 in a sex-dependent manner.|pdf=|usr=}}
 +
{{tp|p=33532779|t=2021. Genome-scale metabolic modeling reveals SARS-CoV-2-induced metabolic changes and antiviral targets.|pdf=|usr=}}
 +
{{tp|p=34075380|t=2021. Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence.|pdf=|usr=}}
 +
{{tp|p=33851168|t=2021. An Autoantigen-ome from HS-Sultan B-Lymphoblasts Offers a Molecular Map for Investigating Autoimmune Sequelae of COVID-19.|pdf=|usr=}}
 +
{{tp|p=33907748|t=2021. Rapid decay of host basal mRNAs during SARS-CoV-2 infection perturbs host antiviral mRNA biogenesis and export.|pdf=|usr=}}
 +
{{tp|p=32676599|t=2020. Role of SARS-CoV-2 in altering the RNA binding protein and miRNA directed post-transcriptional regulatory networks in humans.|pdf=|usr=}}
 +
{{tp|p=32908980|t=2020. Induction of a regulatory myeloid program in bacterial sepsis and severe COVID-19.|pdf=|usr=}}
 +
{{tp|p=32935098|t=2020. Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors.|pdf=|usr=}}
 +
{{tp|p=32511361|t=2020. The Host Cell ViroCheckpoint: Identification and Pharmacologic Targeting of Novel Mechanistic Determinants of Coronavirus-Mediated Hijacked Cell States.|pdf=|usr=}}
 +
{{tp|p=35317263|t=2022. Using bioinformatics and systems biology to discover common pathogenetic processes between sarcoidosis and COVID-19.|pdf=|usr=}}
 +
{{tp|p=34131597|t=2021. A bioinformatics approach for identifying potential molecular mechanisms and key genes involved in COVID-19 associated cardiac remodeling.|pdf=|usr=}}
 +
{{tp|p=33398248|t=2021. Computationally predicted SARS-COV-2 encoded microRNAs target NFKB, JAK/STAT and TGFB signaling pathways.|pdf=|usr=}}
 +
{{tp|p=33263093|t=2021. Gene expression profiling of corona virus microarray datasets to identify crucial targets in COVID-19 patients.|pdf=|usr=}}
 +
{{tp|p=33821222|t=2021. An overview of basic molecular biology of SARS-CoV-2 and current COVID-19 prevention strategies.|pdf=|usr=}}
 +
{{tp|p=34401607|t=2021. Systems level insights into the impact of airborne exposure on SARS-CoV-2 pathogenesis and COVID-19 outcome - A multi-omics big data study.|pdf=|usr=}}
 +
{{tp|p=32835133|t=2020. Phylogenomic proximity and comparative proteomic analysis of SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=33553808|t=2020. Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19.|pdf=|usr=}}
 +
{{tp|p=33093657|t=2021. Self-amplifying RNA vaccines for infectious diseases.|pdf=|usr=}}
 +
{{tp|p=35328087|t=2022. Identification of Genetic Risk Factors of Severe COVID-19 Using Extensive Phenotypic Data: A Proof-of-Concept Study in a Cohort of Russian Patients.|pdf=|usr=}}
 +
{{tp|p=35205390|t=2022. Conserved MicroRNAs in Human Nasopharynx Tissue Samples from Swabs Are Differentially Expressed in Response to SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=33809949|t=2021. A Resource for the Network Representation of Cell Perturbations Caused by SARS-CoV-2 Infection.|pdf=|usr=}}
 +
{{tp|p=34209818|t=2021. Toward a Coronavirus Knowledge Graph.|pdf=|usr=}}
 +
{{tp|p=34202032|t=2021. Direct Measurement of B Lymphocyte Gene Expression Biomarkers in Peripheral Blood Transcriptomics Enables Early Prediction of Vaccine Seroconversion.|pdf=|usr=}}
 +
{{tp|p=34440372|t=2021. Methylation of Host Genes Associated with Coronavirus Infection from Birth to 26 Years.|pdf=|usr=}}
 +
{{tp|p=33034007|t=2020. Combining fragment docking with graph theory to improve ligand docking for homology model structures.|pdf=|usr=}}
 +
{{tp|p=34940501|t=2021. Developmental Aspects of SARS-CoV-2, Potential Role of Exosomes and Their Impact on the Human Transcriptome.|pdf=|usr=}}
 +
{{tp|p=34669152|t=2022. Deciphering the link between Diabetes mellitus and SARS-CoV-2 infection through differential targeting of microRNAs in the human pancreas.|pdf=|usr=}}
 +
{{tp|p=34297037|t=2021. Epigenetic and transcriptional control of interferon-beta.|pdf=|usr=}}
 +
{{tp|p=34128960|t=2021. Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics.|pdf=|usr=}}
 +
{{tp|p=34128959|t=2021. Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19.|pdf=|usr=}}
 +
{{tp|p=34188786|t=2021. Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies.|pdf=|usr=}}
 +
{{tp|p=34193364|t=2022. Innate immune response analysis in COVID-19 and kawasaki disease reveals MIS-C predictors.|pdf=|usr=}}
 +
{{tp|p=35205926|t=2022. Molecular Profiling Reveals Characteristic and Decisive Signatures in Patients after Allogeneic Stem Cell Transplantation Suffering from Invasive Pulmonary Aspergillosis.|pdf=|usr=}}
 +
{{tp|p=35664804|t=2022. The Ramp Atlas: facilitating tissue and cell-specific ramp sequence analyses through an intuitive web interface.|pdf=|usr=}}
 +
{{tp|p=35664994|t=2022. Whole Genome DNA and RNA Sequencing of Whole Blood Elucidates the Genetic Architecture of Gene Expression Underlying a Wide Range of Diseases.|pdf=|usr=}}
 +
{{tp|p=35654986|t=2022. The impact of the suppression of highly connected protein interactions on the corona virus infection.|pdf=|usr=}}
 +
{{tp|p=34448623|t=2021. A Novel Pathway Network Analytics Method Based on Graph Theory.|pdf=|usr=}}
 +
{{tp|p=35060145|t=2022. Epigenetic modifications associated with genes implicated in cytokine storm: The potential biotherapeutic effects of vitamins and minerals in COVID-19.|pdf=|usr=}}
 +
{{tp|p=32643596|t=2020. A review on histotechnology practices in COVID-19 pathology investigations.|pdf=|usr=}}
 +
{{tp|p=34819389|t=2022. ORAI1 Limits SARS-CoV-2 Infection by Regulating Tonic Type I IFN Signaling.|pdf=|usr=}}
 +
{{tp|p=34452933|t=2021. Suppressive Monocytes Impair MAIT Cells Response via IL-10 in Patients with Severe COVID-19.|pdf=|usr=}}
 +
{{tp|p=35639922|t=2022. A distinct dexamethasone-dependent gene expression profile in the lungs of COVID-19 patients.|pdf=|usr=}}
 +
{{tp|p=34558746|t=2021. Dynamic changes in human single-cell transcriptional signatures during fatal sepsis.|pdf=|usr=}}
 +
{{tp|p=34931002|t=2022. Single-cell immunology of SARS-CoV-2 infection.|pdf=|usr=}}
 +
{{tp|p=32591762|t=2020. COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis.|pdf=|usr=}}
 +
{{tp|p=35410380|t=2022. Understanding COVID-19 through genome-wide association studies.|pdf=|usr=}}
 +
{{tp|p=35410379|t=2022. Expanded COVID-19 phenotype definitions reveal distinct patterns of genetic association and protective effects.|pdf=|usr=}}
 +
{{tp|p=33888907|t=2021. Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.|pdf=|usr=}}
 +
{{tp|p=35301508|t=2022. Type I interferon transcriptional network regulates expression of coinhibitory receptors in human T cells.|pdf=|usr=}}
 +
{{tp|p=34663977|t=2021. Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection.|pdf=|usr=}}
 +
{{tp|p=34155406|t=2021. SARS-CoV-2-specific hotspots in virus-host interaction networks.|pdf=|usr=}}
 +
{{tp|p=33277638|t=2021. Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison.|pdf=|usr=}}
 +
{{tp|p=32788748|t=2020. Single-cell landscape of immunological responses in patients with COVID-19.|pdf=|usr=}}
 +
{{tp|p=35177862|t=2022. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19.|pdf=|usr=}}
 +
{{tp|p=33654293|t=2021. Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics.|pdf=|usr=}}
 +
{{tp|p=33837377|t=2021. Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19.|pdf=|usr=}}
 +
{{tp|p=32812012|t=2020. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection.|pdf=|usr=}}
 +
{{tp|p=34158670|t=2021. A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19.|pdf=|usr=}}
 +
{{tp|p=34471255|t=2021. Cellular host factors for SARS-CoV-2 infection.|pdf=|usr=}}
 +
{{tp|p=35354968|t=2022. SARS-CoV-2 pathogenesis.|pdf=|usr=}}
 +
{{tp|p=35255492|t=2022. Whole-genome sequencing reveals host factors underlying critical COVID-19.|pdf=|usr=}}
 +
{{tp|p=33307546|t=2021. Genetic mechanisms of critical illness in COVID-19.|pdf=|usr=}}
 +
{{tp|p=33979833|t=2021. SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis.|pdf=|usr=}}
 +
{{tp|p=33845483|t=2021. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.|pdf=|usr=}}
 +
{{tp|p=32998156|t=2020. The major genetic risk factor for severe COVID-19 is inherited from Neanderthals.|pdf=|usr=}}
 +
{{tp|p=32272481|t=2020. Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors.|pdf=|usr=}}
 +
{{tp|p=32408336|t=2020. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets.|pdf=|usr=}}
 +
{{tp|p=35005991|t=2022. Mass Spectrometry-Based Proteomics Research to Fight COVID-19: An Expert Review on Hopes and Challenges.|pdf=|usr=}}
 +
{{tp|p=34678084|t=2021. Top Trends in Multiomics Research: Evaluation of 52 Published Studies and New Ways of Thinking Terminology and Visual Displays.|pdf=|usr=}}
 +
{{tp|p=34601771|t=2022. PDB-101: Educational resources supporting molecular explorations through biology and medicine.|pdf=|usr=}}
 +
{{tp|p=32960510|t=2020. Urinary Proteomics Associates with COVID-19 Severity: Pilot Proof-of-Principle Data and Design of a Multicentric Diagnostic Study.|pdf=|usr=}}
 +
{{tp|p=33141520|t=2020. Proteomic Biomarkers to Guide Stratification for Covid-19 Treatment: Exemplifying a Path Forward Toward Implementation?|pdf=|usr=}}
 +
{{tp|p=35490333|t=2022. Clinical applications of plasma proteomics and peptidomics: Towards precision medicine.|pdf=|usr=}}
 +
{{tp|p=32720461|t=2020. An overview of the immune mechanisms of viral myocarditis.|pdf=|usr=}}
 +
{{tp|p=34995097|t=2022. Innate immunological pathways in COVID-19 pathogenesis.|pdf=|usr=}}
 +
{{tp|p=35148199|t=2022. SLAMF7 engagement superactivates macrophages in acute and chronic inflammation.|pdf=|usr=}}
 +
{{tp|p=35412852|t=2022. SARS-CoV-2 spike protein-induced cell fusion activates the cGAS-STING pathway and the interferon response.|pdf=|usr=}}
 +
{{tp|p=34698500|t=2022. Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort.|pdf=|usr=}}
 +
{{tp|p=35052382|t=2021. Detection of A-to-I RNA Editing in SARS-COV-2.|pdf=|usr=}}
 +
{{tp|p=33916492|t=2021. Genotyping of the Major SARS-CoV-2 Clade by Short-Amplicon High-Resolution Melting (SA-HRM) Analysis.|pdf=|usr=}}
 +
{{tp|p=33923155|t=2021. Investigating Cellular Trajectories in the Severity of COVID-19 and Their Transcriptional Programs Using Machine Learning Approaches.|pdf=|usr=}}
 +
{{tp|p=33207533|t=2020. Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs.|pdf=|usr=}}
 +
{{tp|p=32646047|t=2020. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.|pdf=|usr=}}
 +
{{tp|p=33271804|t=2020. Transcriptional Differences for COVID-19 Disease Map Genes between Males and Females Indicate a Different Basal Immunophenotype Relevant to the Disease.|pdf=|usr=}}
 +
{{tp|p=34168039|t=2021. Targeting the m(6)A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication.|pdf=|usr=}}
 +
{{tp|p=33521209|t=2022. Immune characteristics analysis reveals two key inflammatory factors correlated to the expressions of SARS-CoV-2 S1-specific antibodies.|pdf=|usr=}}
 +
{{tp|p=34565757|t=2021. AI for the collective analysis of a massive number of genome sequences: various examples from the small genome of pandemic SARS-CoV-2 to the human genome.|pdf=|usr=}}
 +
{{tp|p=33011745|t=2020. Predicting the response of the dental pulp to SARS-CoV2 infection: a transcriptome-wide effect cross-analysis.|pdf=|usr=}}
 +
{{tp|p=34159627|t=2021. Genome-wide association analysis of COVID-19 mortality risk in SARS-CoV-2 genomes identifies mutation in the SARS-CoV-2 spike protein that colocalizes with P.1 of the Brazilian strain.|pdf=|usr=}}
 +
{{tp|p=34183789|t=2021. An integrative multiomics analysis identifies putative causal genes for COVID-19 severity.|pdf=|usr=}}
 +
{{tp|p=34436507|t=2021. Human-SARS-CoV-2 interactome and human genetic diversity: TMPRSS2-rs2070788, associated with severe influenza, and its population genetics caveats in Native Americans.|pdf=|usr=}}
 +
{{tp|p=33237152|t=2020. Molecular mechanisms and pharmacological interventions in the replication cycle of human coronaviruses.|pdf=|usr=}}
 +
{{tp|p=35002537|t=2021. Identification of Differentially Expressed Genes in COVID-19 and Integrated Bioinformatics Analysis of Signaling Pathways.|pdf=|usr=}}
 +
{{tp|p=33395363|t=2021. Epigenetic mechanisms influencing COVID-19.|pdf=|usr=}}
 +
{{tp|p=33197212|t=2021. The treatment of SARS-CoV2 with antivirals and mitigation of the cytokine storm syndrome: the role of gene expression.|pdf=|usr=}}
 +
{{tp|p=33086021|t=2021. Epigenetic regulation of ACE2, the receptor of the SARS-CoV-2 virus(1).|pdf=|usr=}}
 +
{{tp|p=35073995|t=2022. IDEAS: individual level differential expression analysis for single-cell RNA-seq data.|pdf=|usr=}}
 +
{{tp|p=34844647|t=2021. treekoR: identifying cellular-to-phenotype associations by elucidating hierarchical relationships in high-dimensional cytometry data.|pdf=|usr=}}
 +
{{tp|p=33413539|t=2021. HiDeF: identifying persistent structures in multiscale 'omics data.|pdf=|usr=}}
 +
{{tp|p=34694399|t=2021. ADAR Editing in Viruses: An Evolutionary Force to Reckon with.|pdf=|usr=}}
 +
{{tp|p=33713114|t=2021. The Missing Expression Level-Evolutionary Rate Anticorrelation in Viruses Does Not Support Protein Function as a Main Constraint on Sequence Evolution.|pdf=|usr=}}
 +
{{tp|p=35501841|t=2022. Single-cell transcriptomics reveal a unique memory-like NK cell subset that accumulates with ageing and correlates with disease severity in COVID-19.|pdf=|usr=}}
 +
{{tp|p=35610660|t=2022. Transcriptomic perspectives of memory-like NK cells and aging.|pdf=|usr=}}
 +
{{tp|p=35184750|t=2022. Systematic comparison of published host gene expression signatures for bacterial/viral discrimination.|pdf=|usr=}}
 +
{{tp|p=35172892|t=2022. Integrating single-cell sequencing data with GWAS summary statistics reveals CD16+monocytes and memory CD8+T cells involved in severe COVID-19.|pdf=|usr=}}
 +
{{tp|p=34001247|t=2021. An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility.|pdf=|usr=}}
 +
{{tp|p=34281603|t=2021. Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19.|pdf=|usr=}}
 +
{{tp|p=33441124|t=2021. Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients.|pdf=|usr=}}
 +
{{tp|p=33883027|t=2021. Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium.|pdf=|usr=}}
 +
{{tp|p=33879239|t=2021. IFN-gamma and TNF-alpha drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue inflammation.|pdf=|usr=}}
 +
{{tp|p=32723359|t=2020. Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein.|pdf=|usr=}}
 +
{{tp|p=33256807|t=2020. Pervasive generation of non-canonical subgenomic RNAs by SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=35332098|t=2022. Global mapping of RNA homodimers in living cells.|pdf=|usr=}}
 +
{{tp|p=35064006|t=2022. Plasma cell-free RNA characteristics in COVID-19 patients.|pdf=|usr=}}
 +
{{tp|p=33722935|t=2021. Subgenomic RNA identification in SARS-CoV-2 genomic sequencing data.|pdf=|usr=}}
 +
{{tp|p=35074468|t=2022. Betacoronavirus-specific alternate splicing.|pdf=|usr=}}
 +
{{tp|p=33691144|t=2021. Single-cell RNA sequencing reveals the sustained immune cell dysfunction in the pathogenesis of sepsis secondary to bacterial pneumonia.|pdf=|usr=}}
 +
{{tp|p=33482326|t=2021. Transcriptome network analyses in human coronavirus infections suggest a rational use of immunomodulatory drugs for COVID-19 therapy.|pdf=|usr=}}
 +
{{tp|p=32920121|t=2020. SARS-CoV-2 transcriptome analysis and molecular cataloguing of immunodominant epitopes for multi-epitope based vaccine design.|pdf=|usr=}}
 +
{{tp|p=32771622|t=2020. Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approach.|pdf=|usr=}}
 +
{{tp|p=35033679|t=2022. Genomic perspectives on the emerging SARS-CoV-2 omicron variant.|pdf=|usr=}}
 +
{{tp|p=34774773|t=2021. Integrative Multi-omics Landscape of Non-structural Protein 3 of Severe Acute Respiratory Syndrome Coronaviruses.|pdf=|usr=}}
 +
{{tp|p=34748989|t=2021. COVID-ONE-hi: The One-stop Database for COVID-19-specific Humoral Immunity and Clinical Parameters.|pdf=|usr=}}
 +
{{tp|p=34560321|t=2021. Gut Microbiome Alterations in COVID-19.|pdf=|usr=}}
 +
{{tp|p=33418085|t=2020. MicroPhenoDB Associates Metagenomic Data with Pathogenic Microbes, Microbial Core Genes, and Human Disease Phenotypes.|pdf=|usr=}}
 +
{{tp|p=32739507|t=2020. From Mutation Signature to Molecular Mechanism in the RNA World: A Case of SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=35639883|t=2022. Analysis of SARS-CoV-2 known and novel subgenomic mRNAs in cell culture, animal model, and clinical samples using LeTRS, a bioinformatic tool to identify unique sequence identifiers.|pdf=|usr=}}
 +
{{tp|p=34430958|t=2021. Concise Update on Genomics of COVID-19: Approach to Its latest Mutations, Escalated Contagiousness, and Vaccine Resistance.|pdf=|usr=}}
 +
{{tp|p=33174592|t=2021. Composition of the immunoglobulin G glycome associates with the severity of COVID-19.|pdf=|usr=}}
 +
{{tp|p=33135055|t=2021. Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2.|pdf=|usr=}}
 +
{{tp|p=35091890|t=2022. Antibody glycosylation in COVID-19.|pdf=|usr=}}
 +
{{tp|p=32504168|t=2020. Impact of glycoscience in fighting Covid-19.|pdf=|usr=}}
 +
{{tp|p=35574937|t=2022. A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=34965194|t=2022. Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters.|pdf=|usr=}}
 +
{{tp|p=34632957|t=2021. Colonic expression of Ace2, the SARS-CoV-2 entry receptor, is suppressed by commensal human microbiota.|pdf=|usr=}}
 +
{{tp|p=33685349|t=2021. SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota.|pdf=|usr=}}
 +
{{tp|p=33678150|t=2021. Integrated gut virome and bacteriome dynamics in COVID-19 patients.|pdf=|usr=}}
 +
{{tp|p=34863291|t=2021. Gut microbiota imbalance in colorectal cancer patients, the risk factor of COVID-19 mortality.|pdf=|usr=}}
 +
{{tp|p=35284643|t=2022. An experimental in silico study on COVID-19: Response of neutrophil-related genes to antibiotics.|pdf=|usr=}}
 +
{{tp|p=35399374|t=2022. Unique peptide signatures of SARS-ComicronV-2 virus against human proteome reveal variants' immune escape and infectiveness.|pdf=|usr=}}
 +
{{tp|p=34746476|t=2021. Metabologenomics approach to the discovery of novel compounds from Streptomyces sp. GMR22 as anti-SARS-CoV-2 drugs.|pdf=|usr=}}
 +
{{tp|p=33898797|t=2021. Identification of PBMC-based molecular signature associational with COVID-19 disease severity.|pdf=|usr=}}
 +
{{tp|p=33688586|t=2021. In silico analysis of altered expression of long non-coding RNA in SARS-CoV-2 infected cells and their possible regulation by STAT1, STAT3 and interferon regulatory factors.|pdf=|usr=}}
 +
{{tp|p=34179538|t=2021. Computational search of hybrid human/SARS-CoV-2 dsRNA reveals unique viral sequences that diverge from those of other coronavirus strains.|pdf=|usr=}}
 +
{{tp|p=34075347|t=2021. SARS-CoV-2 infection paralyzes cytotoxic and metabolic functions of the immune cells.|pdf=|usr=}}
 +
{{tp|p=33392409|t=2021. Atlas of ACE2 gene expression reveals novel insights into transmission of SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=34458641|t=2021. Host gene variability and SARS-CoV-2 infection: A review article.|pdf=|usr=}}
 +
{{tp|p=32984567|t=2020. A SARS-CoV-2 host infection model network based on genomic human Transcription Factors (TFs) depletion.|pdf=|usr=}}
 +
{{tp|p=33364494|t=2020. Bioinformatic evaluation of the potential animal models for studying SARS-Cov-2.|pdf=|usr=}}
 +
{{tp|p=33289002|t=2020. Enhancement of the IFN-beta-induced host signature informs repurposed drugs for COVID-19.|pdf=|usr=}}
 +
{{tp|p=33883951|t=2021. Binding of the SARS-CoV-2 Spike Protein to the Asialoglycoprotein Receptor on Human Primary Hepatocytes and Immortalized Hepatocyte-Like Cells by Confocal Analysis.|pdf=|usr=}}
 +
{{tp|p=33397514|t=2021. Mediators of SARS-CoV-2 entry are preferentially enriched in cardiomyocytes.|pdf=|usr=}}
 +
{{tp|p=32475052|t=2020. Binding affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide.|pdf=|usr=}}
 +
{{tp|p=34889978|t=2022. Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity.|pdf=|usr=}}
 +
{{tp|p=34155559|t=2021. Association of CXCR6 with COVID-19 severity: delineating the host genetic factors in transcriptomic regulation.|pdf=|usr=}}
 +
{{tp|p=33604698|t=2021. Multi-omics highlights ABO plasma protein as a causal risk factor for COVID-19.|pdf=|usr=}}
 +
{{tp|p=34967936|t=2021. Embeddings from protein language models predict conservation and variant effects.|pdf=|usr=}}
 +
{{tp|p=33726831|t=2021. Exploration and validation of related hub gene expression during SARS-CoV-2 infection of human bronchial organoids.|pdf=|usr=}}
 +
{{tp|p=33390179|t=2021. Alu retrotransposons and COVID-19 susceptibility and morbidity.|pdf=|usr=}}
 +
{{tp|p=33008459|t=2020. Practicing precision medicine with intelligently integrative clinical and multi-omics data analysis.|pdf=|usr=}}
 +
{{tp|p=33949668|t=2021. Integrative genomics analysis reveals a 21q22.11 locus contributing risk to COVID-19.|pdf=|usr=}}
 +
{{tp|p=33577681|t=2021. Integration of genetically regulated gene expression and pharmacological library provides therapeutic drug candidates.|pdf=|usr=}}
 +
{{tp|p=34329437|t=2021. Single-cell RNA sequencing of SARS-CoV-2 cell entry factors in the preconceptional human endometrium.|pdf=|usr=}}
 +
{{tp|p=33469197|t=2021. Maternal endothelial dysfunction in HIV-associated preeclampsia comorbid with COVID-19: a review.|pdf=|usr=}}
 +
{{tp|p=34786557|t=2020. Plasmin Cascade Mediates Thrombotic Events in SARS-CoV-2 Infection via Complement and Platelet-Activating Systems.|pdf=|usr=}}
 +
{{tp|p=34350693|t=2021. Comprehensive investigation of RNA-sequencing dataset reveals the hub genes and molecular mechanisms of coronavirus disease 2019 acute respiratory distress syndrome.|pdf=|usr=}}
 +
{{tp|p=34289534|t=2021. High-resolution HLA genotyping identifies alleles associated with severe COVID-19: A preliminary study from India.|pdf=|usr=}}
 +
{{tp|p=33124193|t=2020. Transcriptomic analysis reveals novel mechanisms of SARS-CoV-2 infection in human lung cells.|pdf=|usr=}}
 +
{{tp|p=33728103|t=2021. Single Cell Transcriptomic Re-analysis of Immune Cells in Bronchoalveolar Lavage Fluids Reveals the Correlation of B Cell Characteristics and Disease Severity of Patients with SARS-CoV-2 Infection.|pdf=|usr=}}
 +
{{tp|p=35151371|t=2022. Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease.|pdf=|usr=}}
 +
{{tp|p=35139355|t=2022. Interferon-gamma primes macrophages for pathogen ligand-induced killing via a caspase-8 and mitochondrial cell death pathway.|pdf=|usr=}}
 +
{{tp|p=34592166|t=2021. Early IFN-alpha signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19.|pdf=|usr=}}
 +
{{tp|p=33891889|t=2021. Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children.|pdf=|usr=}}
 +
{{tp|p=33577760|t=2021. Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity.|pdf=|usr=}}
 +
{{tp|p=34051148|t=2021. Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease.|pdf=|usr=}}
 +
{{tp|p=34048708|t=2021. SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2.|pdf=|usr=}}
 +
{{tp|p=34022127|t=2021. Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets.|pdf=|usr=}}
 +
{{tp|p=33382973|t=2021. Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid.|pdf=|usr=}}
 +
{{tp|p=33765436|t=2021. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19.|pdf=|usr=}}
 +
{{tp|p=33765435|t=2021. Multi-cohort analysis of host immune response identifies conserved protective and detrimental modules associated with severity across viruses.|pdf=|usr=}}
 +
{{tp|p=32783921|t=2020. Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients.|pdf=|usr=}}
 +
{{tp|p=33128875|t=2020. Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19.|pdf=|usr=}}
 +
{{tp|p=33296687|t=2020. Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19.|pdf=|usr=}}
 +
{{tp|p=33232865|t=2021. SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19.|pdf=|usr=}}
 +
{{tp|p=35303126|t=2022. Identification of G-quadruplex DNA sequences in SARS-CoV2.|pdf=|usr=}}
 +
{{tp|p=35434695|t=2022. Association of pyroptosis and severeness of COVID-19 as revealed by integrated single-cell transcriptome data analysis.|pdf=|usr=}}
 +
{{tp|p=34228987|t=2021. SARS-CoV-2 Spike protein enhances ACE2 expression via facilitating Interferon effects in bronchial epithelium.|pdf=|usr=}}
 +
{{tp|p=32946016|t=2020. Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine.|pdf=|usr=}}
 +
{{tp|p=32503824|t=2020. Endoplasmic Reticulum Stress Markers in SARS-COV-2 Infection and Pneumonia: Case-Control Study.|pdf=|usr=}}
 +
{{tp|p=32773420|t=2020. Transcriptome & viral growth analysis of SARS-CoV-2-infected Vero CCL-81 cells.|pdf=|usr=}}
 +
{{tp|p=35216673|t=2022. A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.|pdf=|usr=}}
 +
{{tp|p=35032429|t=2022. Complement activation induces excessive T cell cytotoxicity in severe COVID-19.|pdf=|usr=}}
 +
{{tp|p=34492226|t=2021. The interferon landscape along the respiratory tract impacts the severity of COVID-19.|pdf=|usr=}}
 +
{{tp|p=34767776|t=2021. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.|pdf=|usr=}}
 +
{{tp|p=33836156|t=2021. TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation.|pdf=|usr=}}
 +
{{tp|p=34062119|t=2021. Integrated analysis of multimodal single-cell data.|pdf=|usr=}}
 +
{{tp|p=33382968|t=2021. Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks.|pdf=|usr=}}
 +
{{tp|p=33333024|t=2021. Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses.|pdf=|usr=}}
 +
{{tp|p=33147445|t=2021. Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells.|pdf=|usr=}}
 +
{{tp|p=33147444|t=2021. Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection.|pdf=|usr=}}
 +
{{tp|p=33503446|t=2021. Multi-organ proteomic landscape of COVID-19 autopsies.|pdf=|usr=}}
 +
{{tp|p=34914922|t=2021. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis.|pdf=|usr=}}
 +
{{tp|p=33743211|t=2021. Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions.|pdf=|usr=}}
 +
{{tp|p=33811809|t=2021. BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection.|pdf=|usr=}}
 +
{{tp|p=33691138|t=2021. A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence.|pdf=|usr=}}
 +
{{tp|p=33743212|t=2021. COVID-19 and the human innate immune system.|pdf=|usr=}}
 +
{{tp|p=33713619|t=2021. Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19.|pdf=|usr=}}
 +
{{tp|p=33657410|t=2021. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.|pdf=|usr=}}
 +
{{tp|p=32810438|t=2020. Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.|pdf=|usr=}}
 +
{{tp|p=33096020|t=2020. Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4(+) T Cells in COVID-19.|pdf=|usr=}}
 +
{{tp|p=33080218|t=2020. SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses.|pdf=|usr=}}
 +
{{tp|p=32330414|t=2020. The Architecture of SARS-CoV-2 Transcriptome.|pdf=|usr=}}
 +
{{tp|p=32479746|t=2020. Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients.|pdf=|usr=}}
 +
{{tp|p=32492406|t=2020. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera.|pdf=|usr=}}
 +
{{tp|p=33171100|t=2020. Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.|pdf=|usr=}}
 +
{{tp|p=32645325|t=2020. The Global Phosphorylation Landscape of SARS-CoV-2 Infection.|pdf=|usr=}}
 +
{{tp|p=32643603|t=2020. Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment.|pdf=|usr=}}
 +
{{tp|p=35139909|t=2022. Transcriptional landscape of circulating platelets from patients with COVID-19 reveals key subnetworks and regulators underlying SARS-CoV-2 infection: implications for immunothrombosis.|pdf=|usr=}}
 +
{{tp|p=34496960|t=2021. Inferring SARS-CoV-2 functional genomics from viral transcriptome with identification of potential antiviral drugs and therapeutic targets.|pdf=|usr=}}
 +
{{tp|p=34294141|t=2021. Genome-wide analysis of protein-protein interactions and involvement of viral proteins in SARS-CoV-2 replication.|pdf=|usr=}}
 +
{{tp|p=34281608|t=2021. SARS-CoV-2: from its discovery to genome structure, transcription, and replication.|pdf=|usr=}}
 +
{{tp|p=34672954|t=2022. An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.|pdf=|usr=}}
 +
{{tp|p=34518653|t=2022. Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis.|pdf=|usr=}}
 +
{{tp|p=33037393|t=2020. An aberrant STAT pathway is central to COVID-19.|pdf=|usr=}}
 +
{{tp|p=35568706|t=2022. Sex differences in global metabolomic profiles of COVID-19 patients.|pdf=|usr=}}
 +
{{tp|p=35288537|t=2022. Plasma proteomic and metabolomic characterization of COVID-19 survivors 6 months after discharge.|pdf=|usr=}}
 +
{{tp|p=34716309|t=2021. Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients.|pdf=|usr=}}
 +
{{tp|p=34035220|t=2021. Proteomics of extracellular vesicles in plasma reveals the characteristics and residual traces of COVID-19 patients without underlying diseases after 3 months of recovery.|pdf=|usr=}}
 +
{{tp|p=33707411|t=2021. Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers.|pdf=|usr=}}
 +
{{tp|p=34301919|t=2021. RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes.|pdf=|usr=}}
 +
{{tp|p=34385425|t=2021. Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome.|pdf=|usr=}}
 +
{{tp|p=33293527|t=2020. A cross-talk between epithelium and endothelium mediates human alveolar-capillary injury during SARS-CoV-2 infection.|pdf=|usr=}}
 +
{{tp|p=35314694|t=2022. Genetic alteration of human MYH6 is mimicked by SARS-CoV-2 polyprotein: mapping viral variants of cardiac interest.|pdf=|usr=}}
 +
{{tp|p=34006825|t=2021. Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells.|pdf=|usr=}}
 +
{{tp|p=33293514|t=2020. A blood transcriptome-based analysis of disease progression, immune regulation, and symptoms in coronavirus-infected patients.|pdf=|usr=}}
 +
{{tp|p=33024578|t=2020. Benchmarking evolutionary tinkering underlying human-viral molecular mimicry shows multiple host pulmonary-arterial peptides mimicked by SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=35581179|t=2022. Proteomic characterization of Omicron SARS-CoV-2 host response.|pdf=|usr=}}
 +
{{tp|p=34702802|t=2021. SARS-CoV-2 exploits host DGAT and ADRP for efficient replication.|pdf=|usr=}}
 +
{{tp|p=34697287|t=2021. Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines.|pdf=|usr=}}
 +
{{tp|p=34103487|t=2021. Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19.|pdf=|usr=}}
 +
{{tp|p=34465742|t=2021. Genome-wide association study of COVID-19 severity among the Chinese population.|pdf=|usr=}}
 +
{{tp|p=32377375|t=2020. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing.|pdf=|usr=}}
 +
{{tp|p=32194980|t=2020. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=33357464|t=2021. Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors.|pdf=|usr=}}
 +
{{tp|p=32407669|t=2020. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients.|pdf=|usr=}}
 +
{{tp|p=33359760|t=2021. Effects of vitamin D on macrophages and myeloid-derived suppressor cells (MDSCs) hyperinflammatory response in the lungs of COVID-19 patients.|pdf=|usr=}}
 +
{{tp|p=32610096|t=2020. Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis.|pdf=|usr=}}
 +
{{tp|p=32810597|t=2021. Identification of Transcription Factors Regulating SARS-CoV-2 Entry Genes in the Intestine.|pdf=|usr=}}
 +
{{tp|p=34845370|t=2022. SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy.|pdf=|usr=}}
 +
{{tp|p=34471261|t=2021. Multiomics: unraveling the panoramic landscapes of SARS-CoV-2 infection.|pdf=|usr=}}
 +
{{tp|p=33318629|t=2021. Pathological and molecular examinations of postmortem testis biopsies reveal SARS-CoV-2 infection in the testis and spermatogenesis damage in COVID-19 patients.|pdf=|usr=}}
 +
{{tp|p=32728199|t=2020. SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70.|pdf=|usr=}}
 +
{{tp|p=35079870|t=2022. Citrullination in the pathology of inflammatory and autoimmune disorders: recent advances and future perspectives.|pdf=|usr=}}
 +
{{tp|p=35039944|t=2022. Competing endogenous RNA network mediated by circ_3205 in SARS-CoV-2 infected cells.|pdf=|usr=}}
 +
{{tp|p=32712910|t=2021. Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses.|pdf=|usr=}}
 +
{{tp|p=34117968|t=2022. Mitochondrial DNA Heteroplasmy as an Informational Reservoir Dynamically Linked to Metabolic and Immunological Processes Associated with COVID-19 Neurological Disorders.|pdf=|usr=}}
 +
{{tp|p=33751722|t=2021. Bioinformatic analyses hinted at augmented T helper 17 cell differentiation and cytokine response as the central mechanism of COVID-19-associated Guillain-Barre syndrome.|pdf=|usr=}}
 +
{{tp|p=33211371|t=2021. Direct inhibitory effect on viral entry of influenza A and SARS-CoV-2 viruses by azithromycin.|pdf=|usr=}}
 +
{{tp|p=34804904|t=2021. Role of COVID 19 Inflammatory Markers in Rhino-Orbito-Cerebral Mucormycosis: A Case Study in Predisposed Patients at a Designated Nodal Centre.|pdf=|usr=}}
 +
{{tp|p=32345362|t=2020. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues.|pdf=|usr=}}
 +
{{tp|p=34954105|t=2022. A new insight into sex-specific non-coding RNAs and networks in response to SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=34147651|t=2021. Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.|pdf=|usr=}}
 +
{{tp|p=34004362|t=2021. Analyzing host-viral interactome of SARS-CoV-2 for identifying vulnerable host proteins during COVID-19 pathogenesis.|pdf=|usr=}}
 +
{{tp|p=34004360|t=2021. Differential host circRNA expression profiles in human lung epithelial cells infected with SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=33812037|t=2021. The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.|pdf=|usr=}}
 +
{{tp|p=33848683|t=2021. Systematizing the genomic order and relatedness in the open reading frames (ORFs) of the coronaviruses.|pdf=|usr=}}
 +
{{tp|p=33819681|t=2021. Immunogenicity and antigenicity based T-cell and B-cell epitopes identification from conserved regions of 10664 SARS-CoV-2 genomes.|pdf=|usr=}}
 +
{{tp|p=33422682|t=2021. Identification of SARS-CoV-2 CTL epitopes for development of a multivalent subunit vaccine for COVID-19.|pdf=|usr=}}
 +
{{tp|p=32473977|t=2020. Unfolding SARS-CoV-2 viral genome to understand its gene expression regulation.|pdf=|usr=}}
 +
{{tp|p=32473352|t=2020. Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: A computational way to predict the immunogens.|pdf=|usr=}}
 +
{{tp|p=32712315|t=2020. Decoding the proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for cell-penetrating peptides involved in pathogenesis or applicable as drug delivery vectors.|pdf=|usr=}}
 +
{{tp|p=32707288|t=2020. Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.|pdf=|usr=}}
 +
{{tp|p=32615317|t=2020. Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short- and long-term models.|pdf=|usr=}}
 +
{{tp|p=32526370|t=2020. What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19?|pdf=|usr=}}
 +
{{tp|p=33132111|t=2020. Overlapping host pathways between SARS-CoV-2 and its potential copathogens: An in silico analysis.|pdf=|usr=}}
 +
{{tp|p=33130005|t=2020. A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection.|pdf=|usr=}}
 +
{{tp|p=34841243|t=2021. Genetic epidemiology using whole genome sequencing and haplotype networks revealed the linkage of SARS-CoV-2 infection in nosocomial outbreak.|pdf=|usr=}}
 +
{{tp|p=33014208|t=2020. How COVID-19 induces cytokine storm with high mortality.|pdf=|usr=}}
 +
{{tp|p=33159646|t=2021. The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients.|pdf=|usr=}}
 +
{{tp|p=34981034|t=2022. Systems Biology and Bioinformatics approach to Identify blood based signatures molecules and drug targets of patient with COVID-19.|pdf=|usr=}}
 +
{{tp|p=33846694|t=2021. Computational prediction of potential siRNA and human miRNA sequences to silence orf1ab associated genes for future therapeutics against SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=33072849|t=2020. Understand variability of COVID-19 through population and tissue variations in expression of SARS-CoV-2 host genes.|pdf=|usr=}}
 +
{{tp|p=32835074|t=2020. Identification and classification of differentially expressed genes reveal potential molecular signature associated with SARS-CoV-2 infection in lung adenocarcinomal cells.|pdf=|usr=}}
 +
{{tp|p=34482267|t=2021. Prediction and analysis of microRNAs involved in COVID-19 inflammatory processes associated with the NF-kB and JAK/STAT signaling pathways.|pdf=|usr=}}
 +
{{tp|p=33836368|t=2021. Identification of COVID-19 subtypes based on immunogenomic profiling.|pdf=|usr=}}
 +
{{tp|p=34653729|t=2021. In vitro induction of interleukin-8 by SARS-CoV-2 Spike protein is inhibited in bronchial epithelial IB3-1 cells by a miR-93-5p agomiR.|pdf=|usr=}}
 +
{{tp|p=34601331|t=2021. Cytokine storm in the pathophysiology of COVID-19: Possible functional disturbances of miRNAs.|pdf=|usr=}}
 +
{{tp|p=33895478|t=2021. Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC.|pdf=|usr=}}
 +
{{tp|p=32405156|t=2020. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.|pdf=|usr=}}
 +
{{tp|p=34826456|t=2022. Identifying potential novel insights for COVID-19 pathogenesis and therapeutics using an integrated bioinformatics analysis of host transcriptome.|pdf=|usr=}}
 +
{{tp|p=34517025|t=2021. Genomics-guided targeting of stress granule proteins G3BP1/2 to inhibit SARS-CoV-2 propagation.|pdf=|usr=}}
 +
{{tp|p=33862077|t=2021. Notable sequence homology of the ORF10 protein introspects the architecture of SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=33359807|t=2021. SARS-Cov-2 ORF3a: Mutability and function.|pdf=|usr=}}
 +
{{tp|p=34756970|t=2021. SARS-COV-2, infection, transmission, transcription, translation, proteins, and treatment: A review.|pdf=|usr=}}
 +
{{tp|p=32599245|t=2020. Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective.|pdf=|usr=}}
 +
{{tp|p=34671206|t=2021. The intraviral protein-protein interaction of SARS-CoV-2 reveals the key role of N protein in virus-like particle assembly.|pdf=|usr=}}
 +
{{tp|p=33907518|t=2021. SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3.|pdf=|usr=}}
 +
{{tp|p=33907515|t=2021. Developing effective siRNAs to reduce the expression of key viral genes of COVID-19.|pdf=|usr=}}
 +
{{tp|p=33907514|t=2021. The role of CD4(+)FoxP3(+) regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment.|pdf=|usr=}}
 +
{{tp|p=33767597|t=2021. Evaluation and characterization of HSPA5 (GRP78) expression profiles in normal individuals and cancer patients with COVID-19.|pdf=|usr=}}
 +
{{tp|p=35018096|t=2022. Identification of the Key Immune-Related Genes in Chronic Obstructive Pulmonary Disease Based on Immune Infiltration Analysis.|pdf=|usr=}}
 +
{{tp|p=33165417|t=2020. Network pharmacology-based study of the molecular mechanisms of Qixuekang in treating COVID-19 during the recovery period.|pdf=|usr=}}
 +
{{tp|p=35320721|t=2022. Restriction factor screening identifies RABGAP1L-mediated disruption of endocytosis as a host antiviral defense.|pdf=|usr=}}
 +
{{tp|p=35026155|t=2022. Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19.|pdf=|usr=}}
 +
{{tp|p=34998467|t=2022. SARS-CoV-2 reactive and neutralizing antibodies discovered by single-cell sequencing of plasma cells and mammalian display.|pdf=|usr=}}
 +
{{tp|p=35477000|t=2022. Characterization and functional interrogation of the SARS-CoV-2 RNA interactome.|pdf=|usr=}}
 +
{{tp|p=34587478|t=2021. Single-cell analysis of COVID-19, sepsis, and HIV infection reveals hyperinflammatory and immunosuppressive signatures in monocytes.|pdf=|usr=}}
 +
{{tp|p=34672947|t=2021. Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CL(pro) substrate degradome.|pdf=|usr=}}
 +
{{tp|p=34686343|t=2021. Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome.|pdf=|usr=}}
 +
{{tp|p=34624208|t=2021. Role of miR-2392 in driving SARS-CoV-2 infection.|pdf=|usr=}}
 +
{{tp|p=34624207|t=2021. The N-terminal domain of SARS-CoV-2 nsp1 plays key roles in suppression of cellular gene expression and preservation of viral gene expression.|pdf=|usr=}}
 +
{{tp|p=34644561|t=2021. Proteomics reveal cap-dependent translation inhibitors remodel the translation machinery and translatome.|pdf=|usr=}}
 +
{{tp|p=34731648|t=2021. An airway organoid-based screen identifies a role for the HIF1alpha-glycolysis axis in SARS-CoV-2 infection.|pdf=|usr=}}
 +
{{tp|p=34762851|t=2021. SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues.|pdf=|usr=}}
 +
{{tp|p=33961823|t=2021. METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection.|pdf=|usr=}}
 +
{{tp|p=33961822|t=2021. Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection.|pdf=|usr=}}
 +
{{tp|p=33730572|t=2021. Translational adaptation of human viruses to the tissues they infect.|pdf=|usr=}}
 +
{{tp|p=34242574|t=2021. Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins.|pdf=|usr=}}
 +
{{tp|p=33357411|t=2021. Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients.|pdf=|usr=}}
 +
{{tp|p=33440148|t=2021. MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells.|pdf=|usr=}}
 +
{{tp|p=34297909|t=2021. Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome.|pdf=|usr=}}
 +
{{tp|p=34348131|t=2021. The COVIDome Explorer researcher portal.|pdf=|usr=}}
 +
{{tp|p=33852916|t=2021. Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells.|pdf=|usr=}}
 +
{{tp|p=32946807|t=2020. A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors.|pdf=|usr=}}
 +
{{tp|p=32979938|t=2020. Evasion of Type I Interferon by SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=33007239|t=2020. Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects.|pdf=|usr=}}
 +
{{tp|p=33147460|t=2020. Interferon Regulatory Factors IRF1 and IRF7 Directly Regulate Gene Expression in Bats in Response to Viral Infection.|pdf=|usr=}}
 +
{{tp|p=35474751|t=2022. Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections.|pdf=|usr=}}
 +
{{tp|p=35474745|t=2022. Multi-omics in COVID-19: Seeing the unseen but overlooked in the clinic.|pdf=|usr=}}
 +
{{tp|p=35233546|t=2022. System-wide transcriptome damage and tissue identity loss in COVID-19 patients.|pdf=|usr=}}
 +
{{tp|p=34723226|t=2021. The systemic inflammatory landscape of COVID-19 in pregnancy: Extensive serum proteomic profiling of mother-infant dyads with in utero SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=33969320|t=2021. Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions.|pdf=|usr=}}
 +
{{tp|p=34075365|t=2021. Broad auto-reactive IgM responses are common in critically ill patients, including those with COVID-19.|pdf=|usr=}}
 +
{{tp|p=33521697|t=2021. A distinct innate immune signature marks progression from mild to severe COVID-19.|pdf=|usr=}}
 +
{{tp|p=34873589|t=2021. People critically ill with COVID-19 exhibit peripheral immune profiles predictive of mortality and reflective of SARS-CoV-2 lung viral burden.|pdf=|usr=}}
 +
{{tp|p=34308390|t=2021. Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity.|pdf=|usr=}}
 +
{{tp|p=33778787|t=2021. Spatial mapping of SARS-CoV-2 and H1N1 lung injury identifies differential transcriptional signatures.|pdf=|usr=}}
 +
{{tp|p=34790908|t=2021. Metatranscriptomics to characterize respiratory virome, microbiome, and host response directly from clinical samples.|pdf=|usr=}}
 +
{{tp|p=34737357|t=2022. Comparison of viral RNA-host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=33473155|t=2021. Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages.|pdf=|usr=}}
 +
{{tp|p=33510385|t=2021. The m(6)A methylome of SARS-CoV-2 in host cells.|pdf=|usr=}}
 +
{{tp|p=32913304|t=2021. Single-cell transcriptomic atlas of primate cardiopulmonary aging.|pdf=|usr=}}
 +
{{tp|p=32071427|t=2020. Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses.|pdf=|usr=}}
 +
{{tp|p=33159154|t=2020. Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19.|pdf=|usr=}}
 +
{{tp|p=35461900|t=2022. Exosomal mediated signal transduction through artificial microRNA (amiRNA): A potential target for inhibition of SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=33142113|t=2020. Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=33128895|t=2020. Human Lung Stem Cell-Based Alveolospheres Provide Insights into SARS-CoV-2-Mediated Interferon Responses and Pneumocyte Dysfunction.|pdf=|usr=}}
 +
{{tp|p=32979316|t=2020. SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response.|pdf=|usr=}}
 +
{{tp|p=33096026|t=2021. Large-Scale Multi-omic Analysis of COVID-19 Severity.|pdf=|usr=}}
 +
{{tp|p=33053371|t=2021. A Sweep of Earth's Virome Reveals Host-Guided Viral Protein Structural Mimicry and Points to Determinants of Human Disease.|pdf=|usr=}}
 +
{{tp|p=34139154|t=2021. A time-resolved proteomic and prognostic map of COVID-19.|pdf=|usr=}}
 +
{{tp|p=32673562|t=2020. RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus.|pdf=|usr=}}
 +
{{tp|p=32619549|t=2020. Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection.|pdf=|usr=}}
 +
{{tp|p=35326463|t=2022. Multi-Design Differential Expression Profiling of COVID-19 Lung Autopsy Specimens Reveals Significantly Deregulated Inflammatory Pathways and SFTPC Impaired Transcription.|pdf=|usr=}}
 +
{{tp|p=35269470|t=2022. Severe COVID-19 Shares a Common Neutrophil Activation Signature with Other Acute Inflammatory States.|pdf=|usr=}}
 +
{{tp|p=35053299|t=2022. Hypoxia-Inducible Factor Signaling in Inflammatory Lung Injury and Repair.|pdf=|usr=}}
 +
{{tp|p=35159296|t=2022. Competitive Endogenous RNA Network Activates Host Immune Response in SARS-CoV-2-, panH1N1 (A/California/07/2009)-, and H7N9 (A/Shanghai/1/2013)-Infected Cells.|pdf=|usr=}}
 +
{{tp|p=35203278|t=2022. The ACE2 Receptor for Coronavirus Entry Is Localized at Apical Cell-Cell Junctions of Epithelial Cells.|pdf=|usr=}}
 +
{{tp|p=35406806|t=2022. Plasma Metabolomic Alterations Induced by COVID-19 Vaccination Reveal Putative Biomarkers Reflecting the Immune Response.|pdf=|usr=}}
 +
{{tp|p=35563697|t=2022. Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro.|pdf=|usr=}}
 +
{{tp|p=34572076|t=2021. Host Cell and SARS-CoV-2-Associated Molecular Structures and Factors as Potential Therapeutic Targets.|pdf=|usr=}}
 +
{{tp|p=34831176|t=2021. Impacts of p97 on Proteome Changes in Human Cells during Coronaviral Replication.|pdf=|usr=}}
 +
{{tp|p=34831321|t=2021. In Silico Identification and Clinical Validation of a Novel Long Non-Coding RNA/mRNA/miRNA Molecular Network for Potential Biomarkers for Discriminating SARS CoV-2 Infection Severity.|pdf=|usr=}}
 +
{{tp|p=34831290|t=2021. Endothelial Dysfunction through Oxidatively Generated Epigenetic Mark in Respiratory Viral Infections.|pdf=|usr=}}
 +
{{tp|p=34831243|t=2021. Characterization of RNA Sensing Pathways in Hepatoma Cell Lines and Primary Human Hepatocytes.|pdf=|usr=}}
 +
{{tp|p=34943787|t=2021. SARS-CoV-2 Spike Protein and Its Receptor Binding Domain Promote a Proinflammatory Activation Profile on Human Dendritic Cells.|pdf=|usr=}}
 +
{{tp|p=33801464|t=2021. SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response.|pdf=|usr=}}
 +
{{tp|p=34204705|t=2021. In Silico Identification of miRNA-lncRNA Interactions in Male Reproductive Disorder Associated with COVID-19 Infection.|pdf=|usr=}}
 +
{{tp|p=34440669|t=2021. Multisystemic Cellular Tropism of SARS-CoV-2 in Autopsies of COVID-19 Patients.|pdf=|usr=}}
 +
{{tp|p=34359957|t=2021. MiRNA Profiling in Plasma and Placenta of SARS-CoV-2-Infected Pregnant Women.|pdf=|usr=}}
 +
{{tp|p=34359932|t=2021. Viral MicroRNAs Encoded by Nucleocapsid Gene of SARS-CoV-2 Are Detected during Infection, and Targeting Metabolic Pathways in Host Cells.|pdf=|usr=}}
 +
{{tp|p=33540583|t=2021. Mechanisms of Coronavirus Nsp1-Mediated Control of Host and Viral Gene Expression.|pdf=|usr=}}
 +
{{tp|p=35011641|t=2021. The Genomic Physics of COVID-19 Pathogenesis and Spread.|pdf=|usr=}}
 +
{{tp|p=35011584|t=2021. Role of Human Antigen R (HuR) in the Regulation of Pulmonary ACE2 Expression.|pdf=|usr=}}
 +
{{tp|p=34944012|t=2021. Identifying Putative Causal Links between MicroRNAs and Severe COVID-19 Using Mendelian Randomization.|pdf=|usr=}}
 +
{{tp|p=34944005|t=2021. Transcriptomic Profiles Reveal Downregulation of Low-Density Lipoprotein Particle Receptor Pathway Activity in Patients Surviving Severe COVID-19.|pdf=|usr=}}
 +
{{tp|p=34440765|t=2021. Autophagy and Mitophagy-Related Pathways at the Crossroads of Genetic Pathways Involved in Familial Sarcoidosis and Host-Pathogen Interactions Induced by Coronaviruses.|pdf=|usr=}}
 +
{{tp|p=34571855|t=2021. Two-Step In Vitro Model to Evaluate the Cellular Immune Response to SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=34571838|t=2021. Transcriptomic Analysis of HCN-2 Cells Suggests Connection among Oxidative Stress, Senescence, and Neuron Death after SARS-CoV-2 Infection.|pdf=|usr=}}
 +
{{tp|p=33917481|t=2021. Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.|pdf=|usr=}}
 +
{{tp|p=33919784|t=2021. The Role of Macrophages in the Development of Acute and Chronic Inflammatory Lung Diseases.|pdf=|usr=}}
 +
{{tp|p=33143316|t=2020. Aprotinin Inhibits SARS-CoV-2 Replication.|pdf=|usr=}}
 +
{{tp|p=33138195|t=2020. Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19.|pdf=|usr=}}
 +
{{tp|p=33086697|t=2020. Effects of Coronavirus Persistence on the Genome Structure and Subsequent Gene Expression, Pathogenicity and Adaptation Capability.|pdf=|usr=}}
 +
{{tp|p=32526950|t=2020. Host Gene Expression of Macrophages in Response to Feline Coronavirus Infection.|pdf=|usr=}}
 +
{{tp|p=32283711|t=2020. scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia, Leydig and Sertoli Cells.|pdf=|usr=}}
 +
{{tp|p=32872802|t=2020. Fractional diffusion on the human proteome as an alternative to the multi-organ damage of SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=35598647|t=2022. TRPC6 is altered in COVID-19 pneumonia.|pdf=|usr=}}
 +
{{tp|p=34163728|t=2021. CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules.|pdf=|usr=}}
 +
{{tp|p=33879756|t=2021. Single-cell analysis of angiotensin-converting enzyme II expression in human kidneys and bladders reveals a potential route of 2019 novel coronavirus infection.|pdf=|usr=}}
 +
{{tp|p=35430876|t=2022. Human Coronary Plaque T Cells Are Clonal and Cross-React to Virus and Self.|pdf=|usr=}}
 +
{{tp|p=32967859|t=2020. The pulmonary pathology of COVID-19.|pdf=|usr=}}
 +
{{tp|p=33428900|t=2021. CRISPR-based tools: Alternative methods for the diagnosis of COVID-19.|pdf=|usr=}}
 +
{{tp|p=34332518|t=2021. Could metabolomics drive the fate of COVID-19 pandemic? A narrative review on lights and shadows.|pdf=|usr=}}
 +
{{tp|p=34774827|t=2022. Serum level of testosterone predicts disease severity of male COVID-19 patients and is related to T-cell immune modulation by transcriptome analysis.|pdf=|usr=}}
 +
{{tp|p=34819170|t=2021. Epigenetic modifications in thymic epithelial cells: an evolutionary perspective for thymus atrophy.|pdf=|usr=}}
 +
{{tp|p=34034806|t=2021. Blood DNA methylation and COVID-19 outcomes.|pdf=|usr=}}
 +
{{tp|p=33087172|t=2020. The epigenetic implication in coronavirus infection and therapy.|pdf=|usr=}}
 +
{{tp|p=32758273|t=2020. Management of epigenomic networks entailed in coronavirus infections and COVID-19.|pdf=|usr=}}
 +
{{tp|p=33639276|t=2021. The role of A-to-I RNA editing in infections by RNA viruses: Possible implications for SARS-CoV-2 infection.|pdf=|usr=}}
 +
{{tp|p=34252574|t=2021. Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19.|pdf=|usr=}}
 +
{{tp|p=32325252|t=2020. COVID-19 pathophysiology: A review.|pdf=|usr=}}
 +
{{tp|p=32311462|t=2020. On the molecular determinants of the SARS-CoV-2 attack.|pdf=|usr=}}
 +
{{tp|p=32461193|t=2020. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases.|pdf=|usr=}}
 +
{{tp|p=33270107|t=2021. Viral Cultures for Coronavirus Disease 2019 Infectivity Assessment: A Systematic Review.|pdf=|usr=}}
 +
{{tp|p=33596592|t=2021. Plasma Metabolomic Profiling of Patients Recovered From Coronavirus Disease 2019 (COVID-19) With Pulmonary Sequelae 3 Months After Discharge.|pdf=|usr=}}
 +
{{tp|p=32463434|t=2021. Metatranscriptomic Characterization of Coronavirus Disease 2019 Identified a Host Transcriptional Classifier Associated With Immune Signaling.|pdf=|usr=}}
 +
{{tp|p=32307550|t=2020. Downregulated Gene Expression Spectrum and Immune Responses Changed During the Disease Progression in Patients With COVID-19.|pdf=|usr=}}
 +
{{tp|p=32327413|t=2020. Genetic Roadmap for Kidney Involvement of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.|pdf=|usr=}}
 +
{{tp|p=33631334|t=2021. Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19.|pdf=|usr=}}
 +
{{tp|p=34620315|t=2021. mNUTRIC tool is capable to predict nutritional needs and mortality early in patients suffering from severe pneumonia.|pdf=|usr=}}
 +
{{tp|p=34330510|t=2021. Gene signatures of autopsy lungs from obese patients with COVID-19.|pdf=|usr=}}
 +
{{tp|p=34330463|t=2021. The snapshot of metabolic health in evaluating micronutrient status, the risk of infection and clinical outcome of COVID-19.|pdf=|usr=}}
 +
{{tp|p=33855294|t=2021. Possible Involvement of Central Nervous System in COVID-19 and Sequence Variability of SARS-CoV-2 Revealed in Autopsy Tissue Samples: A Case Report.|pdf=|usr=}}
 +
{{tp|p=32828489|t=2020. Epigenetic susceptibility to severe respiratory viral infections and its therapeutic implications: a narrative review.|pdf=|usr=}}
 +
{{tp|p=32628270|t=2020. Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing.|pdf=|usr=}}
 +
{{tp|p=33125711|t=2021. Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations.|pdf=|usr=}}
 +
{{tp|p=34915155|t=2022. SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: Evidence of PAMP-like properties.|pdf=|usr=}}
 +
{{tp|p=34022369|t=2021. Detection of SARS-CoV-2 genome and whole transcriptome sequencing in frontal cortex of COVID-19 patients.|pdf=|usr=}}
 +
{{tp|p=33892139|t=2021. Double stranded RNA drives anti-viral innate immune responses, sickness behavior and cognitive dysfunction dependent on dsRNA length, IFNAR1 expression and age.|pdf=|usr=}}
 +
{{tp|p=32497778|t=2020. A pharmacological interactome between COVID-19 patient samples and human sensory neurons reveals potential drivers of neurogenic pulmonary dysfunction.|pdf=|usr=}}
 +
{{tp|p=34384361|t=2021. Mass spectrometry-based proteomics in basic and translational research of SARS-CoV-2 coronavirus and its emerging mutants.|pdf=|usr=}}
 +
{{tp|p=33292691|t=2020. Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies.|pdf=|usr=}}
 +
{{tp|p=35538880|t=2022. Proteomic profiling of lung diffusion impairment in the recovery stage of SARS-CoV-2-induced ARDS.|pdf=|usr=}}
 +
{{tp|p=34586723|t=2021. Host transcriptional response to SARS-CoV-2 infection in COVID-19 patients.|pdf=|usr=}}
 +
{{tp|p=34047474|t=2021. Preliminary analyses of scRNA sequencing and immunohistochemistry of children's lung tissues indicate the expression of SARS-CoV-2 entry-related genes may not be the key reason for the milder syndromes of COVID-19 in children.|pdf=|usr=}}
 +
{{tp|p=33135345|t=2020. The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID-19.|pdf=|usr=}}
 +
{{tp|p=32799423|t=2020. Effect of Common Medications on the Expression of SARS-CoV-2 Entry Receptors in Kidney Tissue.|pdf=|usr=}}
 +
{{tp|p=32578831|t=2020. Human Leukocyte Transcriptional Response to SARS-CoV-2 Infection.|pdf=|usr=}}
 +
{{tp|p=33425046|t=2021. COV19-CNNet and COV19-ResNet: Diagnostic Inference Engines for Early Detection of COVID-19.|pdf=|usr=}}
 +
{{tp|p=35091696|t=2022. Epigenomic and transcriptomic analyses reveal differences between low-grade inflammation and severe exhaustion in LPS-challenged murine monocytes.|pdf=|usr=}}
 +
{{tp|p=35022513|t=2022. SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-kappaB.|pdf=|usr=}}
 +
{{tp|p=35017628|t=2022. InterCellar enables interactive analysis and exploration of cell-cell communication in single-cell transcriptomic data.|pdf=|usr=}}
 +
{{tp|p=35136165|t=2022. An extended motif in the SARS-CoV-2 spike modulates binding and release of host coatomer in retrograde trafficking.|pdf=|usr=}}
 +
{{tp|p=34686777|t=2021. Accurate detection and quantification of SARS-CoV-2 genomic and subgenomic mRNAs by ddPCR and meta-transcriptomics analysis.|pdf=|usr=}}
 +
{{tp|p=34002013|t=2021. Genome-wide bioinformatic analyses predict key host and viral factors in SARS-CoV-2 pathogenesis.|pdf=|usr=}}
 +
{{tp|p=33674719|t=2021. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection.|pdf=|usr=}}
 +
{{tp|p=34326461|t=2021. FIP200 restricts RNA virus infection by facilitating RIG-I activation.|pdf=|usr=}}
 +
{{tp|p=33580175|t=2021. Immunoreactive peptide maps of SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=34465887|t=2021. Trans-ethnic genome-wide association study of severe COVID-19.|pdf=|usr=}}
 +
{{tp|p=34552685|t=2021. Infrared light therapy relieves TLR-4 dependent hyper-inflammation of the type induced by COVID-19.|pdf=|usr=}}
 +
{{tp|p=35465056|t=2022. BNT162b2 vaccination enhances interferon-JAK-STAT-regulated antiviral programs in COVID-19 patients infected with the SARS-CoV-2 Beta variant.|pdf=|usr=}}
 +
{{tp|p=35602196|t=2021. Reduced subgenomic RNA expression is a molecular indicator of asymptomatic SARS-CoV-2 infection.|pdf=|usr=}}
 +
{{tp|p=35072167|t=2021. Host methylation predicts SARS-CoV-2 infection and clinical outcome.|pdf=|usr=}}
 +
{{tp|p=33845430|t=2021. The role of human C5a as a non-genomic target in corticosteroid therapy for management of severe COVID19.|pdf=|usr=}}
 +
{{tp|p=35427985|t=2022. Subtractive proteomics assisted therapeutic targets mining and designing ensemble vaccine against Candida auris for immune response induction.|pdf=|usr=}}
 +
{{tp|p=35339845|t=2022. Integration of omics data to generate and analyse COVID-19 specific genome-scale metabolic models.|pdf=|usr=}}
 +
{{tp|p=35114443|t=2022. Systems pharmacology-based drug discovery and active mechanism of natural products for coronavirus pneumonia (COVID-19): An example using flavonoids.|pdf=|usr=}}
 +
{{tp|p=35605482|t=2022. Unveiling the nature's fruit basket to computationally identify Citrus sinensis csi-mir169-3p as a probable plant miRNA against Reference and Omicron SARS-CoV-2 genome.|pdf=|usr=}}
 +
{{tp|p=35533462|t=2022. Network for network concept offers new insights into host- SARS-CoV-2 protein interactions and potential novel targets for developing antiviral drugs.|pdf=|usr=}}
 +
{{tp|p=35533463|t=2022. Enrichment analysis on regulatory subspaces: A novel direction for the superior description of cellular responses to SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=34320442|t=2021. Decrypting the role of predicted SARS-CoV-2 miRNAs in COVID-19 pathogenesis: A bioinformatics approach.|pdf=|usr=}}
 +
{{tp|p=34478921|t=2021. Meta-analysis of single-cell RNA-seq data reveals phenotypic switching of immune cells in severe COVID-19 patients.|pdf=|usr=}}
 +
{{tp|p=34655901|t=2021. Interactome of human and SARS-CoV-2 proteins to identify human hub proteins associated with comorbidities.|pdf=|usr=}}
 +
{{tp|p=34020131|t=2021. Identification and host response interaction study of SARS-CoV-2 encoded miRNA-like sequences: an in silico approach.|pdf=|usr=}}
 +
{{tp|p=33310371|t=2021. Recent trends on omics and bioinformatics approaches to study SARS-CoV-2: A bibliometric analysis and mini-review.|pdf=|usr=}}
 +
{{tp|p=33301953|t=2021. Next-generation computational tools and resources for coronavirus research: From detection to vaccine discovery.|pdf=|usr=}}
 +
{{tp|p=33260034|t=2021. Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing.|pdf=|usr=}}
 +
{{tp|p=33217661|t=2021. Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs.|pdf=|usr=}}
 +
{{tp|p=34246161|t=2021. High-throughput analysis of the interactions between viral proteins and host cell RNAs.|pdf=|usr=}}
 +
{{tp|p=34157472|t=2021. Multilevel systems biology analysis of lung transcriptomics data identifies key miRNAs and potential miRNA target genes for SARS-CoV-2 infection.|pdf=|usr=}}
 +
{{tp|p=33662681|t=2021. Network pharmacology and RNA-sequencing reveal the molecular mechanism of Xuebijing injection on COVID-19-induced cardiac dysfunction.|pdf=|usr=}}
 +
{{tp|p=33131530|t=2020. Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19.|pdf=|usr=}}
 +
{{tp|p=35558576|t=2022. Identification of Diagnostic Gene Markers and Immune Infiltration in Systemic Lupus.|pdf=|usr=}}
 +
{{tp|p=34603483|t=2021. Identification of Novel COVID-19 Biomarkers by Multiple Feature Selection Strategies.|pdf=|usr=}}
 +
{{tp|p=33631640|t=2021. Artificial Intelligence-Based Prediction of Covid-19 Severity on the Results of Protein Profiling.|pdf=|usr=}}
 +
{{tp|p=34777716|t=2021. Lipidomics and metabolomics signatures of SARS-CoV-2 mediators/receptors in peripheral leukocytes, jejunum and colon.|pdf=|usr=}}
 +
{{tp|p=34109017|t=2021. The evolving proteome of SARS-CoV-2 predominantly uses mutation combination strategy for survival.|pdf=|usr=}}
 +
{{tp|p=33907612|t=2021. Comparisons of the immunological landscape between COVID-19, influenza, and respiratory syncytial virus patients by clustering analysis.|pdf=|usr=}}
 +
{{tp|p=33841749|t=2021. Metabolomics reveals sex-specific metabolic shifts and predicts the duration from positive to negative in non-severe COVID-19 patients during recovery process.|pdf=|usr=}}
 +
{{tp|p=33815688|t=2021. Nanopore sequencing and its application to the study of microbial communities.|pdf=|usr=}}
 +
{{tp|p=33584997|t=2021. 3044 Cases reveal important prognosis signatures of COVID-19 patients.|pdf=|usr=}}
 +
{{tp|p=33520118|t=2021. Meta-analysis of transcriptome datasets: An alternative method to study IL-6 regulation in coronavirus disease 2019.|pdf=|usr=}}
 +
{{tp|p=33425248|t=2021. Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes.|pdf=|usr=}}
 +
{{tp|p=33312453|t=2021. Transcriptomic signatures and repurposing drugs for COVID-19 patients: findings of bioinformatics analyses.|pdf=|usr=}}
 +
{{tp|p=33312454|t=2020. L1000 connectivity map interrogation identifies candidate drugs for repurposing as SARS-CoV-2 antiviral therapies.|pdf=|usr=}}
 +
{{tp|p=33106757|t=2020. Probing infectious disease by single-cell RNA sequencing: Progresses and perspectives.|pdf=|usr=}}
 +
{{tp|p=34781986|t=2021. Metabolomic diferences between COVID-19 and H1N1 influenza induced ARDS.|pdf=|usr=}}
 +
{{tp|p=34112226|t=2021. Comparison of renal histopathology and gene expression profiles between severe COVID-19 and bacterial sepsis in critically ill patients.|pdf=|usr=}}
 +
{{tp|p=33134953|t=2020. Metabolomics Profiling of Critically Ill Coronavirus Disease 2019 Patients: Identification of Diagnostic and Prognostic Biomarkers.|pdf=|usr=}}
 +
{{tp|p=35584589|t=2022. Roles of PIKfyve in multiple cellular pathways.|pdf=|usr=}}
 +
{{tp|p=32838054|t=2021. Subcellular hot spots of GPCR signaling promote vascular inflammation.|pdf=|usr=}}
 +
{{tp|p=34534994|t=2021. Host genetics of pediatric SARS-CoV-2 COVID-19 and multisystem inflammatory syndrome in children.|pdf=|usr=}}
 +
{{tp|p=33969287|t=2021. Reduced A-to-I editing of endogenous Alu RNAs in lung after SARS-CoV-2 infection.|pdf=|usr=}}
 +
{{tp|p=34841355|t=2021. A next generation sequencing (NGS) analysis to reveal genomic and proteomic mutation landscapes of SARS-CoV-2 in South Asia.|pdf=|usr=}}
 +
{{tp|p=34725650|t=2021. The severity of SARS-CoV-2 infection is dictated by host factors? Epigenetic perspectives.|pdf=|usr=}}
 +
{{tp|p=32142596|t=2020. Machine Learning, COVID-19 (2019-nCoV), and multi-OMICS.|pdf=|usr=}}
 +
{{tp|p=33394568|t=2021. Illuminating the immunopathology of SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=32864402|t=2020. Dataset of mutational analysis, miRNAs targeting SARS-CoV-2 genes and host gene expression in SARS-CoV and SARS-CoV-2 infections.|pdf=|usr=}}
 +
{{tp|p=32835036|t=2020. Quantitative proteomic dataset from oro- and naso-pharyngeal swabs used for COVID-19 diagnosis: Detection of viral proteins and host's biological processes altered by the infection.|pdf=|usr=}}
 +
{{tp|p=32775582|t=2020. Dataset for homologous proteins in Drosophila melanogaster for SARS-CoV-2/human interactome.|pdf=|usr=}}
 +
{{tp|p=35134150|t=2022. SCANNER: a web platform for annotation, visualization and sharing of single cell RNA-seq data.|pdf=|usr=}}
 +
{{tp|p=33787872|t=2021. Drugmonizome and Drugmonizome-ML: integration and abstraction of small molecule attributes for drug enrichment analysis and machine learning.|pdf=|usr=}}
 +
{{tp|p=33009914|t=2021. A database resource and online analysis tools for coronaviruses on a historical and global scale.|pdf=|usr=}}
 +
{{tp|p=33206959|t=2020. The IMEx coronavirus interactome: an evolving map of Coronaviridae-host molecular interactions.|pdf=|usr=}}
 +
{{tp|p=35233542|t=2022. Mass spectrometry and proteome analysis to identify SARS-CoV-2 protein from COVID-19 patient swab samples.|pdf=|usr=}}
 +
{{tp|p=35141569|t=2022. Transcriptome profiling of PBMCs and formalin-fixed autopsy tissues from COVID-19 patients.|pdf=|usr=}}
 +
{{tp|p=34901888|t=2022. Detection of N6-methyladenosine in SARS-CoV-2 RNA by methylated RNA immunoprecipitation sequencing.|pdf=|usr=}}
 +
{{tp|p=34877545|t=2022. Global metabolome profiling of COVID-19 respiratory specimen using high-resolution mass spectrometry (HRMS).|pdf=|usr=}}
 +
{{tp|p=34870243|t=2022. Protocol for global proteome, virome, and metaproteome profiling of respiratory specimen (VTM) in COVID-19 patient by LC-MS/MS-based analysis.|pdf=|usr=}}
 +
{{tp|p=35611119|t=2022. An antibody-based proximity labeling protocol to identify biotinylated interactors of SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=35582459|t=2022. Analyzing single cell transcriptome data from severe COVID-19 patients.|pdf=|usr=}}
 +
{{tp|p=35310073|t=2022. SARS-CoV-2 proteome microarray for COVID-19 patient sera profiling.|pdf=|usr=}}
 +
{{tp|p=34462737|t=2021. An antigen microarray protocol for COVID-19 serological analysis.|pdf=|usr=}}
 +
{{tp|p=34002169|t=2021. Sample processing and single cell RNA-sequencing of peripheral blood immune cells from COVID-19 patients.|pdf=|usr=}}
 +
{{tp|p=33907739|t=2021. Analysis workflow of publicly available RNA-sequencing datasets.|pdf=|usr=}}
 +
{{tp|p=34746856|t=2021. Computational workflow for functional characterization of COVID-19 through secondary data analysis.|pdf=|usr=}}
 +
{{tp|p=34405154|t=2021. Luciferase reporter assays to monitor interferon signaling modulation by SARS-CoV-2 proteins.|pdf=|usr=}}
 +
{{tp|p=33377120|t=2020. Optimized workflow for single-cell transcriptomics on infectious diseases including COVID-19.|pdf=|usr=}}
 +
{{tp|p=33377107|t=2020. Glycomics-informed glycoproteomic analysis of site-specific glycosylation for SARS-CoV-2 spike protein.|pdf=|usr=}}
 +
{{tp|p=35180397|t=2022. A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4.|pdf=|usr=}}
 +
{{tp|p=35063125|t=2022. The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=33852884|t=2021. Human Pluripotent Stem Cell-Derived Intestinal Organoids Model SARS-CoV-2 Infection Revealing a Common Epithelial Inflammatory Response.|pdf=|usr=}}
 +
{{tp|p=33161843|t=2021. Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection.|pdf=|usr=}}
 +
{{tp|p=34151035|t=2021. Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19.|pdf=|usr=}}
 +
{{tp|p=33354650|t=2020. Host-Viral Interactions Revealed among Shared Transcriptomics Signatures of ARDS and Thrombosis: A Clue into COVID-19 Pathogenesis.|pdf=|usr=}}
 +
{{tp|p=35664076|t=2022. The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events involved in RNA metabolism and immune response.|pdf=|usr=}}
 +
{{tp|p=34335977|t=2021. Multi-omic profiling of plasma reveals molecular alterations in children with COVID-19.|pdf=|usr=}}
 +
{{tp|p=33391477|t=2021. Immunopathogenesis and treatment of cytokine storm in COVID-19.|pdf=|usr=}}
 +
{{tp|p=34048985|t=2021. Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients.|pdf=|usr=}}
 +
{{tp|p=33221483|t=2021. The role of the lectin pathway of the complement system in SARS-CoV-2 lung injury.|pdf=|usr=}}
 +
{{tp|p=33994605|t=2021. Mass spectrometry analytical responses to the SARS-CoV2 coronavirus in review.|pdf=|usr=}}
 +
{{tp|p=33309104|t=2021. Using Genetics To Dissect SARS-CoV-2 Infection.|pdf=|usr=}}
 +
{{tp|p=33451855|t=2021. Dysregulation of Cell Signaling by SARS-CoV-2.|pdf=|usr=}}
 +
{{tp|p=32595353|t=2020. Integration of transcriptomic profile of SARS-CoV-2 infected normal human bronchial epithelial cells with metabolic and protein-protein interaction networks.|pdf=|usr=}}
 +
{{tp|p=32851697|t=2021. Single-cell RNA expression profiling of SARS-CoV-2-related ACE2 and TMPRSS2 in human trophectoderm and placenta.|pdf=|usr=}}

Version vom 20. Juni 2022, 12:28 Uhr

Maybe, specific information might be found in the raw readout of proteomic datasets.

Inhaltsverzeichnis


Searchterm applied

(gives 9900 papers on june 7th 2022)

http://www.moremed.org/SiteSearch.php?S1=transcriptom*+OR+transcription*+OR+proteom*+OR+gene+expression+OR+interactom*+OR+omics+OR+hub+genes+OR+epigenom*+OR+dna+methylation+OR+metabolom*+OR+gene+chip+OR+transcripts+OR+microarray+OR+receptorom*+OR+glycom*+OR+differential+expression&S2=covid19+OR+covid-19+OR+sars-cov2+OR+sars-cov-2+&S3=&submit=submit&px1=proxy.nationallizenzen.de&px2=&px3=&px4=&R=all&Y0=1500&Y1=2025

Covid Omics Databases and Webservers


34845454 2021. Identifying disease-critical cell types and cellular processes across the human body by integration of single-cell profiles and human genetics.
34127975 2021. Implicating Gene and Cell Networks Responsible for Differential COVID-19 Host Responses via an Interactive Single Cell Web Portal.
34075382 2021. CovidExpress: an interactive portal for intuitive investigation on SARS-CoV-2 related transcriptomes.
32587962 2020. The IMEx Coronavirus interactome: an evolving map of Coronaviridae-Host molecular interactions.
33206959 2020. The IMEx coronavirus interactome: an evolving map of Coronaviridae-host molecular interactions.
33413085 2021. H2V: a database of human genes and proteins that respond to SARS-CoV-2, SARS-CoV, and MERS-CoV infection.
34448623 2021. A Novel Pathway Network Analytics Method Based on Graph Theory.
33605735 2021. Open Science Resources for the Mass Spectrometry-Based Analysis of SARS-CoV-2.
32930583 2020. Quantification of mRNA Expression Using Single-Molecule Nanopore Sensing.
33553941 2021. SARSCOVIDB-A New Platform for the Analysis of the Molecular Impact of SARS-CoV-2 Viral Infection.
33501381 2020. Fostering global data sharing: highlighting the recommendations of the Research Data Alliance COVID-19 working group.
34718395 2022. A comprehensive review of the analysis and integration of omics data for SARS-CoV-2 and COVID-19.
34424948 2021. DeepDRIM: a deep neural network to reconstruct cell-type-specific gene regulatory network using single-cell RNA-seq data.
34111889 2021. Single-cell multi-omics sequencing: application trends, COVID-19, data analysis issues and prospects.
34076249 2021. Transcriptomic studies revealed pathophysiological impact of COVID-19 to predominant health conditions.
34009288 2021. Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19.
33592108 2021. Data science in unveiling COVID-19 pathogenesis and diagnosis: evolutionary origin to drug repurposing.
33416848 2021. SARS-CoV-2 3D database: understanding the coronavirus proteome and evaluating possible drug targets.
33057582 2021. Web tools to fight pandemics: the COVID-19 experience.
34767776 2021. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.
33657410 2021. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.
34471261 2021. Multiomics: unraveling the panoramic landscapes of SARS-CoV-2 infection.
34348131 2021. The COVIDome Explorer researcher portal.
33310371 2021. Recent trends on omics and bioinformatics approaches to study SARS-CoV-2: A bibliometric analysis and mini-review.
33301953 2021. Next-generation computational tools and resources for coronavirus research: From detection to vaccine discovery.
32864402 2020. Dataset of mutational analysis, miRNAs targeting SARS-CoV-2 genes and host gene expression in SARS-CoV and SARS-CoV-2 infections.
32835036 2020. Quantitative proteomic dataset from oro- and naso-pharyngeal swabs used for COVID-19 diagnosis: Detection of viral proteins and host's biological processes altered by the infection.
35134150 2022. SCANNER: a web platform for annotation, visualization and sharing of single cell RNA-seq data.
33009914 2021. A database resource and online analysis tools for coronaviruses on a historical and global scale.
32404885 2020. The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic.
33194800 2020. Systems Biology Approaches for Therapeutics Development Against COVID-19.
35003208 2021. COVID-19 Transcriptomic Atlas: A Comprehensive Analysis of COVID-19 Related Transcriptomics Datasets.
34975833 2021. Understanding Gene Expression and Transcriptome Profiling of COVID-19: An Initiative Towards the Mapping of Protective Immunity Genes Against SARS-CoV-2 Infection.
32670298 2020. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.
34557504 2021. Unraveling Risk Genes of COVID-19 by Multi-Omics Integrative Analyses.
35047913 2021. The SIRAH-CoV-2 Initiative: A Coarse-Grained Simulations' Dataset of the SARS-CoV-2 Proteome.
35531299 2022. The Intricacy of the Viral-Human Protein Interaction Networks: Resources, Data, and Analyses.
33324374 2020. Comparative Transcriptome Analysis Reveals the Intensive Early Stage Responses of Host Cells to SARS-CoV-2 Infection.
33585554 2020. SARS-CoV-2 Proteins Exploit Host's Genetic and Epigenetic Mediators for the Annexation of Key Host Signaling Pathways.
34530086 2022. An overview of human proteins and genes involved in SARS-CoV-2 infection.
33263093 2021. Gene expression profiling of corona virus microarray datasets to identify crucial targets in COVID-19 patients.
34401607 2021. Systems level insights into the impact of airborne exposure on SARS-CoV-2 pathogenesis and COVID-19 outcome - A multi-omics big data study.
33553808 2020. Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19.
33809949 2021. A Resource for the Network Representation of Cell Perturbations Caused by SARS-CoV-2 Infection.
34209818 2021. Toward a Coronavirus Knowledge Graph.
35002537 2021. Identification of Differentially Expressed Genes in COVID-19 and Integrated Bioinformatics Analysis of Signaling Pathways.
35184750 2022. Systematic comparison of published host gene expression signatures for bacterial/viral discrimination.
34001247 2021. An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility.
34350693 2021. Comprehensive investigation of RNA-sequencing dataset reveals the hub genes and molecular mechanisms of coronavirus disease 2019 acute respiratory distress syndrome.
34675627 2021. Construction and Investigation of Competing Endogenous RNA Networks and Candidate Genes Involved in SARS-CoV-2 Infection.
34623759 2021. New insights into genetic characteristics between multiple myeloma and COVID-19: An integrative bioinformatics analysis of gene expression omnibus microarray and the cancer genome atlas data.
35269564 2022. COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19.
33207699 2020. Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
32236644 2020. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis.
34522848 2021. An interactive single cell web portal identifies gene and cell networks in COVID-19 host responses.
34487344 2021. A pathway map of signaling events triggered upon SARS-CoV infection.
33730024 2021. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes.
33901166 2021. The first few days of a SARS-CoV-2 infection viewed at single-cell resolution.
34260589 2021. COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.
35468151 2022. Multi-omic analysis reveals enriched pathways associated with COVID-19 and COVID-19 severity.
35390032 2022. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
35085325 2022. Identification of potentially anti-COVID-19 active drugs using the connectivity MAP.
33082228 2020. Transcriptional and proteomic insights into the host response in fatal COVID-19 cases.
35377064 2022. Differential transcriptomic landscapes of multiple organs from SARS-CoV-2 early infected rhesus macaques.
32664949 2020. SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis.
34127904 2021. Network-based transcriptomic analysis identifies the genetic effect of COVID-19 to chronic kidney disease patients: A bioinformatics approach.
32963239 2020. Consensus transcriptional regulatory networks of coronavirus-infected human cells.
34031435 2021. Integrative web-based analysis of omics data for study of drugs against SARS-CoV-2.
33782412 2021. Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway.
33510359 2021. Meta-analysis of host transcriptional responses to SARS-CoV-2 infection reveals their manifestation in human tumors.
34907210 2021. Identification of transcriptional regulatory network associated with response of host epithelial cells to SARS-CoV-2.
34376762 2021. Comparative transcriptome analyses reveal genes associated with SARS-CoV-2 infection of human lung epithelial cells.
33318519 2020. Gene expression network analysis provides potential targets against SARS-CoV-2.
33863870 2021. COVID-19: complexity of disease severity revealed by systemic and localized single cell immune atlas.
33859163 2021. Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery.
32670298 2020. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.
34557504 2021. Unraveling Risk Genes of COVID-19 by Multi-Omics Integrative Analyses.
35047913 2021. The SIRAH-CoV-2 Initiative: A Coarse-Grained Simulations' Dataset of the SARS-CoV-2 Proteome.
35531299 2022. The Intricacy of the Viral-Human Protein Interaction Networks: Resources, Data, and Analyses.
33324374 2020. Comparative Transcriptome Analysis Reveals the Intensive Early Stage Responses of Host Cells to SARS-CoV-2 Infection.
33585554 2020. SARS-CoV-2 Proteins Exploit Host's Genetic and Epigenetic Mediators for the Annexation of Key Host Signaling Pathways.
34530086 2022. An overview of human proteins and genes involved in SARS-CoV-2 infection.
33263093 2021. Gene expression profiling of corona virus microarray datasets to identify crucial targets in COVID-19 patients.
34401607 2021. Systems level insights into the impact of airborne exposure on SARS-CoV-2 pathogenesis and COVID-19 outcome - A multi-omics big data study.
33553808 2020. Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19.
33809949 2021. A Resource for the Network Representation of Cell Perturbations Caused by SARS-CoV-2 Infection.
34209818 2021. Toward a Coronavirus Knowledge Graph.
35002537 2021. Identification of Differentially Expressed Genes in COVID-19 and Integrated Bioinformatics Analysis of Signaling Pathways.
34001247 2021. An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility.
34350693 2021. Comprehensive investigation of RNA-sequencing dataset reveals the hub genes and molecular mechanisms of coronavirus disease 2019 acute respiratory distress syndrome.
34675627 2021. Construction and Investigation of Competing Endogenous RNA Networks and Candidate Genes Involved in SARS-CoV-2 Infection.
34623759 2021. New insights into genetic characteristics between multiple myeloma and COVID-19: An integrative bioinformatics analysis of gene expression omnibus microarray and the cancer genome atlas data.
35269564 2022. COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19.
33207699 2020. Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
32236644 2020. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis.
34522848 2021. An interactive single cell web portal identifies gene and cell networks in COVID-19 host responses.
34487344 2021. A pathway map of signaling events triggered upon SARS-CoV infection.
32806897 2020. Integrative Modeling of Quantitative Plasma Lipoprotein, Metabolic, and Amino Acid Data Reveals a Multiorgan Pathological Signature of SARS-CoV-2 Infection.
35150462 2022. Thrombosis pathways in COVID-19 vs. influenza-associated ARDS: A targeted proteomics approach.
33413422 2021. Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.
34876157 2021. Multi-omics approach to COVID-19: a domain-based literature review.
32811513 2020. The current landscape of coronavirus-host protein-protein interactions.
34319784 2021. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.
34106002 2021. Viral and Host Transcriptomes in SARS-CoV-2-Infected Human Lung Cells.
35530264 2022. Plasma Proteomics of COVID-19-Associated Cardiovascular Complications: Implications for Pathophysiology and Therapeutics.
34254058 2021. Cov-MS: A Community-Based Template Assay for Mass-Spectrometry-Based Protein Detection in SARS-CoV-2 Patients.
35511435 2022. Single-cell transcriptomic profiling of lung endothelial cells identifies dynamic inflammatory and regenerative subpopulations.
35175937 2022. Temporal transcriptomic analysis using TrendCatcher identifies early and persistent neutrophil activation in severe COVID-19.
34618691 2021. Human nasal wash RNA-Seq reveals distinct cell-specific innate immune responses in influenza versus SARS-CoV-2.
33284134 2021. Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2-induced systemic toxicity.
34642644 2021. A Pilot Study of Urine Proteomics in COVID-19-Associated Acute Kidney Injury.
35368565 2022. Single-Cell RNA Sequencing of Urinary Cells Reveals Distinct Cellular Diversity in COVID-19-Associated AKI.
35110370 2022. Proteomic landscape of SARS-CoV-2- and MERS-CoV-infected primary human renal epithelial cells.
34425963 2021. Acute Kidney Injury in Severe COVID-19 Has Similarities to Sepsis-Associated Kidney Injury: A Multi-Omics Study.
35604092 2022. The Translational Landscape of SARS-CoV-2-infected Cells Reveals Suppression of Innate Immune Genes.
34766152 2021. Application of omics technology to combat the COVID-19 pandemic.
33833618 2021. Whole-Transcriptome RNA Sequencing Reveals Significant Differentially Expressed mRNAs, miRNAs, and lncRNAs and Related Regulating Biological Pathways in the Peripheral Blood of COVID-19 Patients.
35547845 2022. Whole Genome DNA and RNA Sequencing of Whole Blood Elucidates the Genetic Architecture of Gene Expression Underlying a Wide Range of Diseases.
33758879 2021. The COVIDome Explorer Researcher Portal.
32743614 2020. Large-scale Multi-omic Analysis of COVID-19 Severity.
33398303 2020. An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility.
33435351 2021. Comprehensive Meta-Analysis of COVID-19 Global Metabolomics Datasets.
34153417 2021. Construction of an autophagy interaction network based on competitive endogenous RNA reveals the key pathways and central genes of SARS-CoV-2 infection in vivo.
34118193 2021. Global analysis of protein-RNA interactions in SARS-CoV-2-infected cells reveals key regulators of infection.
33989516 2021. The SARS-CoV-2 RNA interactome.
35504488 2022. Mapping molecular gene signatures mediated by SARS-COV-2 and large-scale and genome-wide transcriptomics comparative analysis among respiratory viruses of medical importance.
34400346 2021. Proteomic Signature of Host Response to SARS-CoV-2 Infection in the Nasopharynx.
34089862 2021. Proteomics-Based Insights Into the SARS-CoV-2-Mediated COVID-19 Pandemic: A Review of the First Year of Research.
34664389 2021. COVID19 Disease Map, a computational knowledge repository of virus-host interaction mechanisms.
35300459 2022. Transcriptogram analysis reveals relationship between viral titer and gene sets responses during Corona-virus infection.
34876692 2021. A single-cell transcriptomic landscape of the lungs of patients with COVID-19.
34315893 2021. Single-cell transcriptome of bronchoalveolar lavage fluid reveals sequential change of macrophages during SARS-CoV-2 infection in ferrets.
34315889 2021. The trans-omics landscape of COVID-19.
33597532 2021. Dysregulated transcriptional responses to SARS-CoV-2 in the periphery.
34381043 2021. Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19.
33879890 2021. Single-cell multi-omics analysis of the immune response in COVID-19.
34876996 2021. Post-mortem tissue proteomics reveals the pathogenesis of multi-organ injuries of COVID-19.
33915569 2021. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets.
33915568 2021. A molecular single-cell lung atlas of lethal COVID-19.
34237774 2021. Mapping the human genetic architecture of COVID-19.
33274348 2020. CovMulNet19, Integrating Proteins, Diseases, Drugs, and Symptoms: A Network Medicine Approach to COVID-19.
34031419 2021. Comparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infection.
35100418 2022. AggMapNet: enhanced and explainable low-sample omics deep learning with feature-aggregated multi-channel networks.
34761257 2022. SCoV2-MD: a database for the dynamics of the SARS-CoV-2 proteome and variant impact predictions.
34718748 2022. MVIP: multi-omics portal of viral infection.
34634820 2022. SCovid: single-cell atlases for exposing molecular characteristics of COVID-19 across 10 human tissues.
34554255 2022. COVID19db: a comprehensive database platform to discover potential drugs and targets of COVID-19 at whole transcriptomic scale.
35557984 2022. Weighted Gene Co-Expression Network Analysis to Identify Potential Biological Processes and Key Genes in COVID-19-Related Stroke.
34457122 2021. Comprehensive Analysis of the Systemic Transcriptomic Alternations and Inflammatory Response during the Occurrence and Progress of COVID-19.
32667665 2020. Transcriptome-based drug repositioning for coronavirus disease 2019 (COVID-19).
33842903 2021. Secondary analysis of transcriptomes of SARS-CoV-2 infection models to characterize COVID-19.
33868814 2021. Multi-schema computational prediction of the comprehensive SARS-CoV-2 vs. human interactome.
32566414 2020. Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach.
33730024 2021. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes.
33901166 2021. The first few days of a SARS-CoV-2 infection viewed at single-cell resolution.
34260589 2021. COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.
35468151 2022. Multi-omic analysis reveals enriched pathways associated with COVID-19 and COVID-19 severity.
35390032 2022. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
35085325 2022. Identification of potentially anti-COVID-19 active drugs using the connectivity MAP.
33082228 2020. Transcriptional and proteomic insights into the host response in fatal COVID-19 cases.
35377064 2022. Differential transcriptomic landscapes of multiple organs from SARS-CoV-2 early infected rhesus macaques.
32664949 2020. SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis.
34127904 2021. Network-based transcriptomic analysis identifies the genetic effect of COVID-19 to chronic kidney disease patients: A bioinformatics approach.
32963239 2020. Consensus transcriptional regulatory networks of coronavirus-infected human cells.
34031435 2021. Integrative web-based analysis of omics data for study of drugs against SARS-CoV-2.
33782412 2021. Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway.
34907210 2021. Identification of transcriptional regulatory network associated with response of ho
34376762 2021. Comparative transcriptome analyses reveal genes associated with SARS-CoV-2 infection of human lung epithelial cells.
33318519 2020. Gene expression network analysis provides potential targets against SARS-CoV-2.
33863870 2021. COVID-19: complexity of disease severity revealed by systemic and localized single cell immune atlas.
33859163 2021. Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery.
33846224 2021. Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients.
33813307 2021. A SARS-CoV-2 -human metalloproteome interaction map.
33735949 2021. OverCOVID: an integrative web portal for SARS-CoV-2 bioinformatics resources.
34080738 2021. Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns.
33162722 2020. A comprehensive overview of proteomics approach for COVID 19: new perspectives in target therapy strategies.
34550702 2021. Discovery Proteomics for COVID-19: Where We Are Now.
34379420 2021. A Multi-omics Longitudinal Study Reveals Alteration of the Leukocyte Activation Pathway in COVID-19 Patients.
33666082 2021. Ubiquitin-Modified Proteome of SARS-CoV-2-Infected Host Cells Reveals Insights into Virus-Host Interaction and Pathogenesis.
34080435 2021. Proteomic Analysis Identifies Prolonged Disturbances in Pathways Related to Cholesterol Metabolism and Myocardium Function in the COVID-19 Recovery Stage.
34077217 2021. Mass Spectrometric Analysis of Urine from COVID-19 Patients for Detection of SARS-CoV-2 Viral Antigen and to Study Host Response.
33464917 2021. Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology.
33426872 2021. Role of Multiomics Data to Understand Host-Pathogen Interactions in COVID-19 Pathogenesis.
33103435 2020. Computational Identification of Human Biological Processes and Protein Sequence Motifs Putatively Targeted by SARS-CoV-2 Proteins Using Protein-Protein Interaction Networks.
32654489 2020. Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning.
33245774 2021. PAGER-CoV: a comprehensive collection of pathways, annotated gene-lists and gene signatures for coronavirus disease studies.
35511057 2022. deepHPI: a comprehensive deep learning platform for accurate prediction and visualization of host-pathogen protein-protein interactions.

Other interesting papers

these were retrieved by the filtered omics search and seem to be important


35310032 2022. Integrating Metabolomics and Network Pharmacology to Explore the Protective Effect of Ginsenoside Re against Radiotherapy Injury in Mice.
35184750 2022. Systematic comparison of published host gene expression signatures for bacterial/viral discrimination.
34403366 2021. Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19.
32903321 2020. Localization of Cell Receptor-Related Genes of SARS-CoV-2 in the Kidney through Single-Cell Transcriptome Analysis.
35339689 2022. Key benefits of dexamethasone and antibody treatment in COVID-19 hamster models revealed by single-cell transcriptomics.
34312385 2021. Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping'.
34262047 2021. Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.
34116393 2021. Magnesium treatment on methylation changes of transmembrane serine protease 2 (TMPRSS2).
33521378 2021. Hypoxia-inducible factor (HIF): The link between obesity and COVID-19.
33991451 2021. Hypoxia induces expression of angiotensin-converting enzyme II in alveolar epithelial cells: Implications for the pathogenesis of acute lung injury in COVID-19.
34673800 2021. Klotho deficiency intensifies hypoxia-induced expression of IFN-alpha/beta through upregulation of RIG-I in kidneys.
33661927 2021. Hypoxia-induced inflammation: Profiling the first 24-hour posthypoxic plasma and central nervous system changes.
34108245 2021. HIF-1alpha is a negative regulator of interferon regulatory factors: Implications for interferon production by hypoxic monocytes. st epithelial cells to SARS-CoV-2.
35502829 2022. Bees can be trained to identify SARS-CoV-2 infected samples.
35543533 2022. Impaired exercise capacity in post-COVID syndrome: the role of VWF-ADAMTS13 axis.
35496775 2022. Cognitive deficits and memory impairments after COVID-19 (Covishield) vaccination.
35211628 2022. 29 m(6)A-RNA Methylation (Epitranscriptomic) Regulators Are Regulated in 41 Diseases including Atherosclerosis and Tumors Potentially via ROS Regulation - 102 Transcriptomic Dataset Analyses.
33307139 2021. Total infectomes of 162 SARS-CoV-2 cases using meta-transcriptomic sequencing.
35291496 2022. SARS-CoV-2 infecting endothelial cells, biochemical alterations, autopsy findings and outcomes in COVID-19, suggest role of hypoxia-inducible factor-1.
33913550 2021. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
35064792 2022. Disturbed lipid and amino acid metabolisms in COVID-19 patients.
34626364 2022. Activation of STAT3 signaling pathway in the kidney of COVID-19 patients.
33724837 2021. Systemic Perturbations in Amine and Kynurenine Metabolism Associated with Acute SARS-CoV-2 Infection and Inflammatory Cytokine Responses.
34920080 2022. The spike protein of SARS-CoV-2 induces heme oxygenase-1: Pathophysiologic implications.
34835015 2021. SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism.
33991451 2021. Hypoxia induces expression of angiotensin-converting enzyme II in alveolar epithelial cells: Implications for the pathogenesis of acute lung injury in COVID-19.
34673800 2021. Klotho deficiency intensifies hypoxia-induced expression of IFN-alpha/beta through upregulation of RIG-I in kidneys.
33661927 2021. Hypoxia-induced inflammation: Profiling the first 24-hour posthypoxic plasma and central nervous system changes.
34108245 2021. HIF-1alpha is a negative regulator of interferon regulatory factors: Implications for interferon production by hypoxic monocytes.

Full Dataset

the two collections above are the most on-topic results. there were much more items of covid interest retrieved. temporally, anything e.g. about 2000 of 10000 primary results including the above contents will be shown here, later, the above items will be subtracted"


33399506 2021. The RSNA International COVID-19 Open Radiology Database (RICORD).
33932453 2021. Nrf2 activation putatively mediates clinical benefits of low-dose radiotherapy in COVID-19 pneumonia and acute respiratory distress syndrome (ARDS): Novel mechanistic considerations.
34146958 2021. SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione.
35599705 2022. Molecular analysis of vascular gene expression.
35547851 2022. CNBP restricts SARS-CoV2 by regulating IFN and disrupting RNA-protein condensates.
35434729 2022. A path-based analysis of infected cell line and COVID-19 patient transcriptome reveals novel potential targets and drugs against SARS-CoV-2.
35194601 2022. The mechanism of RNA capping by SARS-CoV-2.
34845442 2021. Severe COVID-19 infection is associated with aberrant cytokine production by infected lung epithelial cells rather than by systemic immune dysfunction.
33821262 2021. Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19.
34127967 2021. Type I Interferon Transcriptional Network Regulates Expression of Coinhibitory Receptors in Human T cells.
34127963 2021. Plasma Proteomics of COVID-19 Associated Cardiovascular Complications: Implications for Pathophysiology and Therapeutics.
33469573 2021. COVID-19 ARDS is characterized by a dysregulated host response that differs from cytokine storm and is modified by dexamethasone.
33564755 2021. miR-24 targets SARS-CoV-2 co-factor Neuropilin-1 in human brain microvascular endothelial cells: Insights for COVID-19 neurological manifestations.
34462739 2021. Upper airway gene expression reveals a more robust innate and adaptive immune response to SARS-CoV-2 in children compared with older adults.
34401873 2021. SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release.
33236003 2020. SARS-CoV-2 Infected Cardiomyocytes Recruit Monocytes by Secreting CCL2.
32702734 2020. Potentially repurposable drugs for COVID-19 identified from SARS-CoV-2 Host Protein Interactome.
32702714 2020. Interactome of SARS-CoV-2 / nCoV19 modulated host proteins with computationally predicted PPIs.
32702730 2020. In silico Drug Repurposing to combat COVID-19 based on Pharmacogenomics of Patient Transcriptomic Data.
33398261 2020. Broad Auto-Reactive IgM Responses Are Common In Critically Ill COVID-19 Patients.
34051791 2021. Dysregulation of COVID-19 related gene expression in the COPD lung.
33823870 2021. Adhatoda Vasica attenuates inflammatory and hypoxic responses in preclinical mouse models: potential for repurposing in COVID-19-like conditions.
32664949 2020. SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis.
32597823 2020. AhR and IDO1 in pathogenesis of Covid-19 and the "Systemic AhR Activation Syndrome:" a translational review and therapeutic perspectives.
34252234 2022. Long noncoding RNAs in respiratory viruses: A review.
34773448 2021. C-reactive protein as an effector molecule in Covid-19 pathogenesis.
35232816 2022. The key features of SARS-CoV-2 leader and NSP1 required for viral escape of NSP1-mediated repression.
34937774 2022. sgDI-tector: defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAs.
34127534 2021. Genes with 5' terminal oligopyrimidine tracts preferentially escape global suppression of translation by the SARS-CoV-2 Nsp1 protein.
34315815 2021. SARS-CoV-2 infection triggers widespread host mRNA decay leading to an mRNA export block.
32699064 2020. Viral subversion of nonsense-mediated mRNA decay.
33268501 2020. The viral protein NSP1 acts as a ribosome gatekeeper for shutting down host translation and fostering SARS-CoV-2 translation.
33530819 2021. Peripheral blood microRNAs and the COVID-19 patient: methodological considerations, technical challenges and practice points.
32615049 2021. The emerging role and significance of circular RNAs in viral infections and antiviral immune responses: possible implication as theranostic agents.
34248311 2021. Genetic Control of Human Infection with SARS-CoV-2.
34127904 2021. Network-based transcriptomic analysis identifies the genetic effect of COVID-19 to chronic kidney disease patients: A bioinformatics approach.
34305429 2021. Relevance between COVID-19 and host genetics of immune response.
34366686 2021. Integrated multi-omics approach identified molecular mechanism and pathogenetic processes of COVID-19 that affect patient with Parkinson's disorder.
35648852 2022. A systems biology approach identifies candidate drugs to reduce mortality in severely ill patients with COVID-19.
35108055 2022. Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor-induced dipeptidase-1 expression and glutathione depletion.
34516880 2021. Platelets amplify endotheliopathy in COVID-19.
33888467 2021. SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity.
33277324 2021. MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program.
33547084 2021. Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression.
33536218 2021. A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood.
34407940 2021. Age-dependent regulation of SARS-CoV-2 cell entry genes and cell death programs correlates with COVID-19 severity.
33239293 2020. Regeneration of the pulmonary vascular endothelium after viral pneumonia requires COUP-TF2.
32494691 2020. Surviving COVID-19: A disease tolerance perspective.
32596474 2020. Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2.
33457042 2021. A large-scale transcriptional study reveals inhibition of COVID-19 related cytokine storm by traditional Chinese medicines.
35290573 2022. A urinary proteomic landscape of COVID-19 progression identifies signaling pathways and therapeutic options.
34387838 2022. Overview of SARS-CoV-2 genome-encoded proteins.
35508791 2022. Identification of serum metabolites enhancing inflammatory responses in COVID-19.
33564978 2021. Single-cell transcriptomes of peripheral blood cells indicate and elucidate severity of COVID-19.
32963239 2020. Consensus transcriptional regulatory networks of coronavirus-infected human cells.
33664060 2021. SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8(+) T cell responses.
34376481 2021. Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients.
35277538 2022. Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing.
35102215 2022. Metabolomics study of COVID-19 patients in four different clinical stages.
35079083 2022. Dual RNA-Seq analysis of SARS-CoV-2 correlates specific human transcriptional response pathways directly to viral expression.
35181735 2022. Immune transcriptome analysis of COVID-19 patients infected with SARS-CoV-2 variants carrying the E484K escape mutation identifies a distinct gene module.
35393464 2022. Host-pathogen dynamics in longitudinal clinical specimens from patients with COVID-19.
35477940 2022. Integrated analysis of transcriptomic data reveals the platelet response in COVID-19 disease.
34556735 2021. Network neighbors of viral targets and differentially expressed genes in COVID-19 are drug target candidates.
34535740 2021. Prolyl isomerase Pin1 plays an essential role in SARS-CoV-2 proliferation, indicating its possibility as a novel therapeutic target.
34615949 2021. Transcriptomic analysis revealed increased expression of genes involved in keratinization in the tears of COVID-19 patients.
34615934 2021. Drug repositioning by merging active subnetworks validated in cancer and COVID-19.
34675292 2021. Inferring a causal relationship between ceramide levels and COVID-19 respiratory distress.
34675242 2021. Meta-analysis of COVID-19 single-cell studies confirms eight key immune responses.
34750486 2021. Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis.
34031435 2021. Integrative web-based analysis of omics data for study of drugs against SARS-CoV-2.
34017039 2021. Metabolomics and computational analysis of the role of monoamine oxidase activity in delirium and SARS-COV-2 infection.
33782412 2021. Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway.
33762619 2021. Mining of high throughput screening database reveals AP-1 and autophagy pathways as potential targets for COVID-19 therapeutics.
33737694 2021. Metabolomics analysis reveals a modified amino acid metabolism that correlates with altered oxygen homeostasis in COVID-19 patients.
33737684 2021. Proteomic blood profiling in mild, severe and critical COVID-19 patients.
34112877 2021. Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19.
34226623 2021. UVC disinfects SARS-CoV-2 by induction of viral genome damage without apparent effects on viral morphology and proteins.
34226622 2021. Understanding protection from SARS-CoV-2 using metabolomics.
34282210 2021. Targeted metabolomics identifies high performing diagnostic and prognostic biomarkers for COVID-19.
34272434 2021. Proteomics and metabonomics analyses of Covid-19 complications in patients with pulmonary fibrosis.
33420163 2021. Host mitochondrial transcriptome response to SARS-CoV-2 in multiple cell models and clinical samples.
33510359 2021. Meta-analysis of host transcriptional responses to SARS-CoV-2 infection reveals their manifestation in human tumors.
33510353 2021. Network theoretic analysis of JAK/STAT pathway and extrapolation to drugs and viruses including COVID-19.
33504824 2021. Altered high-density lipoprotein composition and functions during severe COVID-19.
33479353 2021. Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19.
33637823 2021. Homologies between SARS-CoV-2 and allergen proteins may direct T cell-mediated heterologous immune responses.
33627767 2021. Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach.
34857794 2021. Multiscale interactome analysis coupled with off-target drug predictions reveals drug repurposing candidates for human coronavirus disease.
34907210 2021. Identification of transcriptional regulatory network associated with response of host epithelial cells to SARS-CoV-2.
34433832 2021. Homology between SARS CoV-2 and human proteins.
34413339 2021. SARS-CoV-2 infection initiates interleukin-17-enriched transcriptional response in different cells from multiple organs.
34404832 2021. Inhibiting SARS-CoV-2 infection in vitro by suppressing its receptor, angiotensin-converting enzyme 2, via aryl-hydrocarbon receptor signal.
34376762 2021. Comparative transcriptome analyses reveal genes associated with SARS-CoV-2 infection of human lung epithelial cells.
33883570 2021. Evidence of a dysregulated vitamin D endocrine system in SARS-CoV-2 infected patient's lung cells.
33846375 2021. A study of differential circRNA and lncRNA expressions in COVID-19-infected peripheral blood.
32929138 2020. Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition.
33033346 2020. The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism.
33077837 2020. Finding disease modules for cancer and COVID-19 in gene co-expression networks with the Core&Peel method.
33177594 2020. SARS-CoV-2 receptor is co-expressed with elements of the kinin-kallikrein, renin-angiotensin and coagulation systems in alveolar cells.
33173052 2020. Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy.
33293627 2020. SARS-CoV-2 receptor ACE2 is co-expressed with genes related to transmembrane serine proteases, viral entry, immunity and cellular stress.
33376242 2020. In-depth blood proteome profiling analysis revealed distinct functional characteristics of plasma proteins between severe and non-severe COVID-19 patients.
33318519 2020. Gene expression network analysis provides potential targets against SARS-CoV-2.
32843695 2020. Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome.
33431511 2021. Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys.
34581622 2021. A prenylated dsRNA sensor protects against severe COVID-19.
32680882 2020. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2.
35047828 2020. Mini review: Recent progress in RT-LAMP enabled COVID-19 detection.
35091530 2022. Proteomic and phosphoproteomic profiling of COVID-19-associated lung and liver injury: a report based on rhesus macaques.
35091528 2022. Integrated histopathological, lipidomic, and metabolomic profiles reveal mink is a useful animal model to mimic the pathogenicity of severe COVID-19 patients.
35075101 2022. SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules.
34322127 2021. A Single-Cell Atlas of Lymphocyte Adaptive Immune Repertoires and Transcriptomes Reveals Age-Related Differences in Convalescent COVID-19 Patients.
34276672 2021. Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection.
34262555 2021. Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.
34248940 2021. Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism.
34135895 2021. Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients.
34108966 2021. Transcriptional Changes in CD16+ Monocytes May Contribute to the Pathogenesis of COVID-19.
33995382 2021. SARS-CoV-2 Induces Lymphocytopenia by Promoting Inflammation and Decimates Secondary Lymphoid Organs.
33936086 2021. SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human Microglia.
33936072 2021. Single-Cell RNA Sequencing Analysis of the Immunometabolic Rewiring and Immunopathogenesis of Coronavirus Disease 2019.
33868293 2021. MicroLet-7b Regulates Neutrophil Function and Dampens Neutrophilic Inflammation by Suppressing the Canonical TLR4/NF-kappaB Pathway.
33868239 2021. Genetics Insight for COVID-19 Susceptibility and Severity: A Review.
33796097 2021. Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues.
33717140 2021. Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.
33679760 2021. Cyclic-di-GMP Induces STING-Dependent ILC2 to ILC1 Shift During Innate Type 2 Lung Inflammation.
33362771 2020. A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.
33329603 2020. Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways.
33042157 2020. Mast Cells in Alveolar Septa of COVID-19 Patients: A Pathogenic Pathway That May Link Interstitial Edema to Immunothrombosis.
33013872 2020. Excessive Neutrophils and Neutrophil Extracellular Traps in COVID-19.
32983174 2020. Re-analysis of Single Cell Transcriptome Reveals That the NR3C1-CXCL8-Neutrophil Axis Determines the Severity of COVID-19.
32670298 2020. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.
35258762 2022. Integrated analysis of gut microbiome and host immune responses in COVID-19.
35192147 2022. PathogenTrack and Yeskit: tools for identifying intracellular pathogens from single-cell RNA-sequencing datasets as illustrated by application to COVID-19.
34557504 2021. Unraveling Risk Genes of COVID-19 by Multi-Omics Integrative Analyses.
34368185 2021. Potential Implications of a Type 1 Interferon Gene Signature on COVID-19 Severity and Chronic Inflammation in Sickle Cell Disease.
35047913 2021. The SIRAH-CoV-2 Initiative: A Coarse-Grained Simulations' Dataset of the SARS-CoV-2 Proteome.
35572676 2022. Metabolomic Profiling of Plasma Reveals Differential Disease Severity Markers in COVID-19 Patients.
35531299 2022. The Intricacy of the Viral-Human Protein Interaction Networks: Resources, Data, and Analyses.
35464969 2022. Rapid and Accurate Detection of SARS Coronavirus 2 by Nanopore Amplicon Sequencing.
35391730 2022. Inflammatory Bowel Disease and COVID-19: How Microbiomics and Metabolomics Depict Two Sides of the Same Coin.
35369457 2022. Inflammatory Profiles of Tracheal Biopsies From SARS-CoV-2 Patients.
35222346 2022. The Hidden Enemy Within: Non-canonical Peptides in Virus-Induced Autoimmunity.
34925252 2021. Longitudinal Metabolomics Reveals Ornithine Cycle Dysregulation Correlates With Inflammation and Coagulation in COVID-19 Severe Patients.
34917069 2021. The Triangle Relationship Between Long Noncoding RNA, RIG-I-like Receptor Signaling Pathway, and Glycolysis.
34899651 2021. Suppression and Activation of Intracellular Immune Response in Initial Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
34659188 2021. Coronavirus Nsp1: Immune Response Suppression and Protein Expression Inhibition.
34650546 2021. ORF3a Protein of Severe Acute Respiratory Syndrome Coronavirus 2 Inhibits Interferon-Activated Janus Kinase/Signal Transducer and Activator of Transcription Signaling via Elevating Suppressor of Cytokine Signaling 1.
33815307 2021. Genomic Feature Analysis of Betacoronavirus Provides Insights Into SARS and COVID-19 Pandemics.
33329483 2020. Rapid Scanning Electron Microscopy Detection and Sequencing of Severe Acute Respiratory Syndrome Coronavirus 2 and Other Respiratory Viruses.
33324374 2020. Comparative Transcriptome Analysis Reveals the Intensive Early Stage Responses of Host Cells to SARS-CoV-2 Infection.
33178176 2020. Differential Expression of Viral Transcripts From Single-Cell RNA Sequencing of Moderate and Severe COVID-19 Patients and Its Implications for Case Severity.
33071996 2020. Proteomics Insights Into the Molecular Basis of SARS-CoV-2 Infection: What We Can Learn From the Human Olfactory Axis.
35620480 2022. Identifying Methylation Signatures and Rules for COVID-19 With Machine Learning Methods.
35573725 2022. Comparative Analysis of Long Non-Coding RNA Expression and Immune Response in Mild and Severe COVID-19.
35480886 2022. Serum NMR Profiling Reveals Differential Alterations in the Lipoproteome Induced by Pfizer-BioNTech Vaccine in COVID-19 Recovered Subjects and Naive Subjects.
35372520 2022. Host Cell Glycocalyx Remodeling Reveals SARS-CoV-2 Spike Protein Glycomic Binding Sites.
34938772 2021. Metabolic and Lipidomic Markers Differentiate COVID-19 From Non-Hospitalized and Other Intensive Care Patients.
33693030 2021. Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection.
33585567 2020. SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells.
33585554 2020. SARS-CoV-2 Proteins Exploit Host's Genetic and Epigenetic Mediators for the Annexation of Key Host Signaling Pathways.
33195414 2020. Identifying Pathways and Networks Associated With the SARS-CoV-2 Cell Receptor ACE2 Based on Gene Expression Profiles in Normal and SARS-CoV-2-Infected Human Tissues.
32974389 2020. SR/RS Motifs as Critical Determinants of Coronavirus Life Cycle.
34512253 2021. Nervous System-Systemic Crosstalk in SARS-CoV-2/COVID-19: A Unique Dyshomeostasis Syndrome.
35520289 2022. Network Pharmacology and Comparative Transcriptome Reveals Biotargets and Mechanisms of Curcumol Treating Lung Adenocarcinoma Patients With COVID-19.
34070662 2021. Breast Milk and COVID-19: From Conventional Data to "Omics" Technologies to Investigate Changes Occurring in SARS-CoV-2 Positive Mothers.
35639648 2022. Pregnancy, Preeclampsia, and COVID-19: Susceptibility and Mechanisms: A Review Study.
35282650 2022. The Key Genes Underlying Pathophysiology Correlation Between the Acute Myocardial Infarction and COVID-19.
34675627 2021. Construction and Investigation of Competing Endogenous RNA Networks and Candidate Genes Involved in SARS-CoV-2 Infection.
33110916 2020. Exploring Host Genetic Polymorphisms Involved in SARS-CoV Infection Outcomes: Implications for Personalized Medicine in COVID-19.
34569339 2021. A scoping review of the pathophysiology of COVID-19.
33610778 2021. SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections.
34623759 2021. New insights into genetic characteristics between multiple myeloma and COVID-19: An integrative bioinformatics analysis of gene expression omnibus microarray and the cancer genome atlas data.
34104087 2021. SARS-CoV-2 infection activates a subset of intrinsic pathways to inhibit type I interferons in vitro and in vivo.
33526974 2021. Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection induces dysregulation of immunity: in silico gene expression analysis.
35328409 2022. SARS-CoV-2 Membrane Protein: From Genomic Data to Structural New Insights.
35163833 2022. AKR1B10, One of the Triggers of Cytokine Storm in SARS-CoV2 Severe Acute Respiratory Syndrome.
35269564 2022. COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19.
34638812 2021. Untargeted Metabolic Profiling of Extracellular Vesicles of SARS-CoV-2-Infected Patients Shows Presence of Potent Anti-Inflammatory Metabolites.
34638691 2021. The MiR-320 Family Is Strongly Downregulated in Patients with COVID-19 Induced Severe Respiratory Failure.
34502454 2021. The Serum Metabolome of Moderate and Severe COVID-19 Patients Reflects Possible Liver Alterations Involving Carbon and Nitrogen Metabolism.
34681944 2021. Alveolar Regeneration in COVID-19 Patients: A Network Perspective.
34681641 2021. G-Quadruplex Targeting in the Fight against Viruses: An Update.
34884813 2021. Pathogenesis and Treatment of Cytokine Storm Induced by Infectious Diseases.
34073578 2021. Ceramide and Related Molecules in Viral Infections.
33807682 2021. CNBP Binds and Unfolds In Vitro G-Quadruplexes Formed in the SARS-CoV-2 Positive and Negative Genome Strands.
33806254 2021. Ribosome-Profiling Reveals Restricted Post Transcriptional Expression of Antiviral Cytokines and Transcription Factors during SARS-CoV-2 Infection.
34200325 2021. Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors.
34205975 2021. Multifaced Roles of HDL in Sepsis and SARS-CoV-2 Infection: Renal Implications.
34360824 2021. SARS-CoV-2 Infected Pediatric Cerebral Cortical Neurons: Transcriptomic Analysis and Potential Role of Toll-like Receptors in Pathogenesis.
34360778 2021. Detecting and Profiling Endogenous RNA G-Quadruplexes in the Human Transcriptome.
34360732 2021. The Good and Bad of Nrf2: An Update in Cancer and New Perspectives in COVID-19.
33430309 2021. Mapping the SARS-CoV-2-Host Protein-Protein Interactome by Affinity Purification Mass Spectrometry and Proximity-Dependent Biotin Labeling: A Rational and Straightforward Route to Discover Host-Directed Anti-SARS-CoV-2 Therapeutics.
33669808 2021. Ex uno, plures-From One Tissue to Many Cells: A Review of Single-Cell Transcriptomics in Cardiovascular Biology.
34947989 2021. MicroRNA-Mediated Regulation of the Virus Cycle and Pathogenesis in the SARS-CoV-2 Disease.
35008724 2021. Exploring the Catalytic Mechanism of the RNA Cap Modification by nsp16-nsp10 Complex of SARS-CoV-2 through a QM/MM Approach.
35459913 2022. Novel potential metabolic biomarker panel for early detection of severe COVID-19 using full-spectrum metabolome and whole-transcriptome analyses.
34531370 2021. Single-cell immune profiling reveals distinct immune response in asymptomatic COVID-19 patients.
34732709 2021. Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection.
33677468 2021. Dynamic blood single-cell immune responses in patients with COVID-19.
34083512 2021. Sera proteomic features of active and recovered COVID-19 patients: potential diagnostic and prognostic biomarkers.
34330889 2021. Multimodal single-cell omics analysis identifies epithelium-immune cell interactions and immune vulnerability associated with sex differences in COVID-19.
34253708 2021. The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction.
33419962 2021. Pathological features of COVID-19-associated liver injury-a preliminary proteomics report based on clinical samples.
33619245 2021. Genome and epigenome editing identify CCR9 and SLC6A20 as target genes at the 3p21.31 locus associated with severe COVID-19.
34916489 2021. COVID-19 induces new-onset insulin resistance and lipid metabolic dysregulation via regulation of secreted metabolic factors.
34893580 2021. Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks.
33863870 2021. COVID-19: complexity of disease severity revealed by systemic and localized single cell immune atlas.
33859163 2021. Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery.
32883951 2020. COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm.
33037188 2020. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
33024075 2020. Salvianolic acid C potently inhibits SARS-CoV-2 infection by blocking the formation of six-helix bundle core of spike protein.
33024073 2020. Main protease of SARS-CoV-2 serves as a bifunctional molecule in restricting type I interferon antiviral signaling.
33097684 2020. Omics study reveals abnormal alterations of breastmilk proteins and metabolites in puerperant women with COVID-19.
33060566 2020. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples.
32467561 2020. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2.
32561706 2020. Temporal profiling of plasma cytokines, chemokines and growth factors from mild, severe and fatal COVID-19 patients.
32641705 2020. Single cell transcriptome revealed SARS-CoV-2 entry genes enriched in colon tissues and associated with coronavirus infection and cytokine production.
33361761 2020. Longitudinal transcriptome analyses show robust T cell immunity during recovery from COVID-19.
33941271 2021. Multi-omics reveals age-related differences in the diaphragm response to mechanical ventilation: a pilot study.
32578378 2020. Nanopore Targeted Sequencing for the Accurate and Comprehensive Detection of SARS-CoV-2 and Other Respiratory Viruses.
32714115 2020. Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis.
32714116 2020. Activation of the SARS-CoV-2 Receptor Ace2 by Cytokines Through Pan JAK-STAT Enhancers.
32742242 2020. Single-Cell Transcriptomic Analysis of SARS-CoV-2 Reactive CD4 (+) T Cells.
33475497 2020. SARS-CoV infection crosstalk with human host cell noncoding-RNA machinery: An in-silico approach.
35251616 2022. A novel concept of human antiviral protection: It's all about RNA (Review).
35528178 2022. Recognition of Immune Cell Markers of COVID-19 Severity with Machine Learning Methods.
35528173 2022. Discovering Common Pathophysiological Processes between COVID-19 and Cystic Fibrosis by Differential Gene Expression Pattern Analysis.
34307679 2021. Identifying COVID-19-Specific Transcriptomic Biomarkers with Machine Learning Methods.
35453568 2022. Molecular Mechanism of Pancreatic beta-Cell Failure in Type 2 Diabetes Mellitus.
34572329 2021. Epigenetic Mechanisms Underlying COVID-19 Pathogenesis.
33352880 2020. Evidence of SARS-CoV-2 Transcriptional Activity in Cardiomyocytes of COVID-19 Patients without Clinical Signs of Cardiac Involvement.
35625619 2022. Immune-Related Protein Interaction Network in Severe COVID-19 Patients toward the Identification of Key Proteins and Drug Repurposing.
35204689 2022. Looking at COVID-19 from a Systems Biology Perspective.
35169794 2022. Comparative analysis of cell-cell communication at single-cell resolution.
35350199 2022. Autoantibody discovery across monogenic, acquired, and COVID19-associated autoimmunity with scalable PhIP-Seq.
35313584 2022. Genetic control of the dynamic transcriptional response to immune stimuli and glucocorticoids at single cell resolution.
35313583 2022. Dynamic single-cell RNA sequencing reveals BCG vaccination curtails SARS-CoV-2 induced disease severity and lung inflammation.
35118467 2022. Variant to function mapping at single-cell resolution through network propagation.
35043114 2022. A single-cell atlas reveals shared and distinct immune responses and metabolism during SARS-CoV-2 and HIV-1 infections.
35233578 2022. Discovery and functional interrogation of SARS-CoV-2 protein-RNA interactions.
35233572 2022. Targeted Down Regulation Of Core Mitochondrial Genes During SARS-CoV-2 Infection.
35194610 2022. SARS-CoV-2 Nsp14 mediates the effects of viral infection on the host cell transcriptome.
35132419 2022. Human Cardiac Organoids to Model COVID-19 Cytokine Storm Induced Cardiac Injuries.
33907750 2022. Identification of druggable host targets needed for SARS-CoV-2 infection by combined pharmacological evaluation and cellular network directed prioritization both in vitro and in vivo.
34580671 2021. A BioID-derived proximity interactome for SARS-CoV-2 proteins.
34189529 2021. Predicting gene regulatory networks from multi-omics to link genetic risk variants and neuroimmunology to Alzheimer's disease phenotypes.
33173862 2021. The translational landscape of SARS-CoV-2 and infected cells.
34642692 2021. Longitudinal characterization of circulating neutrophils uncovers distinct phenotypes associated with disease severity in hospitalized COVID-19 patients.
34845443 2021. Unambiguous detection of SARS-CoV-2 subgenomic mRNAs with single cell RNA sequencing.
34845454 2021. Identifying disease-critical cell types and cellular processes across the human body by integration of single-cell profiles and human genetics.
33106807 2021. Adult Stem Cell-derived Complete Lung Organoid Models Emulate Lung Disease in COVID-19.
33972946 2021. ORAI1 establishes resistance to SARS-CoV-2 infection by regulating tonic type I interferon signaling.
33972943 2021. Signaling through FcgammaRIIA and the C5a-C5aR pathway mediates platelet hyperactivation in COVID-19.
34075374 2021. SARS-CoV-2 Nsp14 activates NF-kappaB signaling and induces IL-8 upregulation.
32995776 2021. Genes with 5' terminal oligopyrimidine tracts preferentially escape global suppression of translation by the SARS-CoV-2 Nsp1 protein.
33758858 2021. Systemic Tissue and Cellular Disruption from SARS-CoV-2 Infection revealed in COVID-19 Autopsies and Spatial Omics Tissue Maps.
33758849 2021. Comparative host interactomes of the SARS-CoV-2 nonstructural protein 3 and human coronavirus homologs.
33688643 2021. Published Anti-SARS-CoV-2 In Vitro Hits Share Common Mechanisms of Action that Synergize with Antivirals.
33791703 2021. ACE2 protein expression within isogenic cell lines is heterogeneous and associated with distinct transcriptomes.
33619493 2021. Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism.
33758859 2021. Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19.
32511352 2020. Shotgun Transcriptome and Isothermal Profiling of SARS-CoV-2 Infection Reveals Unique Host Responses, Viral Diversification, and Drug Interactions.
32587962 2020. The IMEx Coronavirus interactome: an evolving map of Coronaviridae-Host molecular interactions.
32587963 2020. Single-cell transcriptomic analysis of SARS-CoV-2 reactive CD4 (+) T cells.
32511305 2020. Analysis of Infected Host Gene Expression Reveals Repurposed Drug Candidates and Time-Dependent Host Response Dynamics for COVID-19.
32511372 2020. Nrf2 Activator PB125(R) as a Potential Therapeutic Agent Against COVID-19.
32676594 2020. Unique transcriptional changes in coagulation cascade genes in SARS-CoV-2-infected lung epithelial cells: A potential factor in COVID-19 coagulopathies.
32766585 2020. Multiomic Immunophenotyping of COVID-19 Patients Reveals Early Infection Trajectories.
32766588 2020. Direct exposure to SARS-CoV-2 and cigarette smoke increases infection severity and alters the stem cell-derived airway repair response.
32511341 2020. Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection.
32511379 2020. Consensus transcriptional regulatory networks of coronavirus-infected human cells.
32699849 2020. Comparative multiplexed interactomics of SARS-CoV-2 and homologous coronavirus non-structural proteins identifies unique and shared host-cell dependencies.
32511382 2020. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium.
32676602 2020. Severely ill COVID-19 patients display augmented functional properties in SARS-CoV-2-reactive CD8 + T cells.
32637948 2020. Genetic architecture of host proteins interacting with SARS-CoV-2.
33300002 2020. Chromatin remodeling in peripheral blood cells reflects COVID-19 symptom severity.
33330860 2020. Circular RNA profiling reveals abundant and diverse circRNAs of SARS-CoV-2, SARS-CoV and MERS-CoV origin.
33299989 2020. Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first six months of the COVID-19 pandemic.
33299992 2020. Transcriptional response modules characterise IL-1beta and IL-6 activity in COVID-19.
33299987 2020. COVID-19 genetic risk variants are associated with expression of multiple genes in diverse immune cell types.
33330871 2020. Profound Treg perturbations correlate with COVID-19 severity.
33330870 2020. SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome.
34013266 2020. Serial co-expression analysis of host factors from SARS-CoV viruses highly converges with former high-throughput screenings and proposes key regulators and co-option of cellular pathways.
32793903 2020. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection.
32869031 2020. Elucidation of remdesivir cytotoxicity pathways through genome-wide CRISPR-Cas9 screening and transcriptomics.
32839770 2020. SARS-CoV-2 ORF9c Is a Membrane-Associated Protein that Suppresses Antiviral Responses in Cells.
32511381 2020. An in silico map of the SARS-CoV-2 RNA Structurome.
32511326 2020. Type 2 and interferon inflammation strongly regulate SARS-CoV-2 related gene expression in the airway epithelium.
34313294 2021. A lipidomic view of SARS-CoV-2.
34291285 2021. Biochemical composition, transmission and diagnosis of SARS-CoV-2.
33401144 2021. Entropy-driven electrochemiluminescence ultra-sensitive detection strategy of NF-kappaB p50 as the regulator of cytokine storm.
33612988 2021. Den molekularen Wirtszellveranderungen durch SARS-CoV-2 auf der Spur.
34315173 2021. Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets.
32573711 2020. Platelet gene expression and function in patients with COVID-19.
33635335 2021. A neutrophil activation signature predicts critical illness and mortality in COVID-19.
35180460 2022. Upregulation of cytokine signalling in platelets increases risk of thrombophilia in severe COVID-19 patients.
34837942 2021. A multitask transfer learning framework for the prediction of virus-human protein-protein interactions.
33941085 2021. The Coronavirus Network Explorer: mining a large-scale knowledge graph for effects of SARS-CoV-2 on host cell function.
33663372 2021. OmicLoupe: facilitating biological discovery by interactive exploration of multiple omic datasets and statistical comparisons.
33413085 2021. H2V: a database of human genes and proteins that respond to SARS-CoV-2, SARS-CoV, and MERS-CoV infection.
34922446 2021. GraphOmics: an interactive platform to explore and integrate multi-omics data.
33832440 2021. Common low complexity regions for SARS-CoV-2 and human proteomes as potential multidirectional risk factor in vaccine development.
33008363 2020. Real-time audio and visual display of the Coronavirus genome.
33482803 2021. A protocol for adding knowledge to Wikidata: aligning resources on human coronaviruses.
33980308 2021. Echinacea purpurea (L.) Moench treatment of monocytes promotes tonic interferon signaling, increased innate immunity gene expression and DNA repeat hypermethylated silencing of endogenous retroviral sequences.
35379171 2022. Predicted coronavirus Nsp5 protease cleavage sites in the human proteome.
34775962 2021. Analysis of transcriptomic data sets supports the role of IL-6 in NETosis and immunothrombosis in severe COVID-19.
33407110 2021. Rapid single cell evaluation of human disease and disorder targets using REVEAL: SingleCell.
35027067 2022. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection.
35461273 2022. SARS-COV-2 as potential microRNA sponge in COVID-19 patients.
35421970 2022. Co-expression analysis to identify key modules and hub genes associated with COVID-19 in platelets.
34030677 2021. Extremes of age are associated with differences in the expression of selected pattern recognition receptor genes and ACE2, the receptor for SARS-CoV-2: implications for the epidemiology of COVID-19 disease.
34116667 2021. A blood RNA transcriptome signature for COVID-19.
33413329 2021. Computational analysis to repurpose drugs for COVID-19 based on transcriptional response of host cells to SARS-CoV-2.
35331159 2022. Regulation of SARS CoV-2 host factors in the kidney and heart in rats with 5/6 nephrectomy-effects of salt, ARB, DPP4 inhibitor and SGLT2 blocker.
35123426 2022. Possible kidney-lung cross-talk in COVID-19: in silico modeling of SARS-CoV-2 infection.
34774005 2021. Using genetics to understand the role of kidney function in COVID-19: a mendelian randomization study.
32883368 2020. A protein interaction map identifies existing drugs targeting SARS-CoV-2.
34715923 2021. Dysregulation of RNA interference components in COVID-19 patients.
33312949 2020. Single-Cell Sequencing of Glioblastoma Reveals Central Nervous System Susceptibility to SARS-CoV-2.
35002688 2021. Host Factor Interaction Networks Identified by Integrative Bioinformatics Analysis Reveals Therapeutic Implications in COPD Patients With COVID-19.
34531741 2021. Identification of Novel Gene Signatures using Next-Generation Sequencing Data from COVID-19 Infection Models: Focus on Neuro-COVID and Potential Therapeutics.
34163359 2021. Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19.
34054532 2021. Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19.
33995033 2021. SARS-CoV-2 Switches 'on' MAPK and NFkappaB Signaling via the Reduction of Nuclear DUSP1 and DUSP5 Expression.
33935717 2021. Na(+)/K(+)-ATPase as a Target of Cardiac Glycosides for the Treatment of SARS-CoV-2 Infection.
33762960 2021. Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis.
33716737 2021. In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19.
33289972 2020. Mining a GWAS of Severe Covid-19.
33289971 2020. Mining a GWAS of Severe Covid-19.
34541878 2021. Activation of Type I and Type II Interferon Signaling in SARS-CoV-2-Positive Thyroid Tissue of Patients Dying from COVID-19.
34740309 2021. Bioinformatics analyses reveal cell-barrier junction modulations in lung epithelial cells on SARS-CoV-2 infection.
35301621 2022. Comparative trachea transcriptome analysis in SPF broiler chickens infected with avian infectious bronchitis and avian influenza viruses.
34545716 2021. Potential of application of the RNA interference phenomenon in the treatment of new coronavirus infection COVID-19.
32102777 2020. The 2019 novel coronavirus resource.
34127975 2021. Implicating Gene and Cell Networks Responsible for Differential COVID-19 Host Responses via an Interactive Single Cell Web Portal.
33501435 2021. Severe COVID-19 associated variants linked to chemokine receptor gene control in monocytes and macrophages.
34127970 2021. Identification of ACE2 modifiers by CRISPR screening.
34729561 2021. An Autoantigen Profile from Jurkat T-Lymphoblasts Provides a Molecular Guide for Investigating Autoimmune Sequelae of COVID-19.
34341788 2021. Single-Cell Profiling of the Antigen-Specific Response to BNT162b2 SARS-CoV-2 RNA Vaccine.
34341789 2021. Molecular Pathophysiology of Cardiac Injury and Cardiac Microthrombi in Fatal COVID-19: Insights from Clinico-histopathologic and Single Nuclei RNA Sequencing Analyses.
34312624 2021. SARS-CoV-2 Restructures the Host Chromatin Architecture.
33106805 2021. Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.
32995793 2021. Fixed single-cell RNA sequencing for understanding virus infection and host response.
33501441 2021. Interferon-regulated genetic programs and JAK/STAT pathway activate the intronic promoter of the short ACE2 isoform in renal proximal tubules.
33362557 2020. Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm.
33041797 2020. In Silico Prediction of Molecular Targets of Astragaloside IV for Alleviation of COVID-19 Hyperinflammation by Systems Network Pharmacology and Bioinformatic Gene Expression Analysis.
33013423 2020. Age-Dependent Assessment of Genes Involved in Cellular Senescence, Telomere, and Mitochondrial Pathways in Human Lung Tissue of Smokers, COPD, and IPF: Associations With SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 Axis.
35185603 2021. COVID-19 and Mitochondrial Non-Coding RNAs: New Insights From Published Data.
35153822 2021. The Landscape of Aminoacyl-tRNA Synthetases Involved in Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
32754056 2020. SARS-CoV-2 Molecular Network Structure.
32695025 2020. Regulatory Cross Talk Between SARS-CoV-2 Receptor Binding and Replication Machinery in the Human Host.
35655464 2022. m6A Regulator-Mediated Methylation Modification Patterns and Characteristics in COVID-19 Patients.
34851327 2021. Case Report: First Confirmed Case of Coinfection of SARS-CoV-2 With Choclo orthohantavirus.
32903570 2020. RNA-Seq-Based Whole Transcriptome Analysis of IPEC-J2 Cells During Swine Acute Diarrhea Syndrome Coronavirus Infection.
34306168 2021. Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation.
33224264 2020. Perversely expressed long noncoding RNAs can alter host response and viral proliferation in SARS-CoV-2 infection.
32763951 2020. A Comprehensive, Flexible Collection of SARS-CoV-2 Coding Regions.
33244381 2020. Investigating the human protein-host protein interactome of SARS-CoV-2 infection in the small intestine.
32234303 2020. Multiomics Evaluation of Gastrointestinal and Other Clinical Characteristics of COVID-19.
35248659 2022. Role of genomics in combating COVID-19 pandemic.
34530086 2022. An overview of human proteins and genes involved in SARS-CoV-2 infection.
34848322 2022. Understanding the role of telomere attrition and epigenetic signatures in COVID-19 severity.
34274470 2021. Therapeutic perceptions in antisense RNA-mediated gene regulation for COVID-19.
33737124 2021. Epidemiological transcriptomic data supports BCG protection in viral diseases including COVID-19.
33346100 2021. Recognition of plausible therapeutic agents to combat COVID-19: An omics data based combined approach.
33887367 2021. Inferring molecular mechanisms of dexamethasone therapy in severe COVID-19 from existing transcriptomic data.
35662463 2022. PEPPI: Whole-proteome Protein-protein Interaction Prediction through Structure and Sequence Similarity, Functional Association, and Machine Learning.
32929000 2020. RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges.
35233559 2021. Defense of COVID-19 by Human Organoids.
34315200 2021. Interplays between human microbiota and microRNAs in COVID-19 pathogenesis: a literature review.
32809918 2020. Oxytocin's anti-inflammatory and proimmune functions in COVID-19: a transcriptomic signature-based approach.
32437232 2020. Virus-induced genetics revealed by multidimensional precision medicine transcriptional workflow applicable to COVID-19.
33991451 2021. Hypoxia induces expression of angiotensin-converting enzyme II in alveolar epithelial cells: Implications for the pathogenesis of acute lung injury in COVID-19.
34494892 2022. Implications of the NADase CD38 in COVID pathophysiology.
35032732 2022. Integrated hepatic single-cell RNA sequencing and untargeted metabolomics reveals the immune and metabolic modulation of Qing-Fei-Pai-Du decoction in mice with coronavirus-induced pneumonia.
34517257 2021. Dehydrozingerone ameliorates Lipopolysaccharide induced acute respiratory distress syndrome by inhibiting cytokine storm, oxidative stress via modulating the MAPK/NF-kappaB pathway.
33780434 2021. Disparate temperature-dependent virus-host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium.
33730024 2021. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes.
33901166 2021. The first few days of a SARS-CoV-2 infection viewed at single-cell resolution.
32898168 2020. In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age.
33730015 2021. Gene variants of coagulation related proteins that interact with SARS-CoV-2.
33684134 2021. A network-informed analysis of SARS-CoV-2 and hemophagocytic lymphohistiocytosis genes' interactions points to Neutrophil extracellular traps as mediators of thrombosis in COVID-19.
34260589 2021. COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.
33544720 2021. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
33534793 2021. ViralLink: An integrated workflow to investigate the effect of SARS-CoV-2 on intracellular signalling and regulatory pathways.
33835998 2021. Genome Scale-Differential Flux Analysis reveals deregulation of lung cell metabolism on SARS-CoV-2 infection.
32997660 2020. IL6-mediated HCoV-host interactome regulatory network and GO/Pathway enrichment analysis.
35239653 2022. Proteome-wide Mendelian randomization identifies causal links between blood proteins and severe COVID-19.
35482673 2022. A Phenome-Wide Association Study of genes associated with COVID-19 severity reveals shared genetics with complex diseases in the Million Veteran Program.
35421082 2022. Abnormal global alternative RNA splicing in COVID-19 patients.
35468151 2022. Multi-omic analysis reveals enriched pathways associated with COVID-19 and COVID-19 severity.
35436306 2022. An endogenously activated antiviral state restricts SARS-CoV-2 infection in differentiated primary airway epithelial cells.
35421120 2022. Dysregulation of the leukocyte signaling landscape during acute COVID-19.
35390032 2022. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
35381016 2022. Detection of SARS-CoV-2 infection by microRNA profiling of the upper respiratory tract.
35085325 2022. Identification of potentially anti-COVID-19 active drugs using the connectivity MAP.
35085240 2022. Impact of high platelet turnover on the platelet transcriptome: Results from platelet RNA-sequencing in patients with sepsis.
35081105 2022. RNA Sequencing in COVID-19 patients identifies neutrophil activation biomarkers as a promising diagnostic platform for infections.
35045126 2022. Identification of hub genes associated with COVID-19 and idiopathic pulmonary fibrosis by integrated bioinformatics analysis.
34851990 2021. Towards risk stratification and prediction of disease severity and mortality in COVID-19: Next generation metabolomics for the measurement of host response to COVID-19 infection.
34807957 2021. Core genes involved in the regulation of acute lung injury and their association with COVID-19 and tumor progression: A bioinformatics and experimental study.
34762662 2021. Targeted proteomics as a tool to detect SARS-CoV-2 proteins in clinical specimens.
34673800 2021. Klotho deficiency intensifies hypoxia-induced expression of IFN-alpha/beta through upregulation of RIG-I in kidneys.
34460840 2021. Immunometabolic signatures predict risk of progression to sepsis in COVID-19.
34432798 2021. Oligonucleotide capture sequencing of the SARS-CoV-2 genome and subgenomic fragments from COVID-19 individuals.
34407143 2021. Genomics-guided identification of potential modulators of SARS-CoV-2 entry proteases, TMPRSS2 and Cathepsins B/L.
34379666 2021. Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility.
34010280 2021. The Biobanque quebecoise de la COVID-19 (BQC19)-A cohort to prospectively study the clinical and biological determinants of COVID-19 clinical trajectories.
33661927 2021. Hypoxia-induced inflammation: Profiling the first 24-hour posthypoxic plasma and central nervous system changes.
33630927 2021. Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells.
33606823 2021. Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches.
33596252 2021. The analysis on the human protein domain targets and host-like interacting motifs for the MERS-CoV and SARS-CoV/CoV-2 infers the molecular mimicry of coronavirus.
33301474 2020. The transcriptomic profiling of SARS-CoV-2 compared to SARS, MERS, EBOV, and H1N1.
33079950 2020. Proteins associated with neutrophil degranulation are upregulated in nasopharyngeal swabs from SARS-CoV-2 patients.
35446921 2022. Profiling metabolites and lipoproteins in COMETA, an Italian cohort of COVID-19 patients.
35395058 2022. Ad26.COV2.S prevents upregulation of SARS-CoV-2 induced pathways of inflammation and thrombosis in hamsters and rhesus macaques.
34473805 2021. Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection.
34597346 2021. The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.
33780519 2021. Viral genomic, metagenomic and human transcriptomic characterization and prediction of the clinical forms of COVID-19.
34061905 2021. Extensive C->U transition biases in the genomes of a wide range of mammalian RNA viruses; potential associations with transcriptional mutations, damage- or host-mediated editing of viral RNA.
34320031 2021. Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection.
33635931 2021. Inhibition of anti-viral stress granule formation by coronavirus endoribonuclease nsp15 ensures efficient virus replication.
33556147 2021. Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins.
33539484 2021. Three-dimensional chromatin in infectious disease-A role for gene regulation and pathogenicity?
33524041 2021. Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab.
34882757 2021. Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens.
34437657 2021. SARS-CoV-2 suppresses IFNbeta production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon.
33284859 2020. SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells.
34993416 2021. Repurposable drugs for SARS-CoV-2 and influenza sepsis with scRNA-seq data targeting post-transcription modifications.
35217532 2022. Specialized interferon action in COVID-19.
34969849 2022. A virus-specific monocyte inflammatory phenotype is induced by SARS-CoV-2 at the immune-epithelial interface.
35022217 2022. SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry.
35131898 2022. Differential interferon-alpha subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection.
34452991 2021. Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1.
34433692 2021. Profound Treg perturbations correlate with COVID-19 severity.
33958444 2021. Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues.
34108245 2021. HIF-1alpha is a negative regulator of interferon regulatory factors: Implications for interferon production by hypoxic monocytes.
34045361 2021. Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein.
34031243 2021. Transfer transcriptomic signatures for infectious diseases.
34001664 2021. Detection of differentially abundant cell subpopulations in scRNA-seq data.
33479166 2021. Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation.
33472860 2021. Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit.
35538614 2022. Individual genetic variability mainly of Proinflammatory cytokines, cytokine receptors, and toll-like receptors dictates pathophysiology of COVID-19 disease.
33331649 2021. Dysregulation of the mevalonate pathway during SARS-CoV-2 infection: An in silico study.
33300133 2021. Understanding the pathophysiological changes via untargeted metabolomics in COVID-19 patients.
34695380 2021. Folding Intermediates, Heterogeneous Native Ensembles and Protein Function.
35363626 2022. Patterns of Inflammatory Cell Infiltration and Expression of STAT6 in the Lungs of Patients With COVID-19: An Autopsy Study.
34764623 2022. Decision and feature level fusion of deep features extracted from public COVID-19 data-sets.
34027422 2021. Platelet and Haemostasis are the Main Targets in Severe Cases of COVID-19 Infection; a System Biology Study.
35085577 2022. The importance of accessory protein variants in the pathogenicity of SARS-CoV-2.
33309308 2021. Integrated Bioinformatics Analysis for the Screening of Associated Pathways and Therapeutic Drugs in Coronavirus Disease 2019.
32611485 2020. Molecular Alterations Prompted by SARS-CoV-2 Infection: Induction of Hyaluronan, Glycosaminoglycan and Mucopolysaccharide Metabolism.
35319744 2022. Late Complications of COVID-19: A Morphologic, Imaging, and Droplet Digital Polymerase Chain Reaction Study of Lung Tissue.
33720333 2021. Comparison of In Situ Hybridization, Immunohistochemistry, and Reverse Transcription-Droplet Digital Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing in Tissue.
34258664 2021. Evolutionary insights into the furin cleavage sites of SARS-CoV-2 variants from humans and animals.
33083914 2021. Coronavirus: proteomics analysis of chicken kidney tissue infected with variant 2 (IS-1494)-like avian infectious bronchitis virus.
34089367 2021. Transcriptome analysis of primary chicken cells infected with infectious bronchitis virus strain K047-12 isolated in Korea.
32651741 2020. Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2.
33594340 2021. Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through analysis of Viral Genomics and Structure.
34274539 2021. The mechanism behind flaring/triggering of autoimmunity disorders associated with COVID-19.
34508917 2021. Autoimmunity roots of the thrombotic events after COVID-19 vaccination.
32376402 2020. Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies.
34859136 2021. A Nucleocapsid-based Transcomplementation Cell Culture System of SARS-CoV-2 to Recapitulate the Complete Viral Life Cycle.
35128085 2022. Common genetic aspects between COVID-19 and sarcoidosis: A network-based approach using gene expression data.
35469237 2022. Epigenetic regulation of autophagy in coronavirus disease 2019 (COVID-19).
34307909 2021. Analysis of SARS-CoV-2 infection associated cell entry proteins ACE2, CD147, PPIA, and PPIB in datasets from non SARS-CoV-2 infected neuroblastoma patients, as potential prognostic and infection biomarkers in neuroblastoma.
35663631 2022. Proteomic Analyses Unveil Actionable Disease Pathways in COVID-19: A Step Toward Targeted Therapies.
34903581 2021. SARS-CoV-2 expresses a microRNA-like small RNA able to selectively repress host genes.
34373319 2021. Targeted in situ cross-linking mass spectrometry and integrative modeling reveal the architectures of three proteins from SARS-CoV-2.
33097660 2020. SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.
33082228 2020. Transcriptional and proteomic insights into the host response in fatal COVID-19 cases.
33571544 2021. Dissecting lipid metabolism alterations in SARS-CoV-2.
35377064 2022. Differential transcriptomic landscapes of multiple organs from SARS-CoV-2 early infected rhesus macaques.
34477316 2021. SGLT2-Inhibition reverts urinary peptide changes associated with severe COVID-19: An in-silico proof-of-principle of proteomics-based drug repurposing.
33860983 2021. Mass spectrometry-based proteomic platforms for better understanding of SARS-CoV-2 induced pathogenesis and potential diagnostic approaches.
33945677 2021. Longitudinal proteomic profiling provides insights into host response and proteome dynamics in COVID-19 progression.
33111431 2021. N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.
33987944 2021. Proteomic and metabolomic investigation of serum lactate dehydrogenase elevation in COVID-19 patients.
33615696 2021. Application of spectral library prediction for parallel reaction monitoring of viral peptides.
32462744 2020. Shortlisting SARS-CoV-2 Peptides for Targeted Studies from Experimental Data-Dependent Acquisition Tandem Mass Spectrometry Data.
34075354 2021. A matter of perspective-Cutting-edge technology-driven urine proteome in COVID-19.
33688631 2020. Urine proteome of COVID-19 patients.
34696164 2021. SnoRNAs and miRNAs Networks Underlying COVID-19 Disease Severity.
33467724 2021. Nucleocapsid and Spike Proteins of the Coronavirus SARS-CoV-2 Induce IL6 in Monocytes and Macrophages-Potential Implications for Cytokine Storm Syndrome.
35171039 2022. Endothelial inflammation and dysfunction in COVID-19.
35434485 2022. Replication-transcription complex of coronaviruses: functions of individual viral non-structural subunits, properties and architecture of their complexes.
35305698 2022. The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity.
32725480 2021. Prediction of the Receptorome for the Human-Infecting Virome.
34157565 2021. Age- and airway disease related gene expression patterns of key SARS-CoV-2 entry factors in human nasal epithelia.
34325286 2021. SARS-CoV-2 and other coronaviruses bind to phosphorylated glycans from the human lung.
34788642 2022. The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review.
34058265 2021. Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism.
32918943 2020. The role of host genetics in susceptibility to severe viral infections in humans and insights into host genetics of severe COVID-19: A systematic review.
32987033 2020. Transcription-based drug repurposing for COVID-19.
32368569 2020. The molecular biology of intracellular events during Coronavirus infection cycle.
35632741 2022. SARS-CoV-2 Envelope (E) Protein Binds and Activates TLR2 Pathway: A Novel Molecular Target for COVID-19 Interventions.
35632738 2022. High Expression of HERV-K (HML-2) Might Stimulate Interferon in COVID-19 Patients.
35632779 2022. Signaling Pathway Reporter Screen with SARS-CoV-2 Proteins Identifies nsp5 as a Repressor of p53 Activity.
35336960 2022. Differential Peripheral Blood Glycoprotein Profiles in Symptomatic and Asymptomatic COVID-19.
35336922 2022. Multiorgan and Vascular Tropism of SARS-CoV-2.
35337019 2022. A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.
35215921 2022. Carbohydrate Ligands for COVID-19 Spike Proteins.
35215915 2022. Secondary Structure of Subgenomic RNA M of SARS-CoV-2.
35215969 2022. Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells.
35632654 2022. Associations and Disease-Disease Interactions of COVID-19 with Congenital and Genetic Disorders: A Comprehensive Review.
34696353 2021. SARS-CoV-2 Subgenomic RNAs: Characterization, Utility, and Perspectives.
34578338 2021. Enrichment of SARS-CoV-2 Entry Factors and Interacting Intracellular Genes in Tissue and Circulating Immune Cells.
34834944 2021. Abnormal Blood Coagulation and Kidney Damage in Aged Hamsters Infected with Severe Acute Respiratory Syndrome Coronavirus 2.
34835019 2021. Single-Cell RNAseq Profiling of Human gammadelta T Lymphocytes in Virus-Related Cancers and COVID-19 Disease.
34835015 2021. SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism.
34960648 2021. JAK-STAT Pathway: A Novel Target to Tackle Viral Infections.
34835064 2021. CRISPR Screening: Molecular Tools for Studying Virus-Host Interactions.
34205098 2021. The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner.
34202098 2021. How Do Enveloped Viruses Exploit the Secretory Proprotein Convertases to Regulate Infectivity and Spread?
34200959 2021. Discovery of Antivirals Using Phage Display.
34452305 2021. SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity.
33435561 2021. Transcriptomic Analysis of Respiratory Tissue and Cell Line Models to Examine Glycosylation Machinery during SARS-CoV-2 Infection.
33668405 2021. Comparative Transcriptome Profiling of Human and Pig Intestinal Epithelial Cells after Porcine Deltacoronavirus Infection.
34960725 2021. Plasma Proteome Fingerprints Reveal Distinctiveness and Clinical Outcome of SARS-CoV-2 Infection.
34960822 2021. Microarray-Based Detection of Antibodies against SARS-CoV-2 Proteins, Common Respiratory Viruses and Type I Interferons.
34960687 2021. Single-Cell and Bulk RNASeq Profiling of COVID-19 Patients Reveal Immune and Inflammatory Mechanisms of Infection-Induced Organ Damage.
34960772 2021. Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy.
34960752 2021. Antibody-Dependent Enhancement of SARS-CoV-2 Infection of Human Immune Cells: In Vitro Assessment Provides Insight in COVID-19 Pathogenesis.
34452405 2021. Multi-Tissue Transcriptomic-Informed In Silico Investigation of Drugs for the Treatment of Dengue Fever Disease.
34452458 2021. Detection of SARS-CoV-2 Derived Small RNAs and Changes in Circulating Small RNAs Associated with COVID-19.
32218151 2020. Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins.
32512929 2020. The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities.
32698440 2020. Tiotropium is Predicted to be a Promising Drug for COVID-19 Through Transcriptome-Based Comprehensive Molecular Pathway Analysis.
33291220 2020. The International Virus Bioinformatics Meeting 2020.
33322045 2020. Novel Broad-Spectrum Antiviral Inhibitors Targeting Host Factors Essential for Replication of Pathogenic RNA Viruses.
31744152 2019. A Multi-Omics Study of Chicken Infected by Nephropathogenic Infectious Bronchitis Virus.
33997298 2021. -------A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS--.
33501381 2020. Fostering global data sharing: highlighting the recommendations of the Research Data Alliance COVID-19 working group.
33313418 2020. Integrative vectors for regulated expression of SARS-CoV-2 proteins implicated in RNA metabolism.
35343064 2022. RNA-protein interactomes as invaluable resources to study RNA viruses: Insights from SARS CoV-2 studies.
32638509 2020. The interface between coronaviruses and host cell RNA biology: Novel potential insights for future therapeutic intervention.
34326952 2021. Immunometabolic bases of type 2 diabetes in the severity of COVID-19.
34168400 2021. Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury.
32975064 2020. Quantitative Proteomic Analysis of the Expression of SARS-CoV-2 Receptors in the Gut of Patients with Chronic Enterocolitis.
35657140 2022. Screening the hub genes and analyzing the mechanisms in discharged COVID-19 patients retesting positive through bioinformatics analysis.
35133846 2022. Metabolic Snapshot of Plasma Samples Reveals New Pathways Implicated in SARS-CoV-2 Pathogenesis.
33605735 2021. Open Science Resources for the Mass Spectrometry-Based Analysis of SARS-CoV-2.
34672606 2021. Advances and Utility of the Human Plasma Proteome.
32794723 2020. Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2.
33141192 2020. Newly Discovered Cellular Pathway Blocks Ebola, COVID-19 Viruses.
33393161 2022. Recent advancements in glycoproteomic studies: Glycopeptide enrichment and derivatization, characterization of glycosylation in SARS CoV2, and interacting glycoproteins.
34287999 2022. Structural insights into the distinctive RNA recognition and therapeutic potentials of RIG-I-like receptors.
35622336 2022. Single-Cell Analysis and Tracking of Antigen-Specific T Cells: Integrating Paired Chain AIRR-Seq and Transcriptome Sequencing: A Method by the AIRR Community.
35554915 2022. Antiviral Strategies Against SARS-CoV-2: A Systems Biology Approach.
35554907 2022. Profiling SARS-CoV-2 Infection by High-Throughput Shotgun Proteomics.
34902130 2022. Scenarios for the Integration of Microarray Gene Expression Profiles in COVID-19-Related Studies.
32833216 2020. Ribopuromycylation in Coronavirus-Infected Cells.
32833213 2020. Proximity Labeling for the Identification of Coronavirus-Host Protein Interactions.
34571150 2022. Transcriptome analysis of host response to porcine epidemic diarrhea virus nsp15 in IPEC-J2 cells.
33691178 2021. First description of natural concomitant infection of avian nephritis virus and infectious bronchitis virus reveals exacerbated inflammatory response and renal damage in broiler chicks.
34132373 2021. SARSCoV2 spike proteininduced host inflammatory response signature in human corneal epithelial cells.
35284913 2022. Th1, Th2 and Th17 inflammatory pathways synergistically predict cardiometabolic protein expression in serum of COVID-19 patients.
33683246 2021. A novel multi-omics-based highly accurate prediction of symptoms, comorbid conditions, and possible long-term complications of COVID-19.
32199615 2020. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses.
35235083 2022. Identification of the Hub Genes and the Signaling Pathways in Human iPSC-Cardiomyocytes Infected by SARS-CoV-2.
34787756 2022. Identification of Key Pathways and Genes in SARS-CoV-2 Infecting Human Intestines by Bioinformatics Analysis.
33367597 2021. Structure and regulation of coronavirus genomes: state-of-the-art and novel insights from SARS-CoV-2 studies.
33040727 2020. Transcription Factor Nrf2 as a Potential Therapeutic Target for Prevention of Cytokine Storm in COVID-19 Patients.
34920080 2022. The spike protein of SARS-CoV-2 induces heme oxygenase-1: Pathophysiologic implications.
32544429 2020. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach.
34237472 2021. In silico analysis of the aggregation propensity of the SARS-CoV-2 proteome: Insight into possible cellular pathologies.
33478554 2021. Mechanistic modeling of the SARS-CoV-2 disease map.
34220199 2021. Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins.
34014278 2021. 3DBionotes COVID-19 Edition.
33693506 2021. COVID-19: disease pathways and gene expression changes predict methylprednisolone can improve outcome in severe cases.
33017003 2021. VIRTUS: a pipeline for comprehensive virus analysis from conventional RNA-seq data.
34289024 2021. SPOT: a web-tool enabling swift profiling of transcriptomes.
32805023 2021. Mechanistic insights into SARS-CoV-2 epidemic via revealing the features of SARS-CoV-2 coding proteins and host responses upon its infection.
33244583 2021. Novel SARS-CoV-2 encoded small RNAs in the passage to humans.
32374823 2020. COVID-2019-associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak.
33618659 2021. Effects of Cell Proteostasis Network on the Survival of SARS-CoV-2.
32754004 2020. Expansion of Single Cell Transcriptomics Data of SARS-CoV Infection in Human Bronchial Epithelial Cells to COVID-19.
35205046 2022. Viral and Host Genetic and Epigenetic Biomarkers Related to SARS-CoV-2 Cell Entry, Infection Rate, and Disease Severity.
34801852 2022. Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets.
33655247 2021. A single-cell and spatial atlas of autopsy tissues reveals pathology and cellular targets of SARS-CoV-2.
32587961 2021. Transcriptogram analysis reveals relationship between viral titer and gene sets responses during Corona-virus infection.
33655243 2021. The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.
33655248 2021. An Autoantigen Profile of Human A549 Lung Cells Reveals Viral and Host Etiologic Molecular Attributes of Autoimmunity in COVID-19.
33619490 2021. Association of CXCR6 with COVID-19 severity: Delineating the host genetic factors in transcriptomic regulation.
33619478 2021. The Host Interactome of Spike Expands the Tropism of SARS-CoV-2.
33594364 2021. Bifurcated monocyte states are predictive of mortality in severe COVID-19.
33594362 2021. Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19.
34845446 2021. Systematic temporal analysis of peripheral blood transcriptomes using TrendCatcher identifies early and persistent neutrophil activation as a hallmark of severe COVID-19.
34845452 2021. Genome-wide characterization of SARS-CoV-2 cytopathogenic proteins in the search of antiviral targets.
34931188 2021. SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-beta signaling.
34075382 2021. CovidExpress: an interactive portal for intuitive investigation on SARS-CoV-2 related transcriptomes.
34373855 2021. A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases.
34462747 2021. Woodsmoke particulates alter expression of antiviral host response genes in human nasal epithelial cells infected with SARS-CoV-2 in a sex-dependent manner.
33532779 2021. Genome-scale metabolic modeling reveals SARS-CoV-2-induced metabolic changes and antiviral targets.
34075380 2021. Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence.
33851168 2021. An Autoantigen-ome from HS-Sultan B-Lymphoblasts Offers a Molecular Map for Investigating Autoimmune Sequelae of COVID-19.
33907748 2021. Rapid decay of host basal mRNAs during SARS-CoV-2 infection perturbs host antiviral mRNA biogenesis and export.
32676599 2020. Role of SARS-CoV-2 in altering the RNA binding protein and miRNA directed post-transcriptional regulatory networks in humans.
32908980 2020. Induction of a regulatory myeloid program in bacterial sepsis and severe COVID-19.
32935098 2020. Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors.
32511361 2020. The Host Cell ViroCheckpoint: Identification and Pharmacologic Targeting of Novel Mechanistic Determinants of Coronavirus-Mediated Hijacked Cell States.
35317263 2022. Using bioinformatics and systems biology to discover common pathogenetic processes between sarcoidosis and COVID-19.
34131597 2021. A bioinformatics approach for identifying potential molecular mechanisms and key genes involved in COVID-19 associated cardiac remodeling.
33398248 2021. Computationally predicted SARS-COV-2 encoded microRNAs target NFKB, JAK/STAT and TGFB signaling pathways.
33263093 2021. Gene expression profiling of corona virus microarray datasets to identify crucial targets in COVID-19 patients.
33821222 2021. An overview of basic molecular biology of SARS-CoV-2 and current COVID-19 prevention strategies.
34401607 2021. Systems level insights into the impact of airborne exposure on SARS-CoV-2 pathogenesis and COVID-19 outcome - A multi-omics big data study.
32835133 2020. Phylogenomic proximity and comparative proteomic analysis of SARS-CoV-2.
33553808 2020. Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19.
33093657 2021. Self-amplifying RNA vaccines for infectious diseases.
35328087 2022. Identification of Genetic Risk Factors of Severe COVID-19 Using Extensive Phenotypic Data: A Proof-of-Concept Study in a Cohort of Russian Patients.
35205390 2022. Conserved MicroRNAs in Human Nasopharynx Tissue Samples from Swabs Are Differentially Expressed in Response to SARS-CoV-2.
33809949 2021. A Resource for the Network Representation of Cell Perturbations Caused by SARS-CoV-2 Infection.
34209818 2021. Toward a Coronavirus Knowledge Graph.
34202032 2021. Direct Measurement of B Lymphocyte Gene Expression Biomarkers in Peripheral Blood Transcriptomics Enables Early Prediction of Vaccine Seroconversion.
34440372 2021. Methylation of Host Genes Associated with Coronavirus Infection from Birth to 26 Years.
33034007 2020. Combining fragment docking with graph theory to improve ligand docking for homology model structures.
34940501 2021. Developmental Aspects of SARS-CoV-2, Potential Role of Exosomes and Their Impact on the Human Transcriptome.
34669152 2022. Deciphering the link between Diabetes mellitus and SARS-CoV-2 infection through differential targeting of microRNAs in the human pancreas.
34297037 2021. Epigenetic and transcriptional control of interferon-beta.
34128960 2021. Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics.
34128959 2021. Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19.
34188786 2021. Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies.
34193364 2022. Innate immune response analysis in COVID-19 and kawasaki disease reveals MIS-C predictors.
35205926 2022. Molecular Profiling Reveals Characteristic and Decisive Signatures in Patients after Allogeneic Stem Cell Transplantation Suffering from Invasive Pulmonary Aspergillosis.
35664804 2022. The Ramp Atlas: facilitating tissue and cell-specific ramp sequence analyses through an intuitive web interface.
35664994 2022. Whole Genome DNA and RNA Sequencing of Whole Blood Elucidates the Genetic Architecture of Gene Expression Underlying a Wide Range of Diseases.
35654986 2022. The impact of the suppression of highly connected protein interactions on the corona virus infection.
34448623 2021. A Novel Pathway Network Analytics Method Based on Graph Theory.
35060145 2022. Epigenetic modifications associated with genes implicated in cytokine storm: The potential biotherapeutic effects of vitamins and minerals in COVID-19.
32643596 2020. A review on histotechnology practices in COVID-19 pathology investigations.
34819389 2022. ORAI1 Limits SARS-CoV-2 Infection by Regulating Tonic Type I IFN Signaling.
34452933 2021. Suppressive Monocytes Impair MAIT Cells Response via IL-10 in Patients with Severe COVID-19.
35639922 2022. A distinct dexamethasone-dependent gene expression profile in the lungs of COVID-19 patients.
34558746 2021. Dynamic changes in human single-cell transcriptional signatures during fatal sepsis.
34931002 2022. Single-cell immunology of SARS-CoV-2 infection.
32591762 2020. COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis.
35410380 2022. Understanding COVID-19 through genome-wide association studies.
35410379 2022. Expanded COVID-19 phenotype definitions reveal distinct patterns of genetic association and protective effects.
33888907 2021. Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.
35301508 2022. Type I interferon transcriptional network regulates expression of coinhibitory receptors in human T cells.
34663977 2021. Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection.
34155406 2021. SARS-CoV-2-specific hotspots in virus-host interaction networks.
33277638 2021. Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison.
32788748 2020. Single-cell landscape of immunological responses in patients with COVID-19.
35177862 2022. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19.
33654293 2021. Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics.
33837377 2021. Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19.
32812012 2020. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection.
34158670 2021. A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19.
34471255 2021. Cellular host factors for SARS-CoV-2 infection.
35354968 2022. SARS-CoV-2 pathogenesis.
35255492 2022. Whole-genome sequencing reveals host factors underlying critical COVID-19.
33307546 2021. Genetic mechanisms of critical illness in COVID-19.
33979833 2021. SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis.
33845483 2021. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.
32998156 2020. The major genetic risk factor for severe COVID-19 is inherited from Neanderthals.
32272481 2020. Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors.
32408336 2020. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets.
35005991 2022. Mass Spectrometry-Based Proteomics Research to Fight COVID-19: An Expert Review on Hopes and Challenges.
34678084 2021. Top Trends in Multiomics Research: Evaluation of 52 Published Studies and New Ways of Thinking Terminology and Visual Displays.
34601771 2022. PDB-101: Educational resources supporting molecular explorations through biology and medicine.
32960510 2020. Urinary Proteomics Associates with COVID-19 Severity: Pilot Proof-of-Principle Data and Design of a Multicentric Diagnostic Study.
33141520 2020. Proteomic Biomarkers to Guide Stratification for Covid-19 Treatment: Exemplifying a Path Forward Toward Implementation?
35490333 2022. Clinical applications of plasma proteomics and peptidomics: Towards precision medicine.
32720461 2020. An overview of the immune mechanisms of viral myocarditis.
34995097 2022. Innate immunological pathways in COVID-19 pathogenesis.
35148199 2022. SLAMF7 engagement superactivates macrophages in acute and chronic inflammation.
35412852 2022. SARS-CoV-2 spike protein-induced cell fusion activates the cGAS-STING pathway and the interferon response.
34698500 2022. Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort.
35052382 2021. Detection of A-to-I RNA Editing in SARS-COV-2.
33916492 2021. Genotyping of the Major SARS-CoV-2 Clade by Short-Amplicon High-Resolution Melting (SA-HRM) Analysis.
33923155 2021. Investigating Cellular Trajectories in the Severity of COVID-19 and Their Transcriptional Programs Using Machine Learning Approaches.
33207533 2020. Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs.
32646047 2020. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
33271804 2020. Transcriptional Differences for COVID-19 Disease Map Genes between Males and Females Indicate a Different Basal Immunophenotype Relevant to the Disease.
34168039 2021. Targeting the m(6)A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication.
33521209 2022. Immune characteristics analysis reveals two key inflammatory factors correlated to the expressions of SARS-CoV-2 S1-specific antibodies.
34565757 2021. AI for the collective analysis of a massive number of genome sequences: various examples from the small genome of pandemic SARS-CoV-2 to the human genome.
33011745 2020. Predicting the response of the dental pulp to SARS-CoV2 infection: a transcriptome-wide effect cross-analysis.
34159627 2021. Genome-wide association analysis of COVID-19 mortality risk in SARS-CoV-2 genomes identifies mutation in the SARS-CoV-2 spike protein that colocalizes with P.1 of the Brazilian strain.
34183789 2021. An integrative multiomics analysis identifies putative causal genes for COVID-19 severity.
34436507 2021. Human-SARS-CoV-2 interactome and human genetic diversity: TMPRSS2-rs2070788, associated with severe influenza, and its population genetics caveats in Native Americans.
33237152 2020. Molecular mechanisms and pharmacological interventions in the replication cycle of human coronaviruses.
35002537 2021. Identification of Differentially Expressed Genes in COVID-19 and Integrated Bioinformatics Analysis of Signaling Pathways.
33395363 2021. Epigenetic mechanisms influencing COVID-19.
33197212 2021. The treatment of SARS-CoV2 with antivirals and mitigation of the cytokine storm syndrome: the role of gene expression.
33086021 2021. Epigenetic regulation of ACE2, the receptor of the SARS-CoV-2 virus(1).
35073995 2022. IDEAS: individual level differential expression analysis for single-cell RNA-seq data.
34844647 2021. treekoR: identifying cellular-to-phenotype associations by elucidating hierarchical relationships in high-dimensional cytometry data.
33413539 2021. HiDeF: identifying persistent structures in multiscale 'omics data.
34694399 2021. ADAR Editing in Viruses: An Evolutionary Force to Reckon with.
33713114 2021. The Missing Expression Level-Evolutionary Rate Anticorrelation in Viruses Does Not Support Protein Function as a Main Constraint on Sequence Evolution.
35501841 2022. Single-cell transcriptomics reveal a unique memory-like NK cell subset that accumulates with ageing and correlates with disease severity in COVID-19.
35610660 2022. Transcriptomic perspectives of memory-like NK cells and aging.
35184750 2022. Systematic comparison of published host gene expression signatures for bacterial/viral discrimination.
35172892 2022. Integrating single-cell sequencing data with GWAS summary statistics reveals CD16+monocytes and memory CD8+T cells involved in severe COVID-19.
34001247 2021. An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility.
34281603 2021. Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19.
33441124 2021. Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients.
33883027 2021. Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium.
33879239 2021. IFN-gamma and TNF-alpha drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue inflammation.
32723359 2020. Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein.
33256807 2020. Pervasive generation of non-canonical subgenomic RNAs by SARS-CoV-2.
35332098 2022. Global mapping of RNA homodimers in living cells.
35064006 2022. Plasma cell-free RNA characteristics in COVID-19 patients.
33722935 2021. Subgenomic RNA identification in SARS-CoV-2 genomic sequencing data.
35074468 2022. Betacoronavirus-specific alternate splicing.
33691144 2021. Single-cell RNA sequencing reveals the sustained immune cell dysfunction in the pathogenesis of sepsis secondary to bacterial pneumonia.
33482326 2021. Transcriptome network analyses in human coronavirus infections suggest a rational use of immunomodulatory drugs for COVID-19 therapy.
32920121 2020. SARS-CoV-2 transcriptome analysis and molecular cataloguing of immunodominant epitopes for multi-epitope based vaccine design.
32771622 2020. Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approach.
35033679 2022. Genomic perspectives on the emerging SARS-CoV-2 omicron variant.
34774773 2021. Integrative Multi-omics Landscape of Non-structural Protein 3 of Severe Acute Respiratory Syndrome Coronaviruses.
34748989 2021. COVID-ONE-hi: The One-stop Database for COVID-19-specific Humoral Immunity and Clinical Parameters.
34560321 2021. Gut Microbiome Alterations in COVID-19.
33418085 2020. MicroPhenoDB Associates Metagenomic Data with Pathogenic Microbes, Microbial Core Genes, and Human Disease Phenotypes.
32739507 2020. From Mutation Signature to Molecular Mechanism in the RNA World: A Case of SARS-CoV-2.
35639883 2022. Analysis of SARS-CoV-2 known and novel subgenomic mRNAs in cell culture, animal model, and clinical samples using LeTRS, a bioinformatic tool to identify unique sequence identifiers.
34430958 2021. Concise Update on Genomics of COVID-19: Approach to Its latest Mutations, Escalated Contagiousness, and Vaccine Resistance.
33174592 2021. Composition of the immunoglobulin G glycome associates with the severity of COVID-19.
33135055 2021. Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2.
35091890 2022. Antibody glycosylation in COVID-19.
32504168 2020. Impact of glycoscience in fighting Covid-19.
35574937 2022. A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2.
34965194 2022. Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters.
34632957 2021. Colonic expression of Ace2, the SARS-CoV-2 entry receptor, is suppressed by commensal human microbiota.
33685349 2021. SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota.
33678150 2021. Integrated gut virome and bacteriome dynamics in COVID-19 patients.
34863291 2021. Gut microbiota imbalance in colorectal cancer patients, the risk factor of COVID-19 mortality.
35284643 2022. An experimental in silico study on COVID-19: Response of neutrophil-related genes to antibiotics.
35399374 2022. Unique peptide signatures of SARS-ComicronV-2 virus against human proteome reveal variants' immune escape and infectiveness.
34746476 2021. Metabologenomics approach to the discovery of novel compounds from Streptomyces sp. GMR22 as anti-SARS-CoV-2 drugs.
33898797 2021. Identification of PBMC-based molecular signature associational with COVID-19 disease severity.
33688586 2021. In silico analysis of altered expression of long non-coding RNA in SARS-CoV-2 infected cells and their possible regulation by STAT1, STAT3 and interferon regulatory factors.
34179538 2021. Computational search of hybrid human/SARS-CoV-2 dsRNA reveals unique viral sequences that diverge from those of other coronavirus strains.
34075347 2021. SARS-CoV-2 infection paralyzes cytotoxic and metabolic functions of the immune cells.
33392409 2021. Atlas of ACE2 gene expression reveals novel insights into transmission of SARS-CoV-2.
34458641 2021. Host gene variability and SARS-CoV-2 infection: A review article.
32984567 2020. A SARS-CoV-2 host infection model network based on genomic human Transcription Factors (TFs) depletion.
33364494 2020. Bioinformatic evaluation of the potential animal models for studying SARS-Cov-2.
33289002 2020. Enhancement of the IFN-beta-induced host signature informs repurposed drugs for COVID-19.
33883951 2021. Binding of the SARS-CoV-2 Spike Protein to the Asialoglycoprotein Receptor on Human Primary Hepatocytes and Immortalized Hepatocyte-Like Cells by Confocal Analysis.
33397514 2021. Mediators of SARS-CoV-2 entry are preferentially enriched in cardiomyocytes.
32475052 2020. Binding affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide.
34889978 2022. Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity.
34155559 2021. Association of CXCR6 with COVID-19 severity: delineating the host genetic factors in transcriptomic regulation.
33604698 2021. Multi-omics highlights ABO plasma protein as a causal risk factor for COVID-19.
34967936 2021. Embeddings from protein language models predict conservation and variant effects.
33726831 2021. Exploration and validation of related hub gene expression during SARS-CoV-2 infection of human bronchial organoids.
33390179 2021. Alu retrotransposons and COVID-19 susceptibility and morbidity.
33008459 2020. Practicing precision medicine with intelligently integrative clinical and multi-omics data analysis.
33949668 2021. Integrative genomics analysis reveals a 21q22.11 locus contributing risk to COVID-19.
33577681 2021. Integration of genetically regulated gene expression and pharmacological library provides therapeutic drug candidates.
34329437 2021. Single-cell RNA sequencing of SARS-CoV-2 cell entry factors in the preconceptional human endometrium.
33469197 2021. Maternal endothelial dysfunction in HIV-associated preeclampsia comorbid with COVID-19: a review.
34786557 2020. Plasmin Cascade Mediates Thrombotic Events in SARS-CoV-2 Infection via Complement and Platelet-Activating Systems.
34350693 2021. Comprehensive investigation of RNA-sequencing dataset reveals the hub genes and molecular mechanisms of coronavirus disease 2019 acute respiratory distress syndrome.
34289534 2021. High-resolution HLA genotyping identifies alleles associated with severe COVID-19: A preliminary study from India.
33124193 2020. Transcriptomic analysis reveals novel mechanisms of SARS-CoV-2 infection in human lung cells.
33728103 2021. Single Cell Transcriptomic Re-analysis of Immune Cells in Bronchoalveolar Lavage Fluids Reveals the Correlation of B Cell Characteristics and Disease Severity of Patients with SARS-CoV-2 Infection.
35151371 2022. Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease.
35139355 2022. Interferon-gamma primes macrophages for pathogen ligand-induced killing via a caspase-8 and mitochondrial cell death pathway.
34592166 2021. Early IFN-alpha signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19.
33891889 2021. Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children.
33577760 2021. Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity.
34051148 2021. Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease.
34048708 2021. SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2.
34022127 2021. Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets.
33382973 2021. Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid.
33765436 2021. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19.
33765435 2021. Multi-cohort analysis of host immune response identifies conserved protective and detrimental modules associated with severity across viruses.
32783921 2020. Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients.
33128875 2020. Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19.
33296687 2020. Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19.
33232865 2021. SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19.
35303126 2022. Identification of G-quadruplex DNA sequences in SARS-CoV2.
35434695 2022. Association of pyroptosis and severeness of COVID-19 as revealed by integrated single-cell transcriptome data analysis.
34228987 2021. SARS-CoV-2 Spike protein enhances ACE2 expression via facilitating Interferon effects in bronchial epithelium.
32946016 2020. Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine.
32503824 2020. Endoplasmic Reticulum Stress Markers in SARS-COV-2 Infection and Pneumonia: Case-Control Study.
32773420 2020. Transcriptome & viral growth analysis of SARS-CoV-2-infected Vero CCL-81 cells.
35216673 2022. A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.
35032429 2022. Complement activation induces excessive T cell cytotoxicity in severe COVID-19.
34492226 2021. The interferon landscape along the respiratory tract impacts the severity of COVID-19.
34767776 2021. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.
33836156 2021. TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation.
34062119 2021. Integrated analysis of multimodal single-cell data.
33382968 2021. Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks.
33333024 2021. Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses.
33147445 2021. Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells.
33147444 2021. Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection.
33503446 2021. Multi-organ proteomic landscape of COVID-19 autopsies.
34914922 2021. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis.
33743211 2021. Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions.
33811809 2021. BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection.
33691138 2021. A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence.
33743212 2021. COVID-19 and the human innate immune system.
33713619 2021. Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19.
33657410 2021. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.
32810438 2020. Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.
33096020 2020. Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4(+) T Cells in COVID-19.
33080218 2020. SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses.
32330414 2020. The Architecture of SARS-CoV-2 Transcriptome.
32479746 2020. Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients.
32492406 2020. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera.
33171100 2020. Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.
32645325 2020. The Global Phosphorylation Landscape of SARS-CoV-2 Infection.
32643603 2020. Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment.
35139909 2022. Transcriptional landscape of circulating platelets from patients with COVID-19 reveals key subnetworks and regulators underlying SARS-CoV-2 infection: implications for immunothrombosis.
34496960 2021. Inferring SARS-CoV-2 functional genomics from viral transcriptome with identification of potential antiviral drugs and therapeutic targets.
34294141 2021. Genome-wide analysis of protein-protein interactions and involvement of viral proteins in SARS-CoV-2 replication.
34281608 2021. SARS-CoV-2: from its discovery to genome structure, transcription, and replication.
34672954 2022. An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.
34518653 2022. Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis.
33037393 2020. An aberrant STAT pathway is central to COVID-19.
35568706 2022. Sex differences in global metabolomic profiles of COVID-19 patients.
35288537 2022. Plasma proteomic and metabolomic characterization of COVID-19 survivors 6 months after discharge.
34716309 2021. Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients.
34035220 2021. Proteomics of extracellular vesicles in plasma reveals the characteristics and residual traces of COVID-19 patients without underlying diseases after 3 months of recovery.
33707411 2021. Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers.
34301919 2021. RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes.
34385425 2021. Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome.
33293527 2020. A cross-talk between epithelium and endothelium mediates human alveolar-capillary injury during SARS-CoV-2 infection.
35314694 2022. Genetic alteration of human MYH6 is mimicked by SARS-CoV-2 polyprotein: mapping viral variants of cardiac interest.
34006825 2021. Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells.
33293514 2020. A blood transcriptome-based analysis of disease progression, immune regulation, and symptoms in coronavirus-infected patients.
33024578 2020. Benchmarking evolutionary tinkering underlying human-viral molecular mimicry shows multiple host pulmonary-arterial peptides mimicked by SARS-CoV-2.
35581179 2022. Proteomic characterization of Omicron SARS-CoV-2 host response.
34702802 2021. SARS-CoV-2 exploits host DGAT and ADRP for efficient replication.
34697287 2021. Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines.
34103487 2021. Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19.
34465742 2021. Genome-wide association study of COVID-19 severity among the Chinese population.
32377375 2020. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing.
32194980 2020. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.
33357464 2021. Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors.
32407669 2020. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients.
33359760 2021. Effects of vitamin D on macrophages and myeloid-derived suppressor cells (MDSCs) hyperinflammatory response in the lungs of COVID-19 patients.
32610096 2020. Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis.
32810597 2021. Identification of Transcription Factors Regulating SARS-CoV-2 Entry Genes in the Intestine.
34845370 2022. SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy.
34471261 2021. Multiomics: unraveling the panoramic landscapes of SARS-CoV-2 infection.
33318629 2021. Pathological and molecular examinations of postmortem testis biopsies reveal SARS-CoV-2 infection in the testis and spermatogenesis damage in COVID-19 patients.
32728199 2020. SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70.
35079870 2022. Citrullination in the pathology of inflammatory and autoimmune disorders: recent advances and future perspectives.
35039944 2022. Competing endogenous RNA network mediated by circ_3205 in SARS-CoV-2 infected cells.
32712910 2021. Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses.
34117968 2022. Mitochondrial DNA Heteroplasmy as an Informational Reservoir Dynamically Linked to Metabolic and Immunological Processes Associated with COVID-19 Neurological Disorders.
33751722 2021. Bioinformatic analyses hinted at augmented T helper 17 cell differentiation and cytokine response as the central mechanism of COVID-19-associated Guillain-Barre syndrome.
33211371 2021. Direct inhibitory effect on viral entry of influenza A and SARS-CoV-2 viruses by azithromycin.
34804904 2021. Role of COVID 19 Inflammatory Markers in Rhino-Orbito-Cerebral Mucormycosis: A Case Study in Predisposed Patients at a Designated Nodal Centre.
32345362 2020. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues.
34954105 2022. A new insight into sex-specific non-coding RNAs and networks in response to SARS-CoV-2.
34147651 2021. Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.
34004362 2021. Analyzing host-viral interactome of SARS-CoV-2 for identifying vulnerable host proteins during COVID-19 pathogenesis.
34004360 2021. Differential host circRNA expression profiles in human lung epithelial cells infected with SARS-CoV-2.
33812037 2021. The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.
33848683 2021. Systematizing the genomic order and relatedness in the open reading frames (ORFs) of the coronaviruses.
33819681 2021. Immunogenicity and antigenicity based T-cell and B-cell epitopes identification from conserved regions of 10664 SARS-CoV-2 genomes.
33422682 2021. Identification of SARS-CoV-2 CTL epitopes for development of a multivalent subunit vaccine for COVID-19.
32473977 2020. Unfolding SARS-CoV-2 viral genome to understand its gene expression regulation.
32473352 2020. Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: A computational way to predict the immunogens.
32712315 2020. Decoding the proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for cell-penetrating peptides involved in pathogenesis or applicable as drug delivery vectors.
32707288 2020. Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.
32615317 2020. Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short- and long-term models.
32526370 2020. What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19?
33132111 2020. Overlapping host pathways between SARS-CoV-2 and its potential copathogens: An in silico analysis.
33130005 2020. A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection.
34841243 2021. Genetic epidemiology using whole genome sequencing and haplotype networks revealed the linkage of SARS-CoV-2 infection in nosocomial outbreak.
33014208 2020. How COVID-19 induces cytokine storm with high mortality.
33159646 2021. The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients.
34981034 2022. Systems Biology and Bioinformatics approach to Identify blood based signatures molecules and drug targets of patient with COVID-19.
33846694 2021. Computational prediction of potential siRNA and human miRNA sequences to silence orf1ab associated genes for future therapeutics against SARS-CoV-2.
33072849 2020. Understand variability of COVID-19 through population and tissue variations in expression of SARS-CoV-2 host genes.
32835074 2020. Identification and classification of differentially expressed genes reveal potential molecular signature associated with SARS-CoV-2 infection in lung adenocarcinomal cells.
34482267 2021. Prediction and analysis of microRNAs involved in COVID-19 inflammatory processes associated with the NF-kB and JAK/STAT signaling pathways.
33836368 2021. Identification of COVID-19 subtypes based on immunogenomic profiling.
34653729 2021. In vitro induction of interleukin-8 by SARS-CoV-2 Spike protein is inhibited in bronchial epithelial IB3-1 cells by a miR-93-5p agomiR.
34601331 2021. Cytokine storm in the pathophysiology of COVID-19: Possible functional disturbances of miRNAs.
33895478 2021. Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC.
32405156 2020. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
34826456 2022. Identifying potential novel insights for COVID-19 pathogenesis and therapeutics using an integrated bioinformatics analysis of host transcriptome.
34517025 2021. Genomics-guided targeting of stress granule proteins G3BP1/2 to inhibit SARS-CoV-2 propagation.
33862077 2021. Notable sequence homology of the ORF10 protein introspects the architecture of SARS-CoV-2.
33359807 2021. SARS-Cov-2 ORF3a: Mutability and function.
34756970 2021. SARS-COV-2, infection, transmission, transcription, translation, proteins, and treatment: A review.
32599245 2020. Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective.
34671206 2021. The intraviral protein-protein interaction of SARS-CoV-2 reveals the key role of N protein in virus-like particle assembly.
33907518 2021. SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3.
33907515 2021. Developing effective siRNAs to reduce the expression of key viral genes of COVID-19.
33907514 2021. The role of CD4(+)FoxP3(+) regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment.
33767597 2021. Evaluation and characterization of HSPA5 (GRP78) expression profiles in normal individuals and cancer patients with COVID-19.
35018096 2022. Identification of the Key Immune-Related Genes in Chronic Obstructive Pulmonary Disease Based on Immune Infiltration Analysis.
33165417 2020. Network pharmacology-based study of the molecular mechanisms of Qixuekang in treating COVID-19 during the recovery period.
35320721 2022. Restriction factor screening identifies RABGAP1L-mediated disruption of endocytosis as a host antiviral defense.
35026155 2022. Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19.
34998467 2022. SARS-CoV-2 reactive and neutralizing antibodies discovered by single-cell sequencing of plasma cells and mammalian display.
35477000 2022. Characterization and functional interrogation of the SARS-CoV-2 RNA interactome.
34587478 2021. Single-cell analysis of COVID-19, sepsis, and HIV infection reveals hyperinflammatory and immunosuppressive signatures in monocytes.
34672947 2021. Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CL(pro) substrate degradome.
34686343 2021. Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome.
34624208 2021. Role of miR-2392 in driving SARS-CoV-2 infection.
34624207 2021. The N-terminal domain of SARS-CoV-2 nsp1 plays key roles in suppression of cellular gene expression and preservation of viral gene expression.
34644561 2021. Proteomics reveal cap-dependent translation inhibitors remodel the translation machinery and translatome.
34731648 2021. An airway organoid-based screen identifies a role for the HIF1alpha-glycolysis axis in SARS-CoV-2 infection.
34762851 2021. SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues.
33961823 2021. METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection.
33961822 2021. Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection.
33730572 2021. Translational adaptation of human viruses to the tissues they infect.
34242574 2021. Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins.
33357411 2021. Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients.
33440148 2021. MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells.
34297909 2021. Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome.
34348131 2021. The COVIDome Explorer researcher portal.
33852916 2021. Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells.
32946807 2020. A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors.
32979938 2020. Evasion of Type I Interferon by SARS-CoV-2.
33007239 2020. Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects.
33147460 2020. Interferon Regulatory Factors IRF1 and IRF7 Directly Regulate Gene Expression in Bats in Response to Viral Infection.
35474751 2022. Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections.
35474745 2022. Multi-omics in COVID-19: Seeing the unseen but overlooked in the clinic.
35233546 2022. System-wide transcriptome damage and tissue identity loss in COVID-19 patients.
34723226 2021. The systemic inflammatory landscape of COVID-19 in pregnancy: Extensive serum proteomic profiling of mother-infant dyads with in utero SARS-CoV-2.
33969320 2021. Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions.
34075365 2021. Broad auto-reactive IgM responses are common in critically ill patients, including those with COVID-19.
33521697 2021. A distinct innate immune signature marks progression from mild to severe COVID-19.
34873589 2021. People critically ill with COVID-19 exhibit peripheral immune profiles predictive of mortality and reflective of SARS-CoV-2 lung viral burden.
34308390 2021. Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity.
33778787 2021. Spatial mapping of SARS-CoV-2 and H1N1 lung injury identifies differential transcriptional signatures.
34790908 2021. Metatranscriptomics to characterize respiratory virome, microbiome, and host response directly from clinical samples.
34737357 2022. Comparison of viral RNA-host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2.
33473155 2021. Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages.
33510385 2021. The m(6)A methylome of SARS-CoV-2 in host cells.
32913304 2021. Single-cell transcriptomic atlas of primate cardiopulmonary aging.
32071427 2020. Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses.
33159154 2020. Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19.
35461900 2022. Exosomal mediated signal transduction through artificial microRNA (amiRNA): A potential target for inhibition of SARS-CoV-2.
33142113 2020. Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to SARS-CoV-2.
33128895 2020. Human Lung Stem Cell-Based Alveolospheres Provide Insights into SARS-CoV-2-Mediated Interferon Responses and Pneumocyte Dysfunction.
32979316 2020. SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response.
33096026 2021. Large-Scale Multi-omic Analysis of COVID-19 Severity.
33053371 2021. A Sweep of Earth's Virome Reveals Host-Guided Viral Protein Structural Mimicry and Points to Determinants of Human Disease.
34139154 2021. A time-resolved proteomic and prognostic map of COVID-19.
32673562 2020. RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus.
32619549 2020. Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection.
35326463 2022. Multi-Design Differential Expression Profiling of COVID-19 Lung Autopsy Specimens Reveals Significantly Deregulated Inflammatory Pathways and SFTPC Impaired Transcription.
35269470 2022. Severe COVID-19 Shares a Common Neutrophil Activation Signature with Other Acute Inflammatory States.
35053299 2022. Hypoxia-Inducible Factor Signaling in Inflammatory Lung Injury and Repair.
35159296 2022. Competitive Endogenous RNA Network Activates Host Immune Response in SARS-CoV-2-, panH1N1 (A/California/07/2009)-, and H7N9 (A/Shanghai/1/2013)-Infected Cells.
35203278 2022. The ACE2 Receptor for Coronavirus Entry Is Localized at Apical Cell-Cell Junctions of Epithelial Cells.
35406806 2022. Plasma Metabolomic Alterations Induced by COVID-19 Vaccination Reveal Putative Biomarkers Reflecting the Immune Response.
35563697 2022. Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro.
34572076 2021. Host Cell and SARS-CoV-2-Associated Molecular Structures and Factors as Potential Therapeutic Targets.
34831176 2021. Impacts of p97 on Proteome Changes in Human Cells during Coronaviral Replication.
34831321 2021. In Silico Identification and Clinical Validation of a Novel Long Non-Coding RNA/mRNA/miRNA Molecular Network for Potential Biomarkers for Discriminating SARS CoV-2 Infection Severity.
34831290 2021. Endothelial Dysfunction through Oxidatively Generated Epigenetic Mark in Respiratory Viral Infections.
34831243 2021. Characterization of RNA Sensing Pathways in Hepatoma Cell Lines and Primary Human Hepatocytes.
34943787 2021. SARS-CoV-2 Spike Protein and Its Receptor Binding Domain Promote a Proinflammatory Activation Profile on Human Dendritic Cells.
33801464 2021. SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response.
34204705 2021. In Silico Identification of miRNA-lncRNA Interactions in Male Reproductive Disorder Associated with COVID-19 Infection.
34440669 2021. Multisystemic Cellular Tropism of SARS-CoV-2 in Autopsies of COVID-19 Patients.
34359957 2021. MiRNA Profiling in Plasma and Placenta of SARS-CoV-2-Infected Pregnant Women.
34359932 2021. Viral MicroRNAs Encoded by Nucleocapsid Gene of SARS-CoV-2 Are Detected during Infection, and Targeting Metabolic Pathways in Host Cells.
33540583 2021. Mechanisms of Coronavirus Nsp1-Mediated Control of Host and Viral Gene Expression.
35011641 2021. The Genomic Physics of COVID-19 Pathogenesis and Spread.
35011584 2021. Role of Human Antigen R (HuR) in the Regulation of Pulmonary ACE2 Expression.
34944012 2021. Identifying Putative Causal Links between MicroRNAs and Severe COVID-19 Using Mendelian Randomization.
34944005 2021. Transcriptomic Profiles Reveal Downregulation of Low-Density Lipoprotein Particle Receptor Pathway Activity in Patients Surviving Severe COVID-19.
34440765 2021. Autophagy and Mitophagy-Related Pathways at the Crossroads of Genetic Pathways Involved in Familial Sarcoidosis and Host-Pathogen Interactions Induced by Coronaviruses.
34571855 2021. Two-Step In Vitro Model to Evaluate the Cellular Immune Response to SARS-CoV-2.
34571838 2021. Transcriptomic Analysis of HCN-2 Cells Suggests Connection among Oxidative Stress, Senescence, and Neuron Death after SARS-CoV-2 Infection.
33917481 2021. Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.
33919784 2021. The Role of Macrophages in the Development of Acute and Chronic Inflammatory Lung Diseases.
33143316 2020. Aprotinin Inhibits SARS-CoV-2 Replication.
33138195 2020. Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19.
33086697 2020. Effects of Coronavirus Persistence on the Genome Structure and Subsequent Gene Expression, Pathogenicity and Adaptation Capability.
32526950 2020. Host Gene Expression of Macrophages in Response to Feline Coronavirus Infection.
32283711 2020. scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia, Leydig and Sertoli Cells.
32872802 2020. Fractional diffusion on the human proteome as an alternative to the multi-organ damage of SARS-CoV-2.
35598647 2022. TRPC6 is altered in COVID-19 pneumonia.
34163728 2021. CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules.
33879756 2021. Single-cell analysis of angiotensin-converting enzyme II expression in human kidneys and bladders reveals a potential route of 2019 novel coronavirus infection.
35430876 2022. Human Coronary Plaque T Cells Are Clonal and Cross-React to Virus and Self.
32967859 2020. The pulmonary pathology of COVID-19.
33428900 2021. CRISPR-based tools: Alternative methods for the diagnosis of COVID-19.
34332518 2021. Could metabolomics drive the fate of COVID-19 pandemic? A narrative review on lights and shadows.
34774827 2022. Serum level of testosterone predicts disease severity of male COVID-19 patients and is related to T-cell immune modulation by transcriptome analysis.
34819170 2021. Epigenetic modifications in thymic epithelial cells: an evolutionary perspective for thymus atrophy.
34034806 2021. Blood DNA methylation and COVID-19 outcomes.
33087172 2020. The epigenetic implication in coronavirus infection and therapy.
32758273 2020. Management of epigenomic networks entailed in coronavirus infections and COVID-19.
33639276 2021. The role of A-to-I RNA editing in infections by RNA viruses: Possible implications for SARS-CoV-2 infection.
34252574 2021. Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19.
32325252 2020. COVID-19 pathophysiology: A review.
32311462 2020. On the molecular determinants of the SARS-CoV-2 attack.
32461193 2020. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases.
33270107 2021. Viral Cultures for Coronavirus Disease 2019 Infectivity Assessment: A Systematic Review.
33596592 2021. Plasma Metabolomic Profiling of Patients Recovered From Coronavirus Disease 2019 (COVID-19) With Pulmonary Sequelae 3 Months After Discharge.
32463434 2021. Metatranscriptomic Characterization of Coronavirus Disease 2019 Identified a Host Transcriptional Classifier Associated With Immune Signaling.
32307550 2020. Downregulated Gene Expression Spectrum and Immune Responses Changed During the Disease Progression in Patients With COVID-19.
32327413 2020. Genetic Roadmap for Kidney Involvement of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
33631334 2021. Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19.
34620315 2021. mNUTRIC tool is capable to predict nutritional needs and mortality early in patients suffering from severe pneumonia.
34330510 2021. Gene signatures of autopsy lungs from obese patients with COVID-19.
34330463 2021. The snapshot of metabolic health in evaluating micronutrient status, the risk of infection and clinical outcome of COVID-19.
33855294 2021. Possible Involvement of Central Nervous System in COVID-19 and Sequence Variability of SARS-CoV-2 Revealed in Autopsy Tissue Samples: A Case Report.
32828489 2020. Epigenetic susceptibility to severe respiratory viral infections and its therapeutic implications: a narrative review.
32628270 2020. Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing.
33125711 2021. Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations.
34915155 2022. SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: Evidence of PAMP-like properties.
34022369 2021. Detection of SARS-CoV-2 genome and whole transcriptome sequencing in frontal cortex of COVID-19 patients.
33892139 2021. Double stranded RNA drives anti-viral innate immune responses, sickness behavior and cognitive dysfunction dependent on dsRNA length, IFNAR1 expression and age.
32497778 2020. A pharmacological interactome between COVID-19 patient samples and human sensory neurons reveals potential drivers of neurogenic pulmonary dysfunction.
34384361 2021. Mass spectrometry-based proteomics in basic and translational research of SARS-CoV-2 coronavirus and its emerging mutants.
33292691 2020. Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies.
35538880 2022. Proteomic profiling of lung diffusion impairment in the recovery stage of SARS-CoV-2-induced ARDS.
34586723 2021. Host transcriptional response to SARS-CoV-2 infection in COVID-19 patients.
34047474 2021. Preliminary analyses of scRNA sequencing and immunohistochemistry of children's lung tissues indicate the expression of SARS-CoV-2 entry-related genes may not be the key reason for the milder syndromes of COVID-19 in children.
33135345 2020. The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID-19.
32799423 2020. Effect of Common Medications on the Expression of SARS-CoV-2 Entry Receptors in Kidney Tissue.
32578831 2020. Human Leukocyte Transcriptional Response to SARS-CoV-2 Infection.
33425046 2021. COV19-CNNet and COV19-ResNet: Diagnostic Inference Engines for Early Detection of COVID-19.
35091696 2022. Epigenomic and transcriptomic analyses reveal differences between low-grade inflammation and severe exhaustion in LPS-challenged murine monocytes.
35022513 2022. SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-kappaB.
35017628 2022. InterCellar enables interactive analysis and exploration of cell-cell communication in single-cell transcriptomic data.
35136165 2022. An extended motif in the SARS-CoV-2 spike modulates binding and release of host coatomer in retrograde trafficking.
34686777 2021. Accurate detection and quantification of SARS-CoV-2 genomic and subgenomic mRNAs by ddPCR and meta-transcriptomics analysis.
34002013 2021. Genome-wide bioinformatic analyses predict key host and viral factors in SARS-CoV-2 pathogenesis.
33674719 2021. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection.
34326461 2021. FIP200 restricts RNA virus infection by facilitating RIG-I activation.
33580175 2021. Immunoreactive peptide maps of SARS-CoV-2.
34465887 2021. Trans-ethnic genome-wide association study of severe COVID-19.
34552685 2021. Infrared light therapy relieves TLR-4 dependent hyper-inflammation of the type induced by COVID-19.
35465056 2022. BNT162b2 vaccination enhances interferon-JAK-STAT-regulated antiviral programs in COVID-19 patients infected with the SARS-CoV-2 Beta variant.
35602196 2021. Reduced subgenomic RNA expression is a molecular indicator of asymptomatic SARS-CoV-2 infection.
35072167 2021. Host methylation predicts SARS-CoV-2 infection and clinical outcome.
33845430 2021. The role of human C5a as a non-genomic target in corticosteroid therapy for management of severe COVID19.
35427985 2022. Subtractive proteomics assisted therapeutic targets mining and designing ensemble vaccine against Candida auris for immune response induction.
35339845 2022. Integration of omics data to generate and analyse COVID-19 specific genome-scale metabolic models.
35114443 2022. Systems pharmacology-based drug discovery and active mechanism of natural products for coronavirus pneumonia (COVID-19): An example using flavonoids.
35605482 2022. Unveiling the nature's fruit basket to computationally identify Citrus sinensis csi-mir169-3p as a probable plant miRNA against Reference and Omicron SARS-CoV-2 genome.
35533462 2022. Network for network concept offers new insights into host- SARS-CoV-2 protein interactions and potential novel targets for developing antiviral drugs.
35533463 2022. Enrichment analysis on regulatory subspaces: A novel direction for the superior description of cellular responses to SARS-CoV-2.
34320442 2021. Decrypting the role of predicted SARS-CoV-2 miRNAs in COVID-19 pathogenesis: A bioinformatics approach.
34478921 2021. Meta-analysis of single-cell RNA-seq data reveals phenotypic switching of immune cells in severe COVID-19 patients.
34655901 2021. Interactome of human and SARS-CoV-2 proteins to identify human hub proteins associated with comorbidities.
34020131 2021. Identification and host response interaction study of SARS-CoV-2 encoded miRNA-like sequences: an in silico approach.
33310371 2021. Recent trends on omics and bioinformatics approaches to study SARS-CoV-2: A bibliometric analysis and mini-review.
33301953 2021. Next-generation computational tools and resources for coronavirus research: From detection to vaccine discovery.
33260034 2021. Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing.
33217661 2021. Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs.
34246161 2021. High-throughput analysis of the interactions between viral proteins and host cell RNAs.
34157472 2021. Multilevel systems biology analysis of lung transcriptomics data identifies key miRNAs and potential miRNA target genes for SARS-CoV-2 infection.
33662681 2021. Network pharmacology and RNA-sequencing reveal the molecular mechanism of Xuebijing injection on COVID-19-induced cardiac dysfunction.
33131530 2020. Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19.
35558576 2022. Identification of Diagnostic Gene Markers and Immune Infiltration in Systemic Lupus.
34603483 2021. Identification of Novel COVID-19 Biomarkers by Multiple Feature Selection Strategies.
33631640 2021. Artificial Intelligence-Based Prediction of Covid-19 Severity on the Results of Protein Profiling.
34777716 2021. Lipidomics and metabolomics signatures of SARS-CoV-2 mediators/receptors in peripheral leukocytes, jejunum and colon.
34109017 2021. The evolving proteome of SARS-CoV-2 predominantly uses mutation combination strategy for survival.
33907612 2021. Comparisons of the immunological landscape between COVID-19, influenza, and respiratory syncytial virus patients by clustering analysis.
33841749 2021. Metabolomics reveals sex-specific metabolic shifts and predicts the duration from positive to negative in non-severe COVID-19 patients during recovery process.
33815688 2021. Nanopore sequencing and its application to the study of microbial communities.
33584997 2021. 3044 Cases reveal important prognosis signatures of COVID-19 patients.
33520118 2021. Meta-analysis of transcriptome datasets: An alternative method to study IL-6 regulation in coronavirus disease 2019.
33425248 2021. Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes.
33312453 2021. Transcriptomic signatures and repurposing drugs for COVID-19 patients: findings of bioinformatics analyses.
33312454 2020. L1000 connectivity map interrogation identifies candidate drugs for repurposing as SARS-CoV-2 antiviral therapies.
33106757 2020. Probing infectious disease by single-cell RNA sequencing: Progresses and perspectives.
34781986 2021. Metabolomic diferences between COVID-19 and H1N1 influenza induced ARDS.
34112226 2021. Comparison of renal histopathology and gene expression profiles between severe COVID-19 and bacterial sepsis in critically ill patients.
33134953 2020. Metabolomics Profiling of Critically Ill Coronavirus Disease 2019 Patients: Identification of Diagnostic and Prognostic Biomarkers.
35584589 2022. Roles of PIKfyve in multiple cellular pathways.
32838054 2021. Subcellular hot spots of GPCR signaling promote vascular inflammation.
34534994 2021. Host genetics of pediatric SARS-CoV-2 COVID-19 and multisystem inflammatory syndrome in children.
33969287 2021. Reduced A-to-I editing of endogenous Alu RNAs in lung after SARS-CoV-2 infection.
34841355 2021. A next generation sequencing (NGS) analysis to reveal genomic and proteomic mutation landscapes of SARS-CoV-2 in South Asia.
34725650 2021. The severity of SARS-CoV-2 infection is dictated by host factors? Epigenetic perspectives.
32142596 2020. Machine Learning, COVID-19 (2019-nCoV), and multi-OMICS.
33394568 2021. Illuminating the immunopathology of SARS-CoV-2.
32864402 2020. Dataset of mutational analysis, miRNAs targeting SARS-CoV-2 genes and host gene expression in SARS-CoV and SARS-CoV-2 infections.
32835036 2020. Quantitative proteomic dataset from oro- and naso-pharyngeal swabs used for COVID-19 diagnosis: Detection of viral proteins and host's biological processes altered by the infection.
32775582 2020. Dataset for homologous proteins in Drosophila melanogaster for SARS-CoV-2/human interactome.
35134150 2022. SCANNER: a web platform for annotation, visualization and sharing of single cell RNA-seq data.
33787872 2021. Drugmonizome and Drugmonizome-ML: integration and abstraction of small molecule attributes for drug enrichment analysis and machine learning.
33009914 2021. A database resource and online analysis tools for coronaviruses on a historical and global scale.
33206959 2020. The IMEx coronavirus interactome: an evolving map of Coronaviridae-host molecular interactions.
35233542 2022. Mass spectrometry and proteome analysis to identify SARS-CoV-2 protein from COVID-19 patient swab samples.
35141569 2022. Transcriptome profiling of PBMCs and formalin-fixed autopsy tissues from COVID-19 patients.
34901888 2022. Detection of N6-methyladenosine in SARS-CoV-2 RNA by methylated RNA immunoprecipitation sequencing.
34877545 2022. Global metabolome profiling of COVID-19 respiratory specimen using high-resolution mass spectrometry (HRMS).
34870243 2022. Protocol for global proteome, virome, and metaproteome profiling of respiratory specimen (VTM) in COVID-19 patient by LC-MS/MS-based analysis.
35611119 2022. An antibody-based proximity labeling protocol to identify biotinylated interactors of SARS-CoV-2.
35582459 2022. Analyzing single cell transcriptome data from severe COVID-19 patients.
35310073 2022. SARS-CoV-2 proteome microarray for COVID-19 patient sera profiling.
34462737 2021. An antigen microarray protocol for COVID-19 serological analysis.
34002169 2021. Sample processing and single cell RNA-sequencing of peripheral blood immune cells from COVID-19 patients.
33907739 2021. Analysis workflow of publicly available RNA-sequencing datasets.
34746856 2021. Computational workflow for functional characterization of COVID-19 through secondary data analysis.
34405154 2021. Luciferase reporter assays to monitor interferon signaling modulation by SARS-CoV-2 proteins.
33377120 2020. Optimized workflow for single-cell transcriptomics on infectious diseases including COVID-19.
33377107 2020. Glycomics-informed glycoproteomic analysis of site-specific glycosylation for SARS-CoV-2 spike protein.
35180397 2022. A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4.
35063125 2022. The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2.
33852884 2021. Human Pluripotent Stem Cell-Derived Intestinal Organoids Model SARS-CoV-2 Infection Revealing a Common Epithelial Inflammatory Response.
33161843 2021. Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection.
34151035 2021. Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19.
33354650 2020. Host-Viral Interactions Revealed among Shared Transcriptomics Signatures of ARDS and Thrombosis: A Clue into COVID-19 Pathogenesis.
35664076 2022. The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events involved in RNA metabolism and immune response.
34335977 2021. Multi-omic profiling of plasma reveals molecular alterations in children with COVID-19.
33391477 2021. Immunopathogenesis and treatment of cytokine storm in COVID-19.
34048985 2021. Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients.
33221483 2021. The role of the lectin pathway of the complement system in SARS-CoV-2 lung injury.
33994605 2021. Mass spectrometry analytical responses to the SARS-CoV2 coronavirus in review.
33309104 2021. Using Genetics To Dissect SARS-CoV-2 Infection.
33451855 2021. Dysregulation of Cell Signaling by SARS-CoV-2.
32595353 2020. Integration of transcriptomic profile of SARS-CoV-2 infected normal human bronchial epithelial cells with metabolic and protein-protein interaction networks.
32851697 2021. Single-cell RNA expression profiling of SARS-CoV-2-related ACE2 and TMPRSS2 in human trophectoderm and placenta.

Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis